{ "version": 1, "site": "https://thisglp.com", "revision": "37a0cd1d68670035b5f284fa34ba17c4a6521c11", "pages": [ { "path": "/", "canonical": "https://thisglp.com/", "title": "This GLP | Which GLP-1 seller actually holds up.", "description": "Independent reviews of GLP-1 telehealth sellers — semaglutide and tirzepatide, compounded and brand. We read what each seller publishes, check it against the trial record, and say what it does not tell you.", "hash": "e8699f79d0ed0bcea0c987b2e4356b3c065f240e05d62acc4ca18df4c04318fe", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/index.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/about", "canonical": "https://thisglp.com/about", "title": "About | This GLP", "description": "This GLP is an independent review site for GLP-1 sellers, published under its own editorial byline and funded by affiliate commission. Here's how it works.", "hash": "e7c10764f49dc5460448d2d450db9fd8c8d1eabb3f2a2e19d612cacc5dc67df4", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/about.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/authors", "canonical": "https://thisglp.com/authors", "title": "Editorial Team | This GLP", "description": "This GLP publishes sourced GLP-1 research and provider comparisons. Learn about the publisher, coverage areas, source standards and corrections.", "hash": "b7c28e17d9e504099c6b1f7db0522b56d77e550cb73a44a968659418c37b3660", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/authors.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/authors/dana-sullivan", "canonical": "https://thisglp.com/authors/dana-sullivan", "title": "Evidence reviewer — This GLP | This GLP", "description": "This GLP coverage of what the trials measured, in whom, at what dose, and for how long. Browse sourced articles and the publisher’s editorial standards.", "hash": "0266446fe2b8982dc139d727e54e12c18032484d5c914817c2362c580c302877", "modified": "2026-09-15", "markdown": "https://thisglp.com/ai/authors/dana-sullivan.md", "schemaTypes": [ "CollectionPage", "Organization", "WebPage", "WebSite" ] }, { "path": "/authors/glenn-torres", "canonical": "https://thisglp.com/authors/glenn-torres", "title": "Standards editor — This GLP | This GLP", "description": "This GLP coverage of the ranking rules, the corrections log, and what this site will not publish. Browse sourced articles and the publisher’s editorial standards.", "hash": "ef4d72a93757fc9118698ffec8c2d932d06b44f9be8870fc6cfb2167a4bc638f", "modified": "2026-09-15", "markdown": "https://thisglp.com/ai/authors/glenn-torres.md", "schemaTypes": [ "CollectionPage", "Organization", "WebPage", "WebSite" ] }, { "path": "/authors/ruth-alvarez", "canonical": "https://thisglp.com/authors/ruth-alvarez", "title": "Outcomes writer — This GLP | This GLP", "description": "This GLP coverage of what the months actually look like — the plateau, the side effects, stopping. Browse sourced articles and the publisher’s editorial standards.", "hash": "1f337ae37d22809a9dec65a0c4dd060a18261825eaf9762062493cc7d6571737", "modified": "2026-09-15", "markdown": "https://thisglp.com/ai/authors/ruth-alvarez.md", "schemaTypes": [ "CollectionPage", "Organization", "WebPage", "WebSite" ] }, { "path": "/best", "canonical": "https://thisglp.com/best", "title": "Buyer's guides | This GLP", "description": "Every This GLP buyer's guide in one place — compounded semaglutide and tirzepatide, oral GLP-1, flat-dose pricing and the cheapest standing monthly rates. Ranked by molecule, by price and by who is asking. Affiliate-disclosed.", "hash": "289bd53f3f55a90aff159b0123de2e45b8e81643e797716fb3d01cb4facec34a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/best.md", "schemaTypes": [ "ItemList", "ListItem", "Organization", "WebPage", "WebSite" ] }, { "path": "/best/compounded-semaglutide", "canonical": "https://thisglp.com/best/compounded-semaglutide", "title": "Best compounded semaglutide sellers | This GLP", "description": "Compounded semaglutide sellers ranked on published pricing, state coverage and catalog breadth | every figure read off the seller's own page.", "hash": "1136ee9433edec3eb49ab3e054de69aad6542eed46ee78637ea40224add448fc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/best/compounded-semaglutide.md", "schemaTypes": [ "Answer", "BreadcrumbList", "FAQPage", "ItemList", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/best/oral-glp1", "canonical": "https://thisglp.com/best/oral-glp1", "title": "Best oral GLP-1 sellers | This GLP", "description": "Sellers offering a GLP-1 tablet rather than a weekly injection | ranked on published oral pricing, state coverage and catalog breadth.", "hash": "c6dc3230a8ab3f1323ef8be33b7ae39d1538c39327fa3c4bf232d94a96078ecd", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/best/oral-glp1.md", "schemaTypes": [ "Answer", "BreadcrumbList", "FAQPage", "ItemList", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/best/price-holds-at-every-dose", "canonical": "https://thisglp.com/best/price-holds-at-every-dose", "title": "GLP-1 sellers whose price holds at every dose | This GLP", "description": "Sellers that charge one figure whatever the dose | read off their own pages, ranked, and set against the sellers that raise the price as you titrate.", "hash": "abb0c7485ac46111e63103de715a95de7e68463e6a63ef6d5a9504deec184407", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/best/price-holds-at-every-dose.md", "schemaTypes": [ "Answer", "BreadcrumbList", "FAQPage", "ItemList", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/code-of-conduct", "canonical": "https://thisglp.com/code-of-conduct", "title": "Code of Conduct | This GLP", "description": "This GLP's editorial code of conduct: no fabrication of data or citations, a strict conflicts-of-interest policy, an accuracy commitment, and an advertiser-influence prohibition on editorial verdicts.", "hash": "7d5fb9de88db58676cce9a590f3a057702cddd8be3261753c0d8cefc7496b978", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/code-of-conduct.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare", "canonical": "https://thisglp.com/compare", "title": "Compare GLP-1 sellers head to head | This GLP", "description": "Direct comparisons of GLP-1 sellers — what each one charges, which formats they ship, and who each is actually the better pick for.", "hash": "49ac7787e8cac88cd4824ee695768e9ef699a9c9598c7c5b6a6b048eccfe81fb", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/compare.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/alan-meds-vs-strut-health", "canonical": "https://thisglp.com/compare/alan-meds-vs-strut-health", "title": "Alan Meds vs Strut Health: which GLP-1 seller is right for you? | This GLP", "description": "A flat rate stated outright against a rate conditional on a standing order.", "hash": "1507b6301dc4e96b5571eee08a347229bde0a1c1f33aa1b0fe2110abae35a083", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/alan-meds-vs-strut-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/alloy-vs-everslim", "canonical": "https://thisglp.com/compare/alloy-vs-everslim", "title": "Alloy vs EverSlim: which GLP-1 seller is right for you? | This GLP", "description": "A required fee on top against a consultation already inside the number.", "hash": "e0813334f4e3e72b1612a288e73e89cbcf1cf528f58a5a7570a2ce38b60d71f5", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/alloy-vs-everslim.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/apex-md-vs-maximus-tribe", "canonical": "https://thisglp.com/compare/apex-md-vs-maximus-tribe", "title": "Apex MD vs Maximus: which GLP-1 seller is right for you? | This GLP", "description": "Additives inside the price against branded and compounded on one page.", "hash": "0fdfc27cd3cf296257ea0fcbdc1250910e9696dc1b77694d3b522dabcd1956d4", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/apex-md-vs-maximus-tribe.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/avara-rx-vs-revel-health", "canonical": "https://thisglp.com/compare/avara-rx-vs-revel-health", "title": "AVARA Rx vs Revel Health: which GLP-1 seller is right for you? | This GLP", "description": "A code-dependent rate against an introductory month.", "hash": "9ad57898c7148a00f02713b8f002c683df14e878d035b91d99cb54f6d269e344", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/avara-rx-vs-revel-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/bayan-health-vs-doctoradam", "canonical": "https://thisglp.com/compare/bayan-health-vs-doctoradam", "title": "Bayan Health vs DoctorAdam: which GLP-1 seller is right for you? | This GLP", "description": "Two sellers where the route does not change the bill.", "hash": "bba3f1511cf541ec4ac99f3ba185874da995961289230af0e26d44f911fdf9ce", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/bayan-health-vs-doctoradam.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/care-bare-rx-vs-everslim", "canonical": "https://thisglp.com/compare/care-bare-rx-vs-everslim", "title": "Care Bare Rx vs EverSlim: which GLP-1 seller is right for you? | This GLP", "description": "A rate that rises with the dose against one with the visit already inside it.", "hash": "b274bed223b6f0cb098f0101c33106366f6dd7683899be7b18bbc9f9bdc59440", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/care-bare-rx-vs-everslim.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/collective-vs-alloy", "canonical": "https://thisglp.com/compare/collective-vs-alloy", "title": "Collective vs Alloy: which GLP-1 seller is right for you? | This GLP", "description": "Two sellers that both bill something beside the medication.", "hash": "82cbfc239ef54cb4699210845174428ce60a9c76ea1b727cb97a346a042dd723", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/collective-vs-alloy.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/embody-vs-avara-rx", "canonical": "https://thisglp.com/compare/embody-vs-avara-rx", "title": "Embody vs AVARA Rx: which GLP-1 seller is right for you? | This GLP", "description": "A promotional rate against a rate that needs a code.", "hash": "9eee4cf5ddd9af7ca00a8baa0427d2b9076c44eb10e095ab760baa51078fd723", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/embody-vs-avara-rx.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/embody-vs-revel-health", "canonical": "https://thisglp.com/compare/embody-vs-revel-health", "title": "Embody vs Revel Health: which GLP-1 seller is right for you? | This GLP", "description": "Two headline figures that expire in different ways.", "hash": "c1717d29f482decb509bc19d5dc7ad930733854b81029638a6325a6dc71777c2", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/embody-vs-revel-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/embody-vs-trimi-health", "canonical": "https://thisglp.com/compare/embody-vs-trimi-health", "title": "Embody vs Trimi Health: which GLP-1 seller is right for you? | This GLP", "description": "A promotional monthly rate against an annual plan billed up front.", "hash": "14f139a93077049739c6a38022ada38977150b1823525d66dfec549aba06d22a", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/embody-vs-trimi-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/enhance-md-vs-everslim", "canonical": "https://thisglp.com/compare/enhance-md-vs-everslim", "title": "Enhance MD vs EverSlim: which GLP-1 seller is right for you? | This GLP", "description": "One bills every four weeks; the other puts the visit inside the price.", "hash": "3ccfbf705e0506324e8fcb4c618bffc7eb16651cc9b56fbd8f4e4564fa639691", "modified": "2026-09-18", "markdown": "https://thisglp.com/ai/compare/enhance-md-vs-everslim.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/enhance-md-vs-harper-meds", "canonical": "https://thisglp.com/compare/enhance-md-vs-harper-meds", "title": "Enhance MD vs Harper Meds: which GLP-1 seller is right for you? | This GLP", "description": "Two sellers on a four-week cycle, twenty-three dollars apart.", "hash": "b501d79a8e15784480bb4140620ee9c1d29df2fde82e118d16402ea501b3fc3c", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/enhance-md-vs-harper-meds.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/everslim-vs-trimi-health", "canonical": "https://thisglp.com/compare/everslim-vs-trimi-health", "title": "EverSlim vs Trimi Health: which GLP-1 seller is right for you? | This GLP", "description": "A visit inside the price against a year paid before the first shipment.", "hash": "5d4f48f429e1ff52bb7444460835563f5b8945cc4560afc7c7a3563d910725e3", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/everslim-vs-trimi-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/fidelity-medical-clinic-vs-pallas-health", "canonical": "https://thisglp.com/compare/fidelity-medical-clinic-vs-pallas-health", "title": "Fidelity Medical Clinic vs Pallas Health: which GLP-1 seller is right for you?", "description": "Four-week dosing against twelve-week billing at the same $216.", "hash": "bc14f5e2a36d1bc60a7d71f4bfcf41c59baf106aa9ecaeaa58a2a4e7069bfe8b", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/fidelity-medical-clinic-vs-pallas-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/harper-meds-vs-pallas-health", "canonical": "https://thisglp.com/compare/harper-meds-vs-pallas-health", "title": "Harper Meds vs Pallas Health: which GLP-1 seller is right for you? | This GLP", "description": "A four-week fill against twelve-week billing, which are two different calendars.", "hash": "4dc07700042d7d2c3901d5b02909b763a987bc99dc6ff26d2817e2b53a01ccc6", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/harper-meds-vs-pallas-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/idgie-health-vs-plushcare", "canonical": "https://thisglp.com/compare/idgie-health-vs-plushcare", "title": "Idgie Health vs PlushCare: which GLP-1 seller is right for you? | This GLP", "description": "A seller that states the off-label position against one whose headline covers only the starting dose.", "hash": "aad623ba354e655e0e6f065bb76d8b001b0165a39da6a8373ab1b66798b053cd", "modified": "2026-09-18", "markdown": "https://thisglp.com/ai/compare/idgie-health-vs-plushcare.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/idgie-health-vs-synergy-rx", "canonical": "https://thisglp.com/compare/idgie-health-vs-synergy-rx", "title": "Idgie Health vs Synergy Rx: which GLP-1 seller is right for you? | This GLP", "description": "Candor about the off-label position against candor about every price.", "hash": "62bef6147693cb80d4af0ed085b739a81340d7f68f15f8720615da06e4b0f052", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/idgie-health-vs-synergy-rx.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/kernx-health-vs-breeze-meds", "canonical": "https://thisglp.com/compare/kernx-health-vs-breeze-meds", "title": "KERNX Health vs Breeze Meds: which GLP-1 seller is right for you? | This GLP", "description": "A flat rate with a one-off consult fee against four rates and no dose statement.", "hash": "b771a5b072d3a3d03b12aabd6aad2855068bab1b6ba0b52c801b425ace23e9bf", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/kernx-health-vs-breeze-meds.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/kernx-health-vs-everslim", "canonical": "https://thisglp.com/compare/kernx-health-vs-everslim", "title": "KERNX Health vs EverSlim: which GLP-1 seller is right for you? | This GLP", "description": "A consultation billed per event against one folded into the monthly price.", "hash": "c1edbf8b5df784f6bc4381dfdaa93a4cc710c0007d30cad6793aaf30e5c15313", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/kernx-health-vs-everslim.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/leanmeds-vs-strut-health", "canonical": "https://thisglp.com/compare/leanmeds-vs-strut-health", "title": "Lean Meds vs Strut Health: which GLP-1 seller is right for you? | This GLP", "description": "A general starting offer against a disclosed standing-order discount.", "hash": "1358381bc3b5478c104b3e6724378aa0304ec1d1180a186d0762dd8f4e116728", "modified": "2026-10-14", "markdown": "https://thisglp.com/ai/compare/leanmeds-vs-strut-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/liberty-vs-apex-md", "canonical": "https://thisglp.com/compare/liberty-vs-apex-md", "title": "Liberty vs Apex MD: which GLP-1 seller is right for you? | This GLP", "description": "Named sourcing against named inclusions, a hundred dollars apart.", "hash": "23176b7daaa152bc885cc122cefc3ef2cdc94e58f317d2be31f81323412b07aa", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/liberty-vs-apex-md.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/liberty-vs-coreage-rx", "canonical": "https://thisglp.com/compare/liberty-vs-coreage-rx", "title": "Liberty vs CoreAge Rx: which GLP-1 seller is right for you? | This GLP", "description": "One names the facility behind the vial; the other does not.", "hash": "d6bf3e8c15f3c1919473513c8429ff5ab42a9eba35f03f190bafec9ed17f2f33", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/liberty-vs-coreage-rx.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/liberty-vs-idgie-health", "canonical": "https://thisglp.com/compare/liberty-vs-idgie-health", "title": "Liberty vs Idgie Health: which GLP-1 seller is right for you? | This GLP", "description": "Two sellers that each volunteer something most of the category does not.", "hash": "817a3f0590f93d0839a6a659aedd00ed2f410b854106a3e1a4d3a7cd938131c8", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/liberty-vs-idgie-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/nextmeds-vs-alloy", "canonical": "https://thisglp.com/compare/nextmeds-vs-alloy", "title": "NextMeds vs Alloy: which GLP-1 seller is right for you? | This GLP", "description": "Two services that charge for the relationship, one inside the price and one outside it.", "hash": "dfc9aa8a38abf2bdc9b4ec61e3a55a42e11b0face8239719f72e6a063ccc428c", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/nextmeds-vs-alloy.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/nextmeds-vs-collective", "canonical": "https://thisglp.com/compare/nextmeds-vs-collective", "title": "NextMeds vs Collective: which GLP-1 seller is right for you? | This GLP", "description": "At one seller the membership is the price; at the other it is billed beside it.", "hash": "215c46aeffa3637a702e5c0170f9240e5d803997ab781269241b5bac16a7a57c", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/nextmeds-vs-collective.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/nova-vs-everslim", "canonical": "https://thisglp.com/compare/nova-vs-everslim", "title": "Nova vs EverSlim: which GLP-1 seller is right for you? | This GLP", "description": "Two states against fifty-one, and two ways of counting the service in.", "hash": "df8c7cd7721fb2338bbdec2fdb73e11fe73b5eb53171ba91d30191a2400ae8f6", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/nova-vs-everslim.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/pallas-health-vs-apex-md", "canonical": "https://thisglp.com/compare/pallas-health-vs-apex-md", "title": "Pallas Health vs Apex MD: which GLP-1 seller is right for you? | This GLP", "description": "Quarterly billing against a price that already contains the additives.", "hash": "46d05f314ba040a5c0651d7c010985bae1211c9405545cc8c1371e515a984d0b", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/pallas-health-vs-apex-md.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/preventivemd-vs-maximus-tribe", "canonical": "https://thisglp.com/compare/preventivemd-vs-maximus-tribe", "title": "PreventiveMD vs Maximus: which GLP-1 seller is right for you? | This GLP", "description": "Three molecules priced against branded and compounded priced side by side.", "hash": "9abc6c1df6735ba48f79e5281ca061e056755fae9844a180c64511a1f48eddac", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/preventivemd-vs-maximus-tribe.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/preventivemd-vs-strut-health", "canonical": "https://thisglp.com/compare/preventivemd-vs-strut-health", "title": "PreventiveMD vs Strut Health: which GLP-1 seller is right for you? | This GLP", "description": "Three molecules against two molecules in two formats.", "hash": "16969b67b80678c9e5628e0cbaaf68ce35bcae5651cf71205ee46e62f1ea2430", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/preventivemd-vs-strut-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/synergy-rx-vs-liberty", "canonical": "https://thisglp.com/compare/synergy-rx-vs-liberty", "title": "Synergy Rx vs Liberty: which GLP-1 seller is right for you? | This GLP", "description": "Four published rates on one side, a named 503B facility on the other.", "hash": "32b2512e3bf4216cdd18882674f74cd993638537f1e73cd34a45bfe8478898f8", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/synergy-rx-vs-liberty.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/trimi-health-vs-harper-meds", "canonical": "https://thisglp.com/compare/trimi-health-vs-harper-meds", "title": "Trimi Health vs Harper Meds: which GLP-1 seller is right for you? | This GLP", "description": "An annual plan against an all-inclusive four-week fill.", "hash": "7e9773cadccb07b41d4642d4fb6e81cad2c5db99de19c21e7ef95a04a60046f6", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/trimi-health-vs-harper-meds.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/trimi-health-vs-leanmeds", "canonical": "https://thisglp.com/compare/trimi-health-vs-leanmeds", "title": "Trimi Health vs Lean Meds: which GLP-1 seller is right for you? | This GLP", "description": "A disclosed annual commitment against an offer that needs a medication-specific quote.", "hash": "8c7a35e5ce6e9aceaa56536f3ad07a1b8f09d3bf1c2a5932b17f8a80c1203baf", "modified": "2026-10-14", "markdown": "https://thisglp.com/ai/compare/trimi-health-vs-leanmeds.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/trimi-health-vs-pallas-health", "canonical": "https://thisglp.com/compare/trimi-health-vs-pallas-health", "title": "Trimi Health vs Pallas Health: which GLP-1 seller is right for you? | This GLP", "description": "A year paid up front against a quarter at a time, at the same rate.", "hash": "ec6abb68682886a7f875ba77eb3131d289677840894a5cf98be40c41f262f777", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/trimi-health-vs-pallas-health.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/wholesome-clinic-vs-enhance-md", "canonical": "https://thisglp.com/compare/wholesome-clinic-vs-enhance-md", "title": "Wholesome Clinic vs Enhance MD: which GLP-1 seller is right for you? | This GLP", "description": "Seven states with the ladder published against thirty-nine on a four-week cycle.", "hash": "1e11b8cbd3d0669a603888317cbe9194f20ee6d9e53c5245eec30f8c6d4716f7", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/compare/wholesome-clinic-vs-enhance-md.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/wholesome-clinic-vs-plushcare", "canonical": "https://thisglp.com/compare/wholesome-clinic-vs-plushcare", "title": "Wholesome Clinic vs PlushCare: which GLP-1 seller is right for you? | This GLP", "description": "Every dose rung published against a price that changes once, after the starting dose.", "hash": "25e50f659404fd866c076f29b5713f576caf226281dc3fb9c26403a2bdc9e2a1", "modified": "2026-09-18", "markdown": "https://thisglp.com/ai/compare/wholesome-clinic-vs-plushcare.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/compare/zera-health-vs-plushcare", "canonical": "https://thisglp.com/compare/zera-health-vs-plushcare", "title": "Zera Health vs PlushCare: which GLP-1 seller is right for you? | This GLP", "description": "A monthly rate behind a first-month offer, against a two-step dose price.", "hash": "c5fa2459b5d77829dd78d62a0865f787648bbdf4a975407dd48e7e64d2d70a2a", "modified": "2026-09-18", "markdown": "https://thisglp.com/ai/compare/zera-health-vs-plushcare.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/contact", "canonical": "https://thisglp.com/contact", "title": "Contact This GLP | This GLP", "description": "How to reach This GLP — corrections, provider and pricing updates, press, and partnership enquiries, each with a direct route.", "hash": "84b56d666fccfe4166393da31dc578c5483455a6e956f4df59a0f2f982f07844", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/contact.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/corrections", "canonical": "https://thisglp.com/corrections", "title": "Corrections Policy | This GLP", "description": "This GLP's corrections policy: how to report an error, how we evaluate it, and how corrections are logged, dated, and disclosed on the affected page.", "hash": "5a92d776863f27319dd6c1e80c266e866190c5420399450fba2531e4a4cfa854", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/corrections.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/disclosures", "canonical": "https://thisglp.com/disclosures", "title": "Disclosures | This GLP", "description": "How This GLP earns revenue, our FTC affiliate disclosure under 16 CFR Part 255, and the firewall between commercial partnerships and editorial verdicts.", "hash": "ab046dc24e9f91b8f10bccf41d9c00cecabbb2e881df1af1ea46f931ee1d1f5c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/disclosures.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/editorial-policy", "canonical": "https://thisglp.com/editorial-policy", "title": "Editorial Policy | This GLP", "description": "How This GLP sources clinical claims, verifies them against primary literature, handles corrections, and keeps editorial calls independent of advertisers.", "hash": "b4f92cba5007922448845a637b025bb88f1ed8446b9c3c5f8dfe3e8a17155d9d", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/editorial-policy.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/medical-disclaimer", "canonical": "https://thisglp.com/medical-disclaimer", "title": "Medical Disclaimer | This GLP", "description": "This GLP is not medical advice. Compounded GLP-1 is not FDA-approved. Read this before making any decision based on content here.", "hash": "d4b9d4c405b43886f2e616e98e66adeb88066656e8dd83fdb01287bae36ef030", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/medical-disclaimer.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/methodology", "canonical": "https://thisglp.com/methodology", "title": "Methodology | This GLP", "description": "Every score on This GLP is computed from a published rubric — evidence, price transparency, real monthly cost, formats, and prescribing process. Scores never move with commission.", "hash": "20593e40ddec49428448ee6e70c4ed26c3fae0dc6d4c5aa62b6c76dfd6d83eb0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/methodology.md", "schemaTypes": [ "Answer", "FAQPage", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/nature-of-reviews", "canonical": "https://thisglp.com/nature-of-reviews", "title": "Nature of Reviews | This GLP", "description": "How This GLP assesses providers and products: the editorial criteria we use, why no provider can pay for a favorable verdict, and how monetized partners are labeled and ordered.", "hash": "79bb2ec8615f5bf1a32f01185da3ca86f7ae7d9819b705fdb91dcedf352f40c3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/nature-of-reviews.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/privacy", "canonical": "https://thisglp.com/privacy", "title": "Privacy Policy | This GLP", "description": "How This GLP collects, uses, and protects your information, including our opt-out analytics, GDPR, and CCPA/CPRA practices.", "hash": "ee73aa2b80aa8ff46446be2681852bf38d73ef398a9900e86778e7ec16a56520", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/privacy.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/research", "canonical": "https://thisglp.com/research", "title": "Research | This GLP", "description": "Evidence reviews of the GLP-1 drugs sold online — semaglutide, tirzepatide and what is coming next. Every claim traced to the trial that produced it.", "hash": "81a6fddf45cb82d06b9911b00d93264e2424cc6d90415bdf1dca6c4bd6a4f2c3", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/research.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/research/a-mortality-gap-in-serious-mental-illness", "canonical": "https://thisglp.com/research/a-mortality-gap-in-serious-mental-illness", "title": "Mortality in Serious Mental Illness: GLP-1 vs SGLT2 Inhibitors | This GLP", "description": "A 764,115-pair emulation found four-year mortality of 4.91% vs 6.45% on GLP-1 drugs against SGLT2 inhibitors in serious mental illness, an absolute gap of 1.54 points.", "hash": "d2679f3ecd0149b0b61367a50bf611dd6fd306aaa7ef8653e24f403139a65977", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/a-mortality-gap-in-serious-mental-illness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/apnea-improved-across-every-subgroup", "canonical": "https://thisglp.com/research/apnea-improved-across-every-subgroup", "title": "Tirzepatide Sleep Apnea Results by Age, BMI and Severity | This GLP", "description": "Post hoc SURMOUNT-OSA analyses: tirzepatide cut apnea events in every subgroup, by 27.7 to 34.1 an hour across ages and by 12.1 to 52.2 across baseline severity.", "hash": "7743bc0a960ccc5884fdcdd48e537966d0ca8be1148c8e774a20834e287675a0", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/apnea-improved-across-every-subgroup.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/are-glp1-drugs-bad-for-your-liver", "canonical": "https://thisglp.com/research/are-glp1-drugs-bad-for-your-liver", "title": "Are GLP-1 Drugs Bad for Your Liver? The Evidence Says Better | This GLP", "description": "A meta-analysis of eleven trials in type 2 diabetes and fatty liver reported ALT and HbA1c effects with separate certainty grades — and declined to rank the drug classes.", "hash": "f31aae57d6b1bf6a9c32d635b5b117f728b6cb7075203f44ab6b8eb74604b9ce", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/are-glp1-drugs-bad-for-your-liver.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/are-glp1-drugs-safe-for-older-adults", "canonical": "https://thisglp.com/research/are-glp1-drugs-safe-for-older-adults", "title": "Are GLP-1 Drugs Safe for Older Adults? Seven Trials, and Who They Left Out", "description": "Are GLP-1 drugs safe for older adults? Seven pooled tirzepatide trials, 17,604 SELECT participants by frailty, and the body composition question nobody measured.", "hash": "febf76688cd77b1a2e4a78e44b9e2700e1b632dd5602e4680a221087aaa08269", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/are-glp1-drugs-safe-for-older-adults.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/are-glp1-drugs-safe-for-teens", "canonical": "https://thisglp.com/research/are-glp1-drugs-safe-for-teens", "title": "Are GLP-1 Drugs Safe for Teens? The Trials, and What Is Outside Them | This GLP", "description": "STEP TEENS randomized 201 adolescents to semaglutide 2.4 mg or placebo: mean BMI fell 16.1% against a 0.6% rise, with 73% versus 18% reaching 5% weight loss.", "hash": "443d9e714bc5a29920269e4d22ae198883d7cab23a6d179eee7bfed028ee9323", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/are-glp1-drugs-safe-for-teens.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/atrial-fibrillation-the-other-drug-won", "canonical": "https://thisglp.com/research/atrial-fibrillation-the-other-drug-won", "title": "Atrial Fibrillation Risk: GLP-1 vs SGLT-2 vs DPP-4 Inhibitors | This GLP", "description": "A network meta-analysis of 2,171,267 patients found GLP-1 drugs no different from DPP-4 inhibitors on atrial fibrillation (RR 0.93), with SGLT-2 inhibitors ahead of both.", "hash": "d2e96e95425d46bb1352f5388da949bbbda0405127e4ce8b409125d6c33c4b2e", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/atrial-fibrillation-the-other-drug-won.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/bariatric-surgery-vs-glp1-cardiovascular", "canonical": "https://thisglp.com/research/bariatric-surgery-vs-glp1-cardiovascular", "title": "Bariatric Surgery vs GLP-1 Drugs on Cardiovascular Events | This GLP", "description": "A network meta-analysis put bariatric surgery at 0.66 for major cardiovascular events against 0.85 for GLP-1 drugs, pooling studies from 2000 to 2024.", "hash": "8656577e192c752413e7b7f25f129f62826b122595515de3c0db5aebff5ff38e", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/bariatric-surgery-vs-glp1-cardiovascular.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/bigger-relative-smaller-absolute", "canonical": "https://thisglp.com/research/bigger-relative-smaller-absolute", "title": "Tirzepatide vs Semaglutide for Heart Failure, With and Without Diabetes | This GLP", "description": "A 217,920-person emulation found tirzepatide ahead of semaglutide on heart failure — relative risk 0.60 without diabetes against 0.82 with, but absolute differences of 0.9% and 1.5%.", "hash": "14a005f16e15dad24a612b671b66bfc29b1c92706806e358307ee643fa3f48dd", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/bigger-relative-smaller-absolute.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-a-drug-prevent-muscle-loss-on-a-glp1", "canonical": "https://thisglp.com/research/can-a-drug-prevent-muscle-loss-on-a-glp1", "title": "Can a Drug Prevent Muscle Loss on a GLP-1? Two Antibodies Tested | This GLP", "description": "No approved drug prevents muscle loss on a GLP-1 | apitegromab kept 1.9 kg of lean mass on tirzepatide, bimagrumab added 1.70 kg, and no trial measured strength.", "hash": "8b5fbab8a061299674dd1919ff6fc95dc11a801744436ede699f221799ac34af", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-a-drug-prevent-muscle-loss-on-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-a-glp1-cause-ketoacidosis", "canonical": "https://thisglp.com/research/can-a-glp1-cause-ketoacidosis", "title": "Can a GLP-1 Cause Ketoacidosis? 470 Reports, Most of Them Hospitalized | This GLP", "description": "Can a GLP-1 cause ketoacidosis? Reporting ratios of 3.15 and 1.22 across 470 cases in people without diabetes, over 70% hospitalized, and why none of it is a rate.", "hash": "1e55dbae981dab8f0e35acc8ce6d058790e27f1d64ff1e4377e8ea14dc4aa645", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-a-glp1-cause-ketoacidosis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-a-glp1-cause-thiamine-deficiency", "canonical": "https://thisglp.com/research/can-a-glp1-cause-thiamine-deficiency", "title": "Can a GLP-1 Cause Thiamine Deficiency? Six Cases Say It Can | This GLP", "description": "A systematic review found six published cases of Wernicke's encephalopathy after semaglutide for obesity | all six preceded by prolonged GI symptoms and rapid weight loss.", "hash": "6feccdaac12dde1be82d3cc0b0e984c5049ab733d439c441dcbe01accfd6d664", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-a-glp1-cause-thiamine-deficiency.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-a-pill-keep-weight-off-after-the-injection", "canonical": "https://thisglp.com/research/can-a-pill-keep-weight-off-after-the-injection", "title": "Can a Pill Keep Weight Off After the Injection? ATTAIN-MAINTAIN, Read Carefully", "description": "In ATTAIN-MAINTAIN, an orforglipron tablet held 74.7% and 79.3% of earlier weight loss against 49.2% and 37.6% on placebo. No arm continued the injectable.", "hash": "5295db66b226d0c9e2283c40431e391960f50d1159907f1d1a3cf9c9a1684c0f", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-a-pill-keep-weight-off-after-the-injection.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-tirzepatide-cause-anxiety", "canonical": "https://thisglp.com/research/can-tirzepatide-cause-anxiety", "title": "Can Tirzepatide Cause Anxiety or Depression? Trials Say No, Records Are Mixed", "description": "Can tirzepatide cause anxiety or depression? In SURMOUNT, 18.2% vs 24.3% on placebo shifted to worse depression scores. Anxiety rose slightly only against semaglutide.", "hash": "693fc0dc1c6613b85e40082e392f80ffa85387c13be50115949aa1f0ee5a17b3", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/can-tirzepatide-cause-anxiety.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-smoke-weed-on-ozempic", "canonical": "https://thisglp.com/research/can-you-smoke-weed-on-ozempic", "title": "Can You Smoke Weed on Ozempic? What Cannabis-User Cohorts Found | This GLP", "description": "Can you smoke weed on Ozempic? No trial has tested it and the label is silent | veterans starting a GLP-1 had 2.25 fewer cannabis use disorder diagnoses per 1,000.", "hash": "3fefb3805b74d6e43c782fa44417defa714a5215d9965d9432a531fc2508c9f2", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/can-you-smoke-weed-on-ozempic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-a-glp1-on-dialysis", "canonical": "https://thisglp.com/research/can-you-take-a-glp1-on-dialysis", "title": "Can You Take a GLP-1 on Dialysis? 2,492 Patients, and No Trial | This GLP", "description": "Can you take a GLP-1 on dialysis? A 388-patient pooled review, a 2,492-pair cohort and the FLOW subgroups | with the baseline imbalance behind the mortality figure.", "hash": "6936a2a7339b0900d34714799f573255f124d7b0e2ef1446a3bfb6f3d4561722", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/can-you-take-a-glp1-on-dialysis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-a-glp1-with-a-heart-pump", "canonical": "https://thisglp.com/research/can-you-take-a-glp1-with-a-heart-pump", "title": "Can You Take a GLP-1 With a Heart Pump? 141 Pairs, and No Effect Sizes | This GLP", "description": "A matched cohort of 141 pairs with left ventricular assist devices reported less driveline infection and lower mortality with prior GLP-1 exposure | but published no effect sizes.", "hash": "ad99348d7873584275300992ebd65c8650c47742613cf1d48b50ca7731af64c4", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-you-take-a-glp1-with-a-heart-pump.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-a-glp1-with-epilepsy", "canonical": "https://thisglp.com/research/can-you-take-a-glp1-with-epilepsy", "title": "Can You Take a GLP-1 With Epilepsy? Seizure Risk Did Not Rise | This GLP", "description": "Can you take a GLP-1 with epilepsy? A 452,766-adult cohort found incident epilepsy at 2.35% against 2.41%, a hazard ratio of 0.84, and no trial in people who already have it.", "hash": "f7a87040be6424f8aebc55e973fb2d8d79edeb1f1eadd77ae46e7f027887562b", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-you-take-a-glp1-with-epilepsy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-a-glp1-with-polycystic-kidney-disease", "canonical": "https://thisglp.com/research/can-you-take-a-glp1-with-polycystic-kidney-disease", "title": "Can You Take a GLP-1 With Polycystic Kidney Disease? Not as a Treatment", "description": "Can you take a GLP-1 with polycystic kidney disease? One 320-pair cohort found no rise in kidney injury | reviews say it is not a treatment for ADPKD.", "hash": "144c09f0673f34ecac209e026e3828985ed90213b4266ca87cbb06566bf490b1", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/can-you-take-a-glp1-with-polycystic-kidney-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-a-glp1-with-sickle-cell-disease", "canonical": "https://thisglp.com/research/can-you-take-a-glp1-with-sickle-cell-disease", "title": "Can You Take a GLP-1 With Sickle Cell Disease? One Cohort, 1,391 Pairs | This GLP", "description": "In 1,391 matched pairs with sickle cell disease and type 2 diabetes, GLP-1 use came with fewer cardiovascular events (HR 0.61) and fewer vaso-occlusive crises (HR 0.64).", "hash": "6a591f1a713c04742771fc71ccd0edb088f28ded2ff8fe8b29ea21812795662c", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/can-you-take-a-glp1-with-sickle-cell-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-ibuprofen-with-ozempic", "canonical": "https://thisglp.com/research/can-you-take-ibuprofen-with-ozempic", "title": "Can You Take Ibuprofen With Ozempic? Check Kidney and Stomach Risks | This GLP", "description": "Ozempic does not list a specific ibuprofen prohibition. Dehydration, kidney disease, and your other medicines can change the answer.", "hash": "9de44d2b6e95c418ccbe4c28328a7bcee899bcae7e8a05ffefc0dc498a004866", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/can-you-take-ibuprofen-with-ozempic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-metformin-and-ozempic-together", "canonical": "https://thisglp.com/research/can-you-take-metformin-and-ozempic-together", "title": "Can You Take Metformin and Ozempic Together? Most Trials Required It | This GLP", "description": "Can you take metformin and Ozempic together? All 1,201 adults in SUSTAIN 7 were on metformin | semaglutide left metformin exposure unchanged in an interaction study.", "hash": "1c33b357a86f74837f65e0adae3c63200f407eca42ed6017abb5984a0d93a517", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/can-you-take-metformin-and-ozempic-together.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-ozempic-while-breastfeeding", "canonical": "https://thisglp.com/research/can-you-take-ozempic-while-breastfeeding", "title": "Can You Take Ozempic While Breastfeeding? 8 Mothers, No Drug Detected in Milk", "description": "Eight mothers on injected semaglutide had no detectable drug in milk | what the Ozempic, Rybelsus and Zepbound labels say, and how small the lactation evidence is.", "hash": "02008650c1042f2b6044d615ecadc7f4944323cc70260e8e9d0f58671fd8751e", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/can-you-take-ozempic-while-breastfeeding.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-ozempic-with-levothyroxine", "canonical": "https://thisglp.com/research/can-you-take-ozempic-with-levothyroxine", "title": "Can You Take Ozempic With Levothyroxine? The Tablet Form Is the One Studied", "description": "Ozempic and levothyroxine: thyroxine exposure rose 33% with oral semaglutide in 45 volunteers | the injection label reports no relevant effect on oral drugs.", "hash": "37360b3417553a425a2090a9cda186d86fe7be1fa5cbcc04773c0fd854f3e109", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/can-you-take-ozempic-with-levothyroxine.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-take-phentermine-with-ozempic", "canonical": "https://thisglp.com/research/can-you-take-phentermine-with-ozempic", "title": "Can You Take Phentermine With Ozempic? No Trial Has Tested It, One Tried Liraglutide", "description": "Can you take phentermine with Ozempic? No trial has tested it, and the label advises against it | added to liraglutide, it gave 1.6% vs 0.1% over 12 weeks.", "hash": "e67d100af5b185371e08c851492785e6333bc891f6531d04ea5ca1c63f92c9b7", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/can-you-take-phentermine-with-ozempic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/can-you-trust-glp1-advice-on-social-media", "canonical": "https://thisglp.com/research/can-you-trust-glp1-advice-on-social-media", "title": "Can You Trust GLP-1 Advice on TikTok? Likes Do Not Track Quality | This GLP", "description": "Can you trust GLP-1 advice on TikTok? Four studies found likes a poor guide to quality | median transparency was 2 of 4, and medical creators scored higher.", "hash": "fba8bdb9664e741d1e1e22a32fdfdfd1dce46a1e10fca5e27ed2b50ed0e58281", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/can-you-trust-glp1-advice-on-social-media.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/dialysis-the-evidence-base-just-grew", "canonical": "https://thisglp.com/research/dialysis-the-evidence-base-just-grew", "title": "GLP-1 Drugs at the Start of Hemodialysis: Hospitalization and Death | This GLP", "description": "A matched cohort of 2,492 pairs starting hemodialysis found GLP-1 use linked to 9% lower hospitalization and 17% lower mortality, against a prior literature of 388 patients.", "hash": "590a9a7c6f94d885410149c9f5ad62254f027d18ff16a2b4f3c66e94bac8c091", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/dialysis-the-evidence-base-just-grew.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-discounting-sellers-disclose-less", "canonical": "https://thisglp.com/research/do-discounting-sellers-disclose-less", "title": "GLP-1 Discounts vs Seller Disclosure: Dose Ladders and State Lists | This GLP", "description": "Do GLP-1 sellers using first-month rates, codes or struck-through prices disclose less? Compared on dose ladders, higher-dose pricing and state lists, the answer runs the other way.", "hash": "79538eb43c7f1155d5284d759277ee35414988f65af8963551062642df0fa1dd", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-discounting-sellers-disclose-less.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-affect-breast-surgery", "canonical": "https://thisglp.com/research/do-glp1-drugs-affect-breast-surgery", "title": "Do GLP-1 Drugs Affect Breast Surgery? Implants Fared Worse, Flaps Did Not", "description": "Do GLP-1 drugs affect breast surgery? Implant failure odds were 1.70, breast reduction complications 2.6% vs 1.3%, and free flaps fared no worse | four studies.", "hash": "c509aeb1e009e44d9457840d238b1c53d4d13510cb135f4a5470410a87b65e3d", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-affect-breast-surgery.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-affect-fertility", "canonical": "https://thisglp.com/research/do-glp1-drugs-affect-fertility", "title": "Do GLP-1 Drugs Affect Fertility? 25 Men, and No Trial Measured Pregnancy", "description": "Do GLP-1 drugs affect fertility? A 25-man randomized trial, a 1,899-man network, a pair-fed rat study and 176 women in PCOS | what each design can support.", "hash": "a217bad822be09c089f9b60137878e33b436e0a4c7c2e2682088bb66c0db6775", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-affect-fertility.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-affect-sex-drive", "canonical": "https://thisglp.com/research/do-glp1-drugs-affect-sex-drive", "title": "Do GLP-1 Drugs Affect Sex Drive? Nobody Has Run That Trial | This GLP", "description": "No randomized trial of semaglutide or tirzepatide reported a sexual function endpoint. Here is the pharmacovigilance signal, the cohort data, and the limits of both.", "hash": "3038c463927b21e5d2338c830a0fa02f9317f48d1605ad70caac9ffe14c0ff34", "modified": "2026-09-17", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-affect-sex-drive.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-affect-spinal-fusion-surgery", "canonical": "https://thisglp.com/research/do-glp1-drugs-affect-spinal-fusion-surgery", "title": "Do GLP-1 Drugs Affect Spinal Fusion Surgery? It Depends on the Operation", "description": "A review of twelve cohorts on GLP-1 drugs and cervical spine fusion found procedure-specific associations running in opposite directions | and overlapping source databases.", "hash": "09cfeb06cfe217f216cc0df30808e32b11435e11d5e52e2cc4aa45f2b667f9d6", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-affect-spinal-fusion-surgery.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-acid-reflux", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-acid-reflux", "title": "Do GLP-1 Drugs Cause Acid Reflux? Three Databases Say More Reports | This GLP", "description": "Do GLP-1 drugs cause acid reflux? Reporting ratios of 2.83, 2.91 and 4.76 across three national databases, gastric ultrasound in 124 fasted patients, and what a reporting ratio cannot tell you.", "hash": "20f34cf7f0d27ee6ea909ed5bfea75089db1b2005173ba8539fc7bf88db5654e", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-acid-reflux.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-arrhythmia", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-arrhythmia", "title": "Do GLP-1 Drugs Cause Arrhythmia? Three Intervals, Two Cross One | This GLP", "description": "Do GLP-1 drugs cause arrhythmia? Ten tirzepatide trials gave an atrial fibrillation odds ratio of 2.20, credible interval 0.81 to 6.75 | and ten reviews disagree.", "hash": "22e214c9692b29900f2854b8571ba50bdf7f7c573c82e49eba89e2e0406b6049", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-arrhythmia.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-aspiration-pneumonia", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia", "title": "Do GLP-1 Drugs Raise the Risk of Aspiration Pneumonia? | This GLP", "description": "Pooled endoscopy data found aspiration in 0.16% of GLP-1 users against 0.12% | after emergency stroke thrombectomy it was 26.8% against 10.3% in 41 users.", "hash": "7ed5635db233fd578dd0ca68411c47fcecbe3456da7733acd05e4e03ece97101", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-aspiration-pneumonia.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-blood-clots", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-blood-clots", "title": "Do GLP-1 Drugs Cause Blood Clots? No Untreated Group Was Ever Followed", "description": "A 701,374-person cohort put venous thromboembolism at HR 0.90 on tirzepatide against other GLP-1 drugs | negative controls and E-values tested how fragile that result is.", "hash": "1f4abe2b48f8e52e315b18347a5b6da5f252d46b454ef87dd7fd5bac490bae02", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-blood-clots.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-depression", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-depression", "title": "Do GLP-1 Drugs Cause Depression or Anxiety? The Trials Say No, the Records Say Yes", "description": "Pooled STEP trial data found PHQ-9 depression scores better on semaglutide than placebo (difference -0.56). A matched cohort reported psychiatric disorders at 2.02 instead.", "hash": "5174f6d98f9ebe479b7217c0d57b012a4f469bdeb88dc9b73b81d8a244eaa164", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-depression.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-gastroparesis", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-gastroparesis", "title": "Do GLP-1 Drugs Cause Gastroparesis? Thirteen Cases, and Two Opposite Findings", "description": "Do GLP-1 drugs cause gastroparesis? Thirteen published cases worldwide, plus two studies finding fewer IBS symptoms and faster bowel recovery after surgery.", "hash": "45a23470a8e2e22353db39614dea3140e9ddee29010d358387d325d7df8e750f", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-gastroparesis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-glaucoma", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-glaucoma", "title": "Do GLP-1 Drugs Cause Glaucoma? Nobody Untreated Was Ever Compared", "description": "A 51,540-person cohort links tirzepatide to less incident open-angle glaucoma than other GLP-1 drugs (HR 0.65, 95% CI 0.44-0.96) | and why a two-drug comparison has limits.", "hash": "6b3de439d43f843b2ca3ed7c134396a0e41c02f3fd3eeb139e86960de6ca2368", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-glaucoma.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-gout", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-gout", "title": "Do GLP-1 Drugs Cause Gout? The Study Everyone Cites Cannot Say | This GLP", "description": "Do GLP-1 drugs cause gout? A 295,907-person comparison, a randomized urate analysis in 2,539 adults, and why an active-comparator design cannot answer it.", "hash": "35dd03a7385e93404dbbce1408d131c947a62165b06f2993c0407e674b091a38", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-gout.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-kidney-cancer", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-kidney-cancer", "title": "Do GLP-1 Drugs Cause Kidney Cancer? Trials Say Probably Not | This GLP", "description": "Do GLP-1 drugs cause kidney cancer? 48 trials found an odds ratio of 1.12 (0.78 to 1.60), and one cohort's 1.38 signal crossed 1 | what four studies show.", "hash": "d48e326dc7ccd8e81891fd21d566e986038c84d1e2c6279956453fb6a25c29ab", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-kidney-cancer.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-kidney-stones", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-kidney-stones", "title": "Do GLP-1 Drugs Cause Kidney Stones? Nobody Has Run That Comparison | This GLP", "description": "No study compares GLP-1 users against untreated people for kidney stones | one 358,203-pair cohort put stones at 21.3 per 1,000 person-years against 14.9 on an SGLT2 inhibitor.", "hash": "65bd086b154029a27c558d7056d669cf94eaaf51816741ee99fb957b8f1df4cf", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-kidney-stones.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-pancreatic-cancer", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-pancreatic-cancer", "title": "Do GLP-1 Drugs Cause Pancreatic Cancer? Six Comparators, Five Answers", "description": "A TriNetX propensity-matched study compared GLP-1 users with six antidiabetic classes on pancreatic cancer | hazard ratios ran 1.08 to 1.39, on 0.04 to 0.15 point risk differences.", "hash": "81df3dd282946c5b4799a07caf5af9982a681ecfc0a7781e051b601031cde25b", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-pancreatic-cancer.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-pancreatitis", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-pancreatitis", "title": "Do GLP-1 Drugs Cause Pancreatitis? Risk and Warning Signs | This GLP", "description": "Do GLP-1 drugs cause pancreatitis? What studies show about overall risk, prior pancreatitis, early symptoms and when to seek prompt medical care.", "hash": "be4aff2b039eef829c7e532e3af100bec547a23bb9a04af4480132af072c2e56", "modified": "2026-10-15", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-pancreatitis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-cause-thyroid-cancer", "canonical": "https://thisglp.com/research/do-glp1-drugs-cause-thyroid-cancer", "title": "Do GLP-1 Drugs Cause Thyroid Cancer? A Bound, Not a Verdict | This GLP", "description": "What a three-country cohort of 437,077 patients found on GLP-1 drugs and thyroid cancer, why the bound matters more than the point estimate, and what it cannot settle.", "hash": "83b60752386667eef143ac4990a186374c5123a16dc02deca77dce17ffa01c7a", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-cause-thyroid-cancer.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-change-your-sense-of-taste", "canonical": "https://thisglp.com/research/do-glp1-drugs-change-your-sense-of-taste", "title": "Do GLP-1 Drugs Change Your Sense of Taste? Scores Fell From 40.63 to 28.61", "description": "Do GLP-1 drugs change your sense of taste? 46 users against 46 matched controls scored 28.61 against 40.63, smell was untouched, and the side-effect pattern runs backwards.", "hash": "2e63871273189f8770b837c12a73ef5bb8bd6d187e69ee1e6abb4a5b08f1ce37", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-change-your-sense-of-taste.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-alzheimers", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-alzheimers", "title": "Do GLP-1 Drugs Help Alzheimer's? The Trials and the Records Disagree | This GLP", "description": "Randomized trials including ELAD found no cognitive benefit from GLP-1 drugs in Alzheimer's. Health-record studies report a hazard ratio of 0.46. Why the two disagree.", "hash": "693bb75b39d8a61ed94e9a32bee7705ed2e22099222fbeec70bedafc8bc3940f", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-alzheimers.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-antipsychotic-weight-gain", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-antipsychotic-weight-gain", "title": "Do GLP-1 Drugs Help Antipsychotic Weight Gain? 9.8% Off, Half Back | This GLP", "description": "Do GLP-1 drugs help antipsychotic weight gain? A 76-week schizophrenia study, a 764,115-pair mortality emulation and a 14,694-person bipolar cohort | what each shows.", "hash": "767cc59c27364785e7ae875c9bfdd81ec0b251cc09bda6a027c2dfa4f3768ef5", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-antipsychotic-weight-gain.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-atrial-fibrillation", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-atrial-fibrillation", "title": "Do GLP-1 Drugs Help Atrial Fibrillation? The Evidence Disagrees With Itself", "description": "Do GLP-1 drugs help atrial fibrillation? Two TriNetX cohorts disagree on recurrence after ablation, and a 2.17-million-patient comparison found no clear benefit.", "hash": "3cbb7119cbdaa2ff2bd4f6cdaed04e32062172df8a9610fedb7e95d0dbf62cc1", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-atrial-fibrillation.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-bipolar-disorder", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-bipolar-disorder", "title": "Do GLP-1 Drugs Help Bipolar Disorder? One Drug Moved, Two Did Not | This GLP", "description": "Do GLP-1 drugs help bipolar disorder? A within-individual cohort of 14,694 people found 21% lower psychiatric hospitalization on semaglutide and nothing on two sibling drugs.", "hash": "41f41f403028ea068df56bf247afe0fda7c2c8931ac43f1e35baf9411a9f200c", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-bipolar-disorder.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-carpal-tunnel-syndrome", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-carpal-tunnel-syndrome", "title": "Do GLP-1 Drugs Help Carpal Tunnel Syndrome? Fewer Diagnoses, Same Surgeries", "description": "A TriNetX cohort put carpal tunnel diagnoses at HR 0.82 on tirzepatide against other GLP-1 drugs, while surgery showed no significant difference | what the gap means.", "hash": "4dbc751e7c070311b61ff4df0950371de247fc8342473611ee559ce35cf6251b", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-carpal-tunnel-syndrome.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-copd", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-copd", "title": "Do GLP-1 Drugs Help COPD? Fewer Flare-Ups, Against One Comparator | This GLP", "description": "Do GLP-1 drugs help COPD? 32,107 matched pairs, 9.89 exacerbations per 100 person-years against 11.49, and the head-to-head comparison that finds almost nothing.", "hash": "7734a2dfa5dc624e851afc4b0ef77bba3c5ac0ab8048321a4d11a19a729eabef", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-copd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-crohns-disease", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-crohns-disease", "title": "Do GLP-1 Drugs Help Crohn's Disease? Hospitalization Halved, Steroids Unchanged", "description": "Do GLP-1 drugs help Crohn's disease? 9,766 matched pairs, hospitalization at 10.0% against 24.7%, steroid use unchanged, and authors who disown their own mortality result.", "hash": "4888f48bfb53e0e11d08403f21ffc644b8ddb7f3851a37be5d18ad499ddbf095", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-crohns-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-heart-failure", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-heart-failure", "title": "Do GLP-1 Drugs Help Heart Failure? Symptom Scores Rose 7.5 Points | This GLP", "description": "Do GLP-1 drugs help heart failure? Pooled trial data and cohorts from 50 to 217,920 patients, with the frailty, sex, and composite-endpoint caveats.", "hash": "f9dac5e6ab0220e91acfe3f5b6f93eadfe7b5d60d019d948ccc3ea675e062cea", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-heart-failure.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-hidradenitis-suppurativa", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-hidradenitis-suppurativa", "title": "Do GLP-1 Drugs Help Hidradenitis Suppurativa? Twenty People, No Control Group", "description": "Do GLP-1 drugs help hidradenitis suppurativa? A 20-patient open-label study, a matched cohort reporting a mortality hazard ratio of 0.24, and what neither design can establish.", "hash": "d3a1c44c577ab903ddba6bdd7e04c07db07f5ce45c72ed9e6cc52476317f6620", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-hidradenitis-suppurativa.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-ibs", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-ibs", "title": "Do GLP-1 Drugs Help IBS? Coded Symptoms Fell by Two to Four Points | This GLP", "description": "Do GLP-1 drugs help IBS? A matched analysis of 6,665 per arm found lower coded rates of diarrhea, constipation, pain and bloating | and why coding may explain all of it.", "hash": "a89bfe807b392e5d6f3493bc1f13dff15f4e85f3d829fd9523561d6f28c01ac8", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-ibs.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-intracranial-hypertension", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-intracranial-hypertension", "title": "Do GLP-1 Drugs Help Intracranial Hypertension? Probably, but Less Than Reported", "description": "Two meta-analyses link GLP-1 use in idiopathic intracranial hypertension to less papilledema (RR 0.38 and 0.25) | one also reports an implausible 80% mortality cut.", "hash": "a970abe5b45c7d986a23f7e2347279bbd5ce0e7ab94898db207f0904a3db8433", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-intracranial-hypertension.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-knee-pain", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-knee-pain", "title": "Do GLP-1 Drugs Help Knee Pain? Yes, and Read the Placebo Arm | This GLP", "description": "STEP 9 measured knee osteoarthritis pain directly: a 41.7-point WOMAC reduction on semaglutide against 27.5 on placebo with diet and activity counseling.", "hash": "0cbbdd093b4bd5d07079eb681b541adbae962324dcb89fe3027624c358b5a163", "modified": "2026-10-26", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-knee-pain.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-migraine", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-migraine", "title": "Do GLP-1 Drugs Help Migraine? Triptan Use Fell 7%, Which Is Not a Treatment", "description": "Do GLP-1 drugs help migraine? A 189,392-person Danish register found triptan dispensing down 7% at twelve months, and an interrupted time series has no control group.", "hash": "08d6d1c88d24f317ddb95408f95072455a396f0b916d3b97cf539f1048a45aca", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-migraine.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-parkinsons-disease", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-parkinsons-disease", "title": "Do GLP-1 Drugs Help Parkinson's Disease? Prevention and Treatment Disagree", "description": "Do GLP-1 drugs help Parkinson's disease? 82 pooled studies and a 712,287-patient network analysis | why the prevention signal and the trial null point opposite ways.", "hash": "ef4b080217d95d030be0674d167432343cf435f2ac709196ca6dbfcc08198bdb", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-parkinsons-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-psoriasis", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-psoriasis", "title": "Do GLP-1 Drugs Help Psoriasis? Clear Skin in 40.6% Against 29.0% | This GLP", "description": "Do GLP-1 drugs help psoriasis? A 274-patient phase 3b trial, a 6,096-person matched cohort, and the hidradenitis evidence | what each design can support.", "hash": "a536a82718e74b4f382a3b9f921f5fbac8664ea3f0989fcfeb6f9008ce5c6430", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-psoriasis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-resistant-hypertension", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-resistant-hypertension", "title": "Do GLP-1 Drugs Help Resistant Hypertension? The Pressure Matched | This GLP", "description": "Do GLP-1 drugs help resistant hypertension? A 4,153-per-arm matched cohort found the same pressure fall as an MRA | and mortality at HR 0.34, which is not credible.", "hash": "34d72190af4f4b40f728107e1533623f4522ef69952a648b197970ac17ddd58b", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-resistant-hypertension.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-rheumatoid-arthritis", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-rheumatoid-arthritis", "title": "Do GLP-1 Drugs Help Rheumatoid Arthritis? The Heart Result, Not the Joints", "description": "Do GLP-1 drugs help rheumatoid arthritis? 1,017 matched pairs, a MACCE hazard ratio of 0.75 driven entirely by heart failure, and no measurement of joint disease.", "hash": "e8edf4b314481207ea43991bab5ae114908a0b3f7e260211991d5a159ea63011", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-rheumatoid-arthritis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-help-ulcerative-colitis", "canonical": "https://thisglp.com/research/do-glp1-drugs-help-ulcerative-colitis", "title": "Do GLP-1 Drugs Help Ulcerative Colitis? Remission Was 66.7% Against 25.3%", "description": "Do GLP-1 drugs help ulcerative colitis? A 300-patient matched cohort, a 9,766-pair Crohn's cohort, and the motility caution | what each can and cannot support.", "hash": "8e6193a68ff3deb4376f224c9b641ba1e987203dea1c8b1c5ef96ecf4c535ee1", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-help-ulcerative-colitis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-improve-blood-vessel-function", "canonical": "https://thisglp.com/research/do-glp1-drugs-improve-blood-vessel-function", "title": "Do GLP-1 Drugs Improve Blood Vessel Function? The Same Number, Two Answers", "description": "Do GLP-1 drugs improve blood vessel function? An identical 0.11 estimate was significant against baseline and not against placebo, while hsCRP fell 37.8% in SELECT.", "hash": "a88f5c4113c6a257b7119f3920fc804b1e259acc98112297d34262a6a279ceb5", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-improve-blood-vessel-function.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-improve-quality-of-life", "canonical": "https://thisglp.com/research/do-glp1-drugs-improve-quality-of-life", "title": "Do GLP-1 Drugs Improve Your Quality of Life? 2.12 Points on the SF-36 | This GLP", "description": "Do GLP-1 drugs improve quality of life? Cochrane found SF-36 physical functioning up 2.12 points | EQ-5D utility rose 0.03, and KCCQ rose 11.0 in the most frail.", "hash": "b7cc966355d9639e5a7c2a3e8a46cfb57bd6b278f1eae001566f194722cb992d", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-improve-quality-of-life.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-make-you-tired", "canonical": "https://thisglp.com/research/do-glp1-drugs-make-you-tired", "title": "Do GLP-1 Drugs Make You Tired? Daytime Sleepiness Improved by 0.20 Points", "description": "Do GLP-1 drugs make you tired? No trial measured fatigue | daytime sleepiness improved 0.20 Epworth points, while ferritin ran 26% to 30% below a comparison group.", "hash": "2ac93422db6ad17141d5198cec5f0b6521dffe007afaeb8c3462dda8484cded9", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-make-you-tired.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-prevent-contrast-kidney-injury", "canonical": "https://thisglp.com/research/do-glp1-drugs-prevent-contrast-kidney-injury", "title": "Do GLP-1 Drugs Prevent Contrast Kidney Injury? 8.7% Against 25.7% | This GLP", "description": "Do GLP-1 drugs prevent contrast-induced kidney injury? In 336 adults having coronary angiography it was 8.7% against 25.7%, odds ratio 0.290 | creatinine did not differ.", "hash": "53e23f82a35e22b7d94ed3ae093cc30b8900a5690c09fe8b98f4f339c4dd96cb", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-prevent-contrast-kidney-injury.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-prevent-diabetic-foot-ulcers", "canonical": "https://thisglp.com/research/do-glp1-drugs-prevent-diabetic-foot-ulcers", "title": "Do GLP-1 Drugs Prevent Diabetic Foot Ulcers? The Database Cannot Say | This GLP", "description": "A FAERS analysis put diabetic foot at 6.38 per 1,000 GLP-1 reports against 11.31 per 1,000 elsewhere, a ratio of 0.56 | a share of reports, not a rate in patients.", "hash": "ea1c8afb0e351f955063a92bf9e46ec7c1d2d52e93e7e9be11970ccce77c0239", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-prevent-diabetic-foot-ulcers.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-prevent-heart-attacks-and-strokes", "canonical": "https://thisglp.com/research/do-glp1-drugs-prevent-heart-attacks-and-strokes", "title": "Do GLP-1 Drugs Prevent Heart Attacks and Strokes? One, Not Both | This GLP", "description": "In 52,971 adults, MACE occurred in 2.9% on tirzepatide against 4.4% on sitagliptin at one year (HR 0.68, NNT 70), with stroke unchanged at HR 0.91.", "hash": "cea884bfbafccad1bddbe68716eb27f9e6ef22b55a24676c1f6bfe91de8e2468", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-prevent-heart-attacks-and-strokes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-prevent-stroke", "canonical": "https://thisglp.com/research/do-glp1-drugs-prevent-stroke", "title": "Do GLP-1 Drugs Prevent Stroke? The Composite Moves, Stroke Alone Is Thin", "description": "SELECT found composite cardiovascular events at 6.5% vs 8.0% (HR 0.80). Stroke measured alone rests on one underpowered trial and a cohort where it did not move.", "hash": "e02ed6c11bcfe89108c62cb091c13aa1ca483fa576e1754de6a74089a9a38dc9", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-prevent-stroke.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-protect-against-dementia", "canonical": "https://thisglp.com/research/do-glp1-drugs-protect-against-dementia", "title": "Do GLP-1 Drugs Protect Against Dementia? A Predictor Moved | This GLP", "description": "A post hoc SELECT analysis found semaglutide reduced increases in a proteomic dementia risk score, odds ratio 0.74 at five years and 0.91 at twenty.", "hash": "6610485e05dcb087022b56d47e8f6a39ca3a8d523fee67ba95ba515bc7e50d3e", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-protect-against-dementia.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-raise-testosterone", "canonical": "https://thisglp.com/research/do-glp1-drugs-raise-testosterone", "title": "Do GLP-1 Drugs Raise Testosterone? Not in the Trials That Measured It | This GLP", "description": "Do GLP-1 drugs raise testosterone? A 23-trial network in 1,899 men, a 25-man randomized head-to-head, and a matched cohort on erectile function.", "hash": "7b3a2fc2a279b1c9e47d949e99645d05f19c093851af6d4204ea1526f072a357", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-raise-testosterone.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-reduce-inflammation", "canonical": "https://thisglp.com/research/do-glp1-drugs-reduce-inflammation", "title": "Do GLP-1 Drugs Reduce Inflammation? hsCRP Fell 37.8% in SELECT | This GLP", "description": "Do GLP-1 drugs reduce inflammation? A prespecified SELECT substudy, a 120-person endothelial trial and a 4,153-pair hypertension cohort | and what each can support.", "hash": "363f148f5c44683411e3299abafdddecbebd84a715dcfe77b93d487cb443c699", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-reduce-inflammation.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-slow-aging", "canonical": "https://thisglp.com/research/do-glp1-drugs-slow-aging", "title": "Do GLP-1 Drugs Slow Aging? Three Clocks Moved, One Mouse Lifespan Did", "description": "Do GLP-1 drugs slow aging? Methylation clocks over 32 weeks, a mouse lifespan trial with a calorie-restricted control, and what the mortality data can support.", "hash": "b44a72c6e17cdb76e7c5b6e2e8858e8a735d491a19057fa4d73a10349cfbc950", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-slow-aging.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-work-in-menopause", "canonical": "https://thisglp.com/research/do-glp1-drugs-work-in-menopause", "title": "Do GLP-1 Drugs Work in Menopause? The Subgroup Nobody Reported | This GLP", "description": "Most participants in the GLP-1 weight trials were women in their forties, and none of the trials analyzed menopausal status. What is known, and what is not.", "hash": "bd61e76c5d9a0f7790d2ccd647f9f19904275461e558b5ed16a02b6351ee0af7", "modified": "2026-10-26", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-work-in-menopause.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-glp1-drugs-work-the-same-in-asian-patients", "canonical": "https://thisglp.com/research/do-glp1-drugs-work-the-same-in-asian-patients", "title": "Do GLP-1 Drugs Work the Same in Asian Patients? The Percentages Match", "description": "Do GLP-1 drugs work the same in Asian patients? Tirzepatide gave 18.16% against 17.92% across Asian and non-Asian trials | in kilograms it was 16.72 against 23.46.", "hash": "a191b5f25eb469ce6c95933d71abf382cef5676a8e7a65f5975992e81f599795", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/do-glp1-drugs-work-the-same-in-asian-patients.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-you-lose-muscle-on-a-glp1", "canonical": "https://thisglp.com/research/do-you-lose-muscle-on-a-glp1", "title": "Do You Lose Muscle on a GLP-1? And What Comes Back Is Fat | This GLP", "description": "A review reports lean mass losses of 6 to 7 kg during incretin therapy and fat-preferential regain averaging 5.6 kg within a year of stopping.", "hash": "1c542b8a8eabeed26472defcd296736a9bcca2122d15c848e30734e18df219eb", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-you-lose-muscle-on-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/do-you-need-vitamins-on-a-glp1", "canonical": "https://thisglp.com/research/do-you-need-vitamins-on-a-glp1", "title": "Do You Need Vitamins on a GLP-1? Over 60% Eat Below the Iron Requirement", "description": "Do you need vitamins on a GLP-1? Deficiency rates across 480,825 adults, the 271-calorie intake drop behind them, and six cases of thiamine deficiency.", "hash": "de69d77b7dbfef6f2e5dd6cb5166b679695140d8ee26f62a6938312084fa524e", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/do-you-need-vitamins-on-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-a-glp1-affect-surgery-outcomes", "canonical": "https://thisglp.com/research/does-a-glp1-affect-surgery-outcomes", "title": "Does a GLP-1 Affect Surgery Outcomes? Four Procedures, Four Different Answers", "description": "Does a GLP-1 affect surgery outcomes? Four studies on knee, shoulder, spinal, and neck surgery, and what each one actually found once you read past the headline.", "hash": "49f79aac75cdd61cdea32308c2b10e92d71af4a72f31c1ec8e6438aa63223004", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/does-a-glp1-affect-surgery-outcomes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-a-glp1-before-pregnancy-raise-preeclampsia-risk", "canonical": "https://thisglp.com/research/does-a-glp1-before-pregnancy-raise-preeclampsia-risk", "title": "Does Taking a GLP-1 Before Pregnancy Raise Preeclampsia Risk? The Studies Split", "description": "Does a GLP-1 before pregnancy raise preeclampsia risk? A JAMA cohort found 46% vs 36% after stopping; another found 19.9% vs 22.8% | the pooled OR was 0.91.", "hash": "2f0a46b44bb25f4b74d434df5cb3664567c457b4f63f4d6c60e4c02e54a74784", "modified": "2026-10-15", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/does-a-glp1-before-pregnancy-raise-preeclampsia-risk.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-orforglipron-work-for-type-2-diabetes", "canonical": "https://thisglp.com/research/does-orforglipron-work-for-type-2-diabetes", "title": "Does Orforglipron Work for Type 2 Diabetes? Three Phase 3 Trials | This GLP", "description": "Orforglipron cut HbA1c 1.23 to 1.91 points in three phase 3 trials | it beat placebo, dapagliflozin and oral semaglutide, with more side effects and discontinuations.", "hash": "c2f680bbe690101d400b5836aa72aa341eac3402a8d5b41c0ecee9659b7de8e0", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/does-orforglipron-work-for-type-2-diabetes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-ozempic-cause-constipation", "canonical": "https://thisglp.com/research/does-ozempic-cause-constipation", "title": "Does Ozempic Cause Constipation? What the Trials Counted, and When It Eases", "description": "Does Ozempic cause constipation? 5.0% on 0.5 mg vs 1.5% on placebo, and 24.2% vs 11.1% at the 2.4 mg dose | mostly mild and early, during dose steps.", "hash": "5cd0e898e657ca84eb5836009f03145854d9109759467a5ac2cd7373af736b8f", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/does-ozempic-cause-constipation.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-ozempic-cause-diarrhea", "canonical": "https://thisglp.com/research/does-ozempic-cause-diarrhea", "title": "Does Ozempic Cause Diarrhea? Rates, Timing, and When to Call | This GLP", "description": "Diarrhea affected about 9 in 100 adults in Ozempic trials. Learn what those figures mean, what to track, and which symptoms need prompt attention.", "hash": "8c657ea5cfe3e72872b965fa72e30907645f4968425fb29b9a6e81e305bb4ac0", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/does-ozempic-cause-diarrhea.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-ozempic-cause-dizziness", "canonical": "https://thisglp.com/research/does-ozempic-cause-dizziness", "title": "Does Ozempic Cause Dizziness? What to Check First | This GLP", "description": "Dizziness is listed in Ozempic prescribing information. Low glucose, fluid loss, and other causes need different responses.", "hash": "50415f27b5412f9fd776e1d0ccc20b73ec48cc228ce41dff2548b1703a1689fa", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/does-ozempic-cause-dizziness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-ozempic-cause-hair-loss", "canonical": "https://thisglp.com/research/does-ozempic-cause-hair-loss", "title": "Does Ozempic Cause Hair Loss? What 1,091,743 Records Show | This GLP", "description": "Pooled across 17 studies, GLP-1 use raised the odds of non-scarring hair loss to 1.40. Telogen effluvium rose to 1.76; autoimmune alopecia areata did not rise at all.", "hash": "01b30d258d6a715e04382cb66c260e85394762704bdb38e47afc73ef4b0861f6", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/does-ozempic-cause-hair-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-ozempic-lower-cholesterol", "canonical": "https://thisglp.com/research/does-ozempic-lower-cholesterol", "title": "Does Ozempic Lower Cholesterol? What the Lipid Results in the Trials Show", "description": "Does Ozempic lower cholesterol? A little: LDL fell 2.5% vs a 1.3% rise on placebo in STEP 1 | triglycerides fell 21.9%, and tirzepatide moved lipids further.", "hash": "15d310e074ebaf32d2483dc256810d2cb8ce4b147d2ad7a9283d3f7155deedbe", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/does-ozempic-lower-cholesterol.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-semaglutide-cause-vision-loss", "canonical": "https://thisglp.com/research/does-semaglutide-cause-vision-loss", "title": "Does Semaglutide Cause Vision Loss? The Signal Sits in Diabetes | This GLP", "description": "Does semaglutide cause vision loss? NAION, retinopathy and glaucoma evidence across 5.9 million people | and why the signal concentrates in diabetes.", "hash": "4aecdd0d6fd06d969b5ceecdd54687f9b0fb677b321a610d482ccc37b192f86f", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/does-semaglutide-cause-vision-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-semaglutide-help-liver-cirrhosis", "canonical": "https://thisglp.com/research/does-semaglutide-help-liver-cirrhosis", "title": "Does Semaglutide Help Liver Cirrhosis? Not in the Trial That Tested It | This GLP", "description": "Does semaglutide help liver cirrhosis? In the cirrhosis trial, fibrosis improved in 11% on the drug vs 29% on placebo | cohort benefits appear earlier.", "hash": "3262a75674a7d723c09973346aa2a2c1802ec7d7e5938e9eedb981c9f5117e61", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/does-semaglutide-help-liver-cirrhosis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-semaglutide-make-diabetic-retinopathy-worse", "canonical": "https://thisglp.com/research/does-semaglutide-make-diabetic-retinopathy-worse", "title": "Does Semaglutide Make Diabetic Retinopathy Worse? In One Trial, Yes | This GLP", "description": "SUSTAIN 6 found more diabetic retinopathy complications on semaglutide than placebo | who the signal applies to, and why a post hoc mechanism does not dismiss it.", "hash": "548a4d9d521839edcfc958e3a8fd89c972a9d76de76e670c473e90063ccd17c9", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/does-semaglutide-make-diabetic-retinopathy-worse.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-semaglutide-reduce-alcohol-use", "canonical": "https://thisglp.com/research/does-semaglutide-reduce-alcohol-use", "title": "Does Semaglutide Reduce Alcohol Use? One Trial Found a 13.7-Point Gap | This GLP", "description": "Does semaglutide reduce alcohol use? Six studies, three of them randomized trials, with the doses and populations each one tested and the outcome one trial missed.", "hash": "52730e7d56a7d314c10430b89dd4c187e390f7e986424ebc92e113fae6302b23", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/does-semaglutide-reduce-alcohol-use.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-starting-weight-change-the-answer", "canonical": "https://thisglp.com/research/does-starting-weight-change-the-answer", "title": "BMI Above 30 and Type 2 Diabetes Drug Response: Weight vs HbA1c | This GLP", "description": "A 2026 study of 1,016 adults found higher baseline BMI predicted more weight loss on SGLT2 or GLP-1 therapy, while HbA1c improvement was comparable.", "hash": "5108969262e2c1e37ec41ebd75ae12a3293771e0f42a9a9771de6758b2d332f4", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/does-starting-weight-change-the-answer.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-the-glp1-pill-work-as-well-as-the-injection", "canonical": "https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection", "title": "Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers | This GLP", "description": "Is there a GLP-1 pill that works? Orforglipron and oral semaglutide compared: what each trial found, what got approved, and the 50 mg dose sellers do not mean.", "hash": "8cc20061776e94cd771f08523a9ce6312970dc99a1801bdcf3c6004d0c620f97", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/does-the-glp1-pill-work-as-well-as-the-injection.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-tirzepatide-cause-skin-sensitivity", "canonical": "https://thisglp.com/research/does-tirzepatide-cause-skin-sensitivity", "title": "Does Tirzepatide Cause Skin Sensitivity? The Allodynia Reports, Counted | This GLP", "description": "Does tirzepatide cause skin sensitivity? Zepbound's trials found dysesthesia in 0.2% to 0.4% against 0.1% on placebo | the rest of the evidence is case reports.", "hash": "516572e6057635a5d4d3b850fcbfda1fd45e1951d8c377a7ab15e85de04db417", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/does-tirzepatide-cause-skin-sensitivity.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-wegovy-increase-heart-rate", "canonical": "https://thisglp.com/research/does-wegovy-increase-heart-rate", "title": "Does Wegovy Increase Heart Rate? Understanding the Numbers | This GLP", "description": "Wegovy injection trials found a small average rise in resting pulse. Larger changes and symptoms still need individual assessment.", "hash": "d86c2540add6f69b479e5edc016ff03bfc0021e8d9741d36fc729115416f5047", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/does-wegovy-increase-heart-rate.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/does-zepbound-cause-headaches", "canonical": "https://thisglp.com/research/does-zepbound-cause-headaches", "title": "Does Zepbound Cause Headaches? Headache Never Made Its Side-Effect Table", "description": "Does Zepbound cause headaches? Headache is missing from its label table of 2,519 treated adults | tirzepatide trials in diabetes found a risk ratio of 1.00.", "hash": "0c7ec7597741ba64095d7fae9f794a8e986ace75db890a599f8e60569642dd32", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/does-zepbound-cause-headaches.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/each-dose-step-took-insulin-away", "canonical": "https://thisglp.com/research/each-dose-step-took-insulin-away", "title": "Semaglutide Dose Escalation and Insulin Reduction in Type 2 Diabetes | This GLP", "description": "In 62 patients, total daily insulin fell 5.6%, 22.2% and 36.9% across semaglutide dose steps while HbA1c dropped from 7.7% to 7.1%.", "hash": "3f37d345b800993744ef6b6036543cdf3b3ba1b192839029a9d114c340cda893", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/each-dose-step-took-insulin-away.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/eight-storefronts-one-application", "canonical": "https://thisglp.com/research/eight-storefronts-one-application", "title": "GLP-1 Storefronts Sharing One Application Build, Matched by Hash | This GLP", "description": "What it means for a comparison when several GLP-1 storefronts run the same compiled build, how it was established, and the rendering defect it also explains.", "hash": "4ac873869e78543636e723c4a8a225e961d0825b33344c09eae31a0447f9ae62", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/eight-storefronts-one-application.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/eight-trials-and-nobody-counted-the-deaths", "canonical": "https://thisglp.com/research/eight-trials-and-nobody-counted-the-deaths", "title": "Weight-Loss Drugs in Hypertension: What the Cochrane Review Lacked | This GLP", "description": "A Cochrane review of long-term weight drugs in hypertension found the semaglutide and tirzepatide trials reported no mortality, cardiovascular or adverse event results.", "hash": "002cd022064991c8315e41e1e1f1b8fecabffdc51d3db2642d0debe4c96dc4c7", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/eight-trials-and-nobody-counted-the-deaths.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/exercise-on-ozempic", "canonical": "https://thisglp.com/research/exercise-on-ozempic", "title": "Exercise on Ozempic: Building Strength Without Ignoring Symptoms | This GLP", "description": "Activity remains useful during semaglutide treatment. The evidence supports a sustainable routine, while injection-day workout rules remain unproven.", "hash": "2d26970438948791684688e1c2cf7c916b0546362e29b81aa883e4e30af4a554", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/exercise-on-ozempic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/fewer-knee-replacements-eight-years-on", "canonical": "https://thisglp.com/research/fewer-knee-replacements-eight-years-on", "title": "GLP-1 Use and Knee Replacement: Absolute Risk at Eight Years | This GLP", "description": "GLP-1 use and knee replacement in osteoarthritis: at eight years, risk was 2.80 percentage points lower after one year of any GLP-1 and 4.71 after three years of semaglutide or tirzepatide.", "hash": "36678052af0483f4001f42fe391f84539e0a621aa9d8aa8c9c478a2cf354621c", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/fewer-knee-replacements-eight-years-on.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/frailty-did-not-change-the-answer", "canonical": "https://thisglp.com/research/frailty-did-not-change-the-answer", "title": "Frailty and Semaglutide's Cardiovascular Benefit in the SELECT Trial | This GLP", "description": "A SELECT secondary analysis found no heterogeneity in semaglutide's cardiovascular benefit by frailty, and frailty category itself improved (OR 2.46, 95% CI 1.80-3.37).", "hash": "769573b9974cdef59de1f3704567802e9f0ff29f06718ca0c181ace61b3324b3", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/frailty-did-not-change-the-answer.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-adolescent-suicidality-comparators", "canonical": "https://thisglp.com/research/glp1-adolescent-suicidality-comparators", "title": "Adolescent Suicidality on GLP-1 Drugs vs Lifestyle Intervention and Metformin", "description": "A cohort of 9,222 matched adolescent pairs found no increased psychiatric risk with incretin drugs, a protective signal against lifestyle intervention, and none against metformin.", "hash": "9244914cb39d28675d2e504bd24f644c605aa94de3197087275a17884126fb0a", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-adolescent-suicidality-comparators.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-advertised-vs-billed-corrections", "canonical": "https://thisglp.com/research/glp1-advertised-vs-billed-corrections", "title": "Advertised vs Billed GLP-1 Prices: Every Correction, by Type | This GLP", "description": "Every corrected GLP-1 seller price, sorted by outcome: restated upward for a fee, a four-week cycle or a prepay rung, withdrawn entirely, or corrected in a field other than the price.", "hash": "4b526b49ee20091b376299ec555f97d42f3a55ff5c6b8cae89499c2680332716", "modified": "2026-10-28", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-advertised-vs-billed-corrections.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-after-bariatric-surgery", "canonical": "https://thisglp.com/research/glp1-after-bariatric-surgery", "title": "Semaglutide vs Liraglutide After Bariatric Surgery: Weight and Lean Mass", "description": "A meta-analysis of eight studies in 557 post-bariatric patients: liraglutide −6.0 kg against placebo, semaglutide ahead by 4.15 points at a year, with lean mass and bone concerns.", "hash": "1f9cc4547ceb7499bfdab01972a8a211f210146c1f1e5455c0725f88361907d2", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/glp1-after-bariatric-surgery.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-after-bariatric-surgery-evidence", "canonical": "https://thisglp.com/research/glp1-after-bariatric-surgery-evidence", "title": "Do GLP-1 Drugs Work After Bariatric Surgery? Two Randomized Trials Say Yes", "description": "Two randomized trials tested GLP-1 drugs after bariatric surgery underdelivered. Semaglutide: -18.0% vs +0.4%. Liraglutide after gastric bypass: -8.8% vs +1.1%.", "hash": "a451b854ab791134db21627063c4781264b7b2c4c24682276b3a451cd5596c6e", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/glp1-after-bariatric-surgery-evidence.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-and-eating-disorders", "canonical": "https://thisglp.com/research/glp1-and-eating-disorders", "title": "GLP-1 and Eating Disorders: What the Evidence Does and Does Not Show | This GLP", "description": "A smaller appetite is not the same as recovery. Learn why eating-disorder history, symptoms, and coordinated care matter before and during treatment.", "hash": "280ba8fbe9261b85047635c3872600e2e8a3c43336cdc5d80eb0988b32dfbf72", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/glp1-and-eating-disorders.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-and-gallbladder-disease", "canonical": "https://thisglp.com/research/glp1-and-gallbladder-disease", "title": "Gallstone Risk on GLP-1 Drugs: Weight-Loss vs Diabetes Trials | This GLP", "description": "A 76-trial meta-analysis found GLP-1 drugs raise gallbladder and biliary disease risk, with a relative risk of 2.29 in weight-loss trials against 1.27 in diabetes trials.", "hash": "2da081c6f9a05134e0711715ba9bbfad98b771a0a3f2ccdc7a6ed2254efef293", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/glp1-and-gallbladder-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-and-pregnancy", "canonical": "https://thisglp.com/research/glp1-and-pregnancy", "title": "Unexpected Pregnancy on a GLP-1: Why Weight Loss Makes It Likelier | This GLP", "description": "What 36 studies show about GLP-1 exposure around conception and in early pregnancy, why the reviews stop short of calling it safe, and the mechanism that makes exposure likelier.", "hash": "5584185e924bd4cdede7d2c45496fc9e86c9173a22012f6332694ce3bc8b2887", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-and-pregnancy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-and-sleep-apnea", "canonical": "https://thisglp.com/research/glp1-and-sleep-apnea", "title": "Tirzepatide Sleep Apnea Trial (SURMOUNT-OSA): AHI Results at 52 Weeks", "description": "SURMOUNT-OSA: tirzepatide cut the apnea–hypopnea index by 20 to 24 events an hour against placebo over 52 weeks, in adults with severe apnea and obesity.", "hash": "48fd3b7af9515c4035beb15fe35e855ab014060870b2908ee70707274a5d57a6", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/glp1-and-sleep-apnea.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-and-suicidal-ideation", "canonical": "https://thisglp.com/research/glp1-and-suicidal-ideation", "title": "Semaglutide and Suicidal Ideation: The Large Matched Cohort Studies | This GLP", "description": "What the large matched cohorts found on GLP-1 drugs and suicidal ideation, why every one of them is observational, and where the systematic review still disagrees.", "hash": "ac2153c483550a24db586d627f45b650c9524a5a69fb00ed28ea6f5a92d831d9", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-and-suicidal-ideation.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-asthma-relative-and-absolute", "canonical": "https://thisglp.com/research/glp1-asthma-relative-and-absolute", "title": "Asthma Exacerbations on GLP-1 Drugs vs Other Weight Medications | This GLP", "description": "A 2026 propensity-matched cohort found asthma exacerbations in 1.7% of GLP-1 patients versus 4.0% on other weight drugs — a risk ratio of 0.438 and a 2.2-point difference.", "hash": "588b4dcd45f2d4596205f62aa257a84997a96849d5ac82a6089e6ef4c11816be", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/glp1-asthma-relative-and-absolute.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-before-surgery", "canonical": "https://thisglp.com/research/glp1-before-surgery", "title": "Residual Stomach Contents on GLP-1 Drugs: A Gastric Ultrasound Study | This GLP", "description": "Gastric ultrasound found increased residual stomach contents in 56% of GLP-1 users versus 19% of non-users after standard fasting, with no benefit from longer drug interruption.", "hash": "fa60cc040107d552159f9512cc90d19a76b1100470e6847179590c518dadb0a8", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/glp1-before-surgery.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-body-composition-smart-scale", "canonical": "https://thisglp.com/research/glp1-body-composition-smart-scale", "title": "Smart Scale Body Composition on GLP-1 Drugs: Fat vs Muscle Lost | This GLP", "description": "Connected-scale data showed a 9.8% median weight reduction on GLP-1 drugs, 7.5% fat and 2.3% muscle, with systolic pressure down 2.5 mm Hg in 148 exposed users.", "hash": "ba7f0fd61794396011293fbd55109ae33e147a7338cf8f210a102c67de756e48", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-body-composition-smart-scale.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-bone-density-vs-fractures", "canonical": "https://thisglp.com/research/glp1-bone-density-vs-fractures", "title": "Bone Mineral Density on GLP-1 Drugs in Type 2 Diabetes: 25 Trials | This GLP", "description": "A 25-trial meta-analysis found GLP-1 agonists raised lumbar spine, hip neck and total hip bone density, while pooled fracture risk was 0.80 (95% CI 0.47 to 1.36).", "hash": "babc4a4da4c0d6e57a426877ae9bac42995818ba5b90014dd9f10eed74877076", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-bone-density-vs-fractures.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-dehydration-symptoms", "canonical": "https://thisglp.com/research/glp1-dehydration-symptoms", "title": "GLP-1 Dehydration Symptoms: What to Watch For | This GLP", "description": "Fluid loss from vomiting or diarrhea can become more than a nuisance. Recognize warning signs and prepare a plan that fits your health history.", "hash": "db65d85a7767b8addea7c83173638831d7bc05be9b648ad33d2ccf014469f05a", "modified": "2026-10-13", "published": "2026-10-13", "markdown": "https://thisglp.com/ai/research/glp1-dehydration-symptoms.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-depression-depends-on-comparator", "canonical": "https://thisglp.com/research/glp1-depression-depends-on-comparator", "title": "Depression Risk on GLP-1 Drugs vs DPP-4 and SGLT2 Inhibitors | This GLP", "description": "A Medicare target trial emulation found a depression hazard ratio of 0.90 for GLP-1 against DPP-4 inhibitors and 1.07 against SGLT2 inhibitors.", "hash": "a42f67c23af40249831dfc030ced12a67ae8cd896b6593e231079e63d8473a45", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-depression-depends-on-comparator.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-dose-errors-in-adverse-reports", "canonical": "https://thisglp.com/research/glp1-dose-errors-in-adverse-reports", "title": "GLP-1 Dosing Errors in FDA Adverse Event Reports | This GLP", "description": "Across 243,114 GLP-1 adverse event records, frequently reported terms included incorrect dose administered and extra dose administered alongside nausea and vomiting.", "hash": "5d5358e4a72285d2a92d3f87bb9bdc3ea2f3d30e3a3baa88e54f6b9d4f09cc07", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-dose-errors-in-adverse-reports.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-four-week-billing-cycles", "canonical": "https://thisglp.com/research/glp1-four-week-billing-cycles", "title": "GLP-1 Sellers Billing Every Four Weeks: Thirteen Charges a Year | This GLP", "description": "How many GLP-1 sellers bill on four-week rather than calendar-month intervals, what the thirteenth charge costs, and why two prices are not comparable without it.", "hash": "d02a0d8518d62ac180956ec66528681c533c66677a581bfa80d312c881ab04e1", "modified": "2026-10-26", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/glp1-four-week-billing-cycles.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-heart-failure-frailty", "canonical": "https://thisglp.com/research/glp1-heart-failure-frailty", "title": "Frailty and Semaglutide in Heart Failure: The STEP-HFpEF Analysis | This GLP", "description": "A prespecified analysis of the STEP-HFpEF trials found semaglutide's weight loss was identical across frailty strata while symptom improvement was not. What that decoupling means.", "hash": "5e6f8eb47c845e3d487c4fcf2bb12e10ca7eaa7b7dec1886be4fc397a5a2d30d", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-heart-failure-frailty.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-in-children-all-eighteen-trials", "canonical": "https://thisglp.com/research/glp1-in-children-all-eighteen-trials", "title": "GLP-1 Drugs in Children and Adolescents: 18 Randomized Trials Pooled | This GLP", "description": "Meta-analysis of 18 GLP-1 trials in 1,402 children and adolescents: body weight down 3.02 kg, BMI down 1.45, and a median treatment duration of 0.51 years.", "hash": "b4661fa8d8af741a71704499bd01662e814ae085fcca8b649c3023aeb0758933", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-in-children-all-eighteen-trials.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-in-pregnancy-what-the-evidence-shows", "canonical": "https://thisglp.com/research/glp1-in-pregnancy-what-the-evidence-shows", "title": "GLP-1 Drugs in Pregnancy: What the Evidence Shows, and What It Cannot | This GLP", "description": "Pooled across 40,000+ exposed pregnancies, congenital malformations were not significantly raised (OR 1.11). Continuing into the first trimester gave a nonlive birth ratio of 1.09.", "hash": "8b8e4ce4f4b6e2e163e8d5e2723f68aab117304c7519c8ca99ca91ed81918754", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/glp1-in-pregnancy-what-the-evidence-shows.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-liver-cancer-absolute-risk", "canonical": "https://thisglp.com/research/glp1-liver-cancer-absolute-risk", "title": "Liver Cancer Risk on GLP-1 Drugs vs Other Diabetes Treatments | This GLP", "description": "A target trial emulation found five-year liver cancer risk 0.37 to 0.52 percentage points lower among GLP-1 initiators than four comparator treatments.", "hash": "9b63ce4156340c334c73731dfa6b82c3ad8be886f5c44f2aefda56be8f1ff400", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-liver-cancer-absolute-risk.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-liver-cancer-signal-dismissed", "canonical": "https://thisglp.com/research/glp1-liver-cancer-signal-dismissed", "title": "GLP-1 Drugs in MASH: Deaths, Ascites and a Small Liver Cancer Signal | This GLP", "description": "A matched cohort of 168,733 adults with MASH found 2.2 fewer deaths per hundred on a GLP-1, and a liver-cancer signal too small to mean anything.", "hash": "b6817ccbf4004539686c7a6efcdb6df3654653830e99bd4bfa24230bb6981c82", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-liver-cancer-signal-dismissed.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-mortality-authors-doubt-their-own", "canonical": "https://thisglp.com/research/glp1-mortality-authors-doubt-their-own", "title": "GLP-1 Drugs and Mortality in Type 2 Diabetes With a BMI Under 27 | This GLP", "description": "In adults with type 2 diabetes and BMI under 27, GLP-1 drugs showed mortality HR 0.61 against DPP-4 inhibitors and 0.89 against SGLT2 inhibitors.", "hash": "e13ac8704f3dbad0ef91c109789c16608c5522b05068b350200749a063c0a742", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-mortality-authors-doubt-their-own.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-mortality-in-hidradenitis", "canonical": "https://thisglp.com/research/glp1-mortality-in-hidradenitis", "title": "Mortality on GLP-1 Drugs in Hidradenitis Suppurativa: A Record Study | This GLP", "description": "A TriNetX cohort reported all-cause mortality at HR 0.24 in GLP-1 users with hidradenitis suppurativa. The size of the effect is the reason to doubt it.", "hash": "f310f31694dba1ce65ab586c41f1213b2675ad768f90af2c10b90f89908a4cc5", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-mortality-in-hidradenitis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-neck-fusion-high-dose", "canonical": "https://thisglp.com/research/glp1-neck-fusion-high-dose", "title": "High-Dose vs Standard-Dose GLP-1 Before Neck Fusion (ACDF) Surgery | This GLP", "description": "A matched study of 921 patients per group found high-dose GLP-1 therapy before neck fusion surgery produced no more complications, readmissions or failed fusions.", "hash": "8dd398b415574ed16a8a24c44a11f4fdf48056e9fe148748468edea2cb3ca6bd", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-neck-fusion-high-dose.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-pcos-insulin-resistance", "canonical": "https://thisglp.com/research/glp1-pcos-insulin-resistance", "title": "Insulin Resistance in PCOS on GLP-1 Drugs: A Four-Trial Meta-Analysis | This GLP", "description": "A meta-analysis of four randomized trials in PCOS found significant falls in waist, BMI and testosterone, and no significant change in HOMA-IR.", "hash": "a2a39923282cb452b094ec2d6e1a47accf1abd9d5506568d450cbe39b09463ca", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-pcos-insulin-resistance.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-prescriptions-to-young-children", "canonical": "https://thisglp.com/research/glp1-prescriptions-to-young-children", "title": "GLP-1 Prescribing to Children Aged 8 to 11: Who Gets Them | This GLP", "description": "Among 3.5 million children aged 8 to 11 with obesity, 0.6% received a GLP-1 prescription, and prescribing skewed toward less socially vulnerable families.", "hash": "82c8ebc198de3205a899548e21ec54d0b93e4368f3591f1ae7b510051be205e8", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-prescriptions-to-young-children.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-price-spread-across-sellers", "canonical": "https://thisglp.com/research/glp1-price-spread-across-sellers", "title": "GLP-1 Price Spread Across Sellers: The Range and the Middle Half | This GLP", "description": "How far apart GLP-1 monthly prices sit across every seller that publishes a figure: the lowest, the highest, the median and the middle-half band, derived when the page renders.", "hash": "cefac59f5522c1d0b57736b41517f09c64c8548088e367c126adabd37b2e25af", "modified": "2026-10-28", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-price-spread-across-sellers.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-psoriasis-comorbidities", "canonical": "https://thisglp.com/research/glp1-psoriasis-comorbidities", "title": "GLP-1 Drugs in Psoriasis: Mortality, Heart Events and Substance Use | This GLP", "description": "A TriNetX cohort of 3,048 matched pairs found GLP-1 use in psoriasis carried a mortality hazard ratio of 0.219 and a cardiac hazard ratio of 0.561 against other obesity drugs.", "hash": "fbf6e6163bb13f9bb0ba62bbc60d5f83305d9d46811589baccd9a45a9733df98", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-psoriasis-comorbidities.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-shoulder-surgery-adjustment", "canonical": "https://thisglp.com/research/glp1-shoulder-surgery-adjustment", "title": "GLP-1 Drugs and Rotator Cuff Repair Complications in Type 2 Diabetes | This GLP", "description": "Among 5,876 rotator cuff repairs, raw odds ratios of 3.85, 2.20 and 1.97 against GLP-1 users all vanished once the comparison was adjusted.", "hash": "d69349e7e9adfbd267bc6d66e1e5e386cfaa131c68696540bf2468b4ddec3f56", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-shoulder-surgery-adjustment.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-smoking-cessation-subgroups", "canonical": "https://thisglp.com/research/glp1-smoking-cessation-subgroups", "title": "Exenatide for Smoking Cessation: Five Subgroups From One Pilot Trial | This GLP", "description": "How a secondary analysis of a pilot trial generated five answers to who a drug works for, why posterior probabilities are not significance, and what that means for any 'works best for' claim.", "hash": "a5c65cef4980251ca4757e45853b7abf2192868ae998164923d00661d223b327", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-smoking-cessation-subgroups.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-two-meta-analyses-same-six-trials", "canonical": "https://thisglp.com/research/glp1-two-meta-analyses-same-six-trials", "title": "Atrial Fibrillation After Ablation on GLP-1 Drugs: An Umbrella Review | This GLP", "description": "An umbrella review of ten GLP-1 and atrial fibrillation meta-analyses found substantial overlap, low confidence throughout, and identical evidence bases giving different answers.", "hash": "50efaa3a739704ee3e3e503bfcc7a330a2a3d65bc51ac523c269a2ff90a25102", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-two-meta-analyses-same-six-trials.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-uptake-after-heart-attack-stroke", "canonical": "https://thisglp.com/research/glp1-uptake-after-heart-attack-stroke", "title": "GLP-1 Prescribing After a Heart Attack or Stroke: Czech Registry Data | This GLP", "description": "Czech registry data on GLP-1 prescribing after heart attack and stroke in type 2 diabetes: about 2 percent uptake, lower MACE in matched users, and a mortality figure that points to healthy-user bias.", "hash": "b712a5129d369b71de6a29aa208917eb189cea4c27de33b4890e4c30c18eb1b9", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-uptake-after-heart-attack-stroke.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-weight-loss-in-ordinary-care", "canonical": "https://thisglp.com/research/glp1-weight-loss-in-ordinary-care", "title": "Real-World GLP-1 Weight Loss: Discontinuation, Dose and the Trial Gap | This GLP", "description": "Real-world GLP-1 weight loss runs below the trial results. The gap comes from 20 to 50 percent stopping in the first year and from lower doses, not from the drug behaving differently.", "hash": "5ee6685e8d25120adfb145dccfedba8a657b10708279d9ae9d115c5f57b31282", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-weight-loss-in-ordinary-care.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/glp1-weight-loss-pooled-average", "canonical": "https://thisglp.com/research/glp1-weight-loss-pooled-average", "title": "GLP-1 Weight Loss Across 32 Trials: The 9.36% Average and Its Spread | This GLP", "description": "A meta-regression of 32 trials and 40,408 participants found 9.36% mean weight reduction with I² of 99.6% — and what actually explained the spread between trials.", "hash": "0f54fa4e8646c53ef2f572d86e286b1b26e527c2c065d38ac63091c1ccfdffec", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/glp1-weight-loss-pooled-average.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-deep-a-published-dose-ladder-goes", "canonical": "https://thisglp.com/research/how-deep-a-published-dose-ladder-goes", "title": "GLP-1 Dose Ladders: How Many Price Rungs Sellers Publish | This GLP", "description": "Among GLP-1 sellers that publish a dose ladder, how many priced rungs each one shows, and why a three-rung table runs out before titration settles.", "hash": "b08338bb9498de2e8066e7ceb5791678c1c46172739f9a55f04509f82440cc0a", "modified": "2026-10-28", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/how-deep-a-published-dose-ladder-goes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-do-you-take-oral-semaglutide", "canonical": "https://thisglp.com/research/how-do-you-take-oral-semaglutide", "title": "How Do You Take Oral Semaglutide? Empty Stomach, and Little Water | This GLP", "description": "A pharmacokinetics review puts oral semaglutide's absolute bioavailability at 0.4% to 1% fasted | and below the limit of quantification in the fed state, which is why the rules exist.", "hash": "2858d4f8109569cd2fca6d0427e0a3f6ad833b2388580c051b4068bcb40f8210", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/how-do-you-take-oral-semaglutide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-long-does-nausea-last-on-a-glp1", "canonical": "https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1", "title": "How Long Does Nausea Last on a GLP-1? Through the Escalation | This GLP", "description": "Semaglutide and tirzepatide both escalate over about twenty weeks. Here are the reported gastrointestinal event and discontinuation rates, and what they mean for a plan.", "hash": "22c172de83d9d327fabb60abc2b86c98a3fa5842fda416cccc7a9c4a132c2c89", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/how-long-does-nausea-last-on-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-long-does-zepbound-stay-in-your-system", "canonical": "https://thisglp.com/research/how-long-does-zepbound-stay-in-your-system", "title": "How Long Does Zepbound Stay in Your System? About a Month | This GLP", "description": "How long Zepbound stays in your system | a 5-6 day half-life, about a month to clear, and what the label says on missed doses, the pill, pregnancy and surgery.", "hash": "6184ef3a29f21ee17e065313516ebbf5690f64f4d66b4dd340dcb06c8bb3cef5", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/how-long-does-zepbound-stay-in-your-system.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-many-heart-attacks-could-semaglutide-prevent", "canonical": "https://thisglp.com/research/how-many-heart-attacks-could-semaglutide-prevent", "title": "How Many Heart Attacks Could Semaglutide Prevent in the US? | This GLP", "description": "US models project semaglutide preventing 496,400 to 1.93 million cardiovascular events over 10 years | every figure is a model output that assumes full treatment.", "hash": "c0de0a798657694e1957bf30ca2466e37067d65dbe0184e83288cf95ecfa4554", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/how-many-heart-attacks-could-semaglutide-prevent.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-many-people-use-compounded-glp1-drugs", "canonical": "https://thisglp.com/research/how-many-people-use-compounded-glp1-drugs", "title": "How Many People Use Compounded GLP-1 Drugs? Records Catch 8.2% | This GLP", "description": "Compounded GLP-1 use was documented in 8.2% of 153,044 primary care patients, against about 23% in surveys | a compounded prescription leaves no structured record.", "hash": "f44254d59e31f85759fdf7d247764f5b68907a28197ee8aca58eb729cf3f5bd5", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/how-many-people-use-compounded-glp1-drugs.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-much-glp1-pricing-is-promotional", "canonical": "https://thisglp.com/research/how-much-glp1-pricing-is-promotional", "title": "Promotional GLP-1 Pricing: First-Month Rates, Codes and Struck Prices | This GLP", "description": "How much published GLP-1 pricing is an offer rather than a standing rate, counted from sellers' own words, and why a struck-through anchor distorts a comparison differently from an intro rate.", "hash": "75855810cdb626c66c4b5186f6a1974069531308cacdc4ceba71c8841ae3f915", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/how-much-glp1-pricing-is-promotional.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-much-less-do-you-eat-on-a-glp1", "canonical": "https://thisglp.com/research/how-much-less-do-you-eat-on-a-glp1", "title": "How Much Less Do You Eat on a GLP-1? About 271 Calories at One Meal | This GLP", "description": "How much less do you eat on a GLP-1? A 209-participant test-meal meta-analysis, a 60-week trial, and what happens to taste | with the limits of a single lunch.", "hash": "f188c46f29990cbab3b5443db7f6e7d36c56735689fac579f387f358495ac577", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/how-much-less-do-you-eat-on-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-old-is-the-price-you-are-reading", "canonical": "https://thisglp.com/research/how-old-is-the-price-you-are-reading", "title": "GLP-1 Price Freshness: How Old Published Seller Prices Are | This GLP", "description": "How many recorded GLP-1 seller prices were read this month, how many are older, and how often a second reading found the price had moved up or down.", "hash": "06f3a58cefb132c656299b5be4f950f00b465ec69970765d9a5af09370a2e136", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/how-old-is-the-price-you-are-reading.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/how-to-avoid-ozempic-face", "canonical": "https://thisglp.com/research/how-to-avoid-ozempic-face", "title": "How Do You Avoid Ozempic Face? No Tested Way to Prevent It | This GLP", "description": "How to avoid Ozempic face: midface volume fell a median 9.0% in 20 GLP-1 users, about 7% per 10 kg lost | no prevention has been tested against the face.", "hash": "a32c2941c803c1136fd182733ea7334d5bbec7c0f325a0fd1d7c689837fcf153", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/how-to-avoid-ozempic-face.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/is-a-glp1-better-than-metformin", "canonical": "https://thisglp.com/research/is-a-glp1-better-than-metformin", "title": "Is a GLP-1 Better Than Metformin? Nobody Has Run That Trial | This GLP", "description": "Is a GLP-1 better than metformin? A 93-trial network puts metformin at OR 0.69 and GLP-1 agonists at 0.87, with overlapping intervals and no head-to-head trial.", "hash": "76607efd4a351e0c4f1a1d0676a08db8409fc9706bfd8e5b6f551cd28daf5bc1", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/is-a-glp1-better-than-metformin.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/is-a-higher-semaglutide-dose-worth-it", "canonical": "https://thisglp.com/research/is-a-higher-semaglutide-dose-worth-it", "title": "Is a Higher Semaglutide Dose Worth It? Three Points, Four Times the Symptom", "description": "What the 7.2 mg semaglutide trial found against the existing dose, what the extra dose cost in side effects, and the one number that does not fit a dose-response story.", "hash": "89069ce58f547c6d2e2103371199295c45acb1a5a77e88e36a765e836bb70089", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/is-a-higher-semaglutide-dose-worth-it.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/is-cagrisema-better-than-semaglutide", "canonical": "https://thisglp.com/research/is-cagrisema-better-than-semaglutide", "title": "Is CagriSema Better Than Semaglutide Alone? By 6.5 Points, Head to Head", "description": "A 331-person randomized trial found cagrilintide-semaglutide cut weight 18.4% against 11.9% for semaglutide alone, with adverse events of 87% vs 84%.", "hash": "695e2502324d081e84026b7ac115728945b1e778d0bde8a3c718cd957f5d2495", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/is-cagrisema-better-than-semaglutide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/is-seller-disclosure-a-trait", "canonical": "https://thisglp.com/research/is-seller-disclosure-a-trait", "title": "GLP-1 Seller Disclosures: Does Publishing One Predict Another? | This GLP", "description": "Testing whether GLP-1 sellers that disclose one thing disclose others, across four disclosures: a state list, higher-dose pricing, a rankable price and a full dose ladder.", "hash": "e277270690998bb2210bece303650a78f4c30c7d3075aed5c7a95f3b3e373637", "modified": "2026-10-28", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/is-seller-disclosure-a-trait.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/is-semaglutide-safe-for-people-with-hiv", "canonical": "https://thisglp.com/research/is-semaglutide-safe-for-people-with-hiv", "title": "Is Semaglutide Safe for People With HIV? Four Studies So Far | This GLP", "description": "Is semaglutide safe for people with HIV? Four studies found no new safety problem | visceral fat fell 30.6% in a trial and depression scores did not worsen.", "hash": "fa840923c9cee33418fc491ada870d6b111ca644e7fa6c4246488801a903ec22", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/is-semaglutide-safe-for-people-with-hiv.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/is-tirzepatide-better-than-dulaglutide", "canonical": "https://thisglp.com/research/is-tirzepatide-better-than-dulaglutide", "title": "Is Tirzepatide Better Than Dulaglutide? One Trial Is 92% of the Answer | This GLP", "description": "A network meta-analysis put tirzepatide 15 mg 2.68 kg ahead of 5 mg at week 16 | one of its four trials contributes 91.8% of the 14,348 participants it pools.", "hash": "ee68b8a57857f0e049e0b29ee5724f61373c77aacdc61a1213ff6319a49b7bbe", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/is-tirzepatide-better-than-dulaglutide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/liver-repair-that-was-not-the-weight", "canonical": "https://thisglp.com/research/liver-repair-that-was-not-the-weight", "title": "Survodutide in MASH: How Much of the Liver Benefit Was Weight Loss | This GLP", "description": "A mediation analysis of a phase 2 MASH trial found 77.4% of survodutide's liver fat effect ran through weight loss, against 36.3% for fibrosis improvement.", "hash": "cd615a83bf45f791b9d8eddfad2a3cd33d34852d530439b933b3bd9c1636bdec", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/liver-repair-that-was-not-the-weight.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/motivation-in-depression-a-secondary-finding", "canonical": "https://thisglp.com/research/motivation-in-depression-a-secondary-finding", "title": "Semaglutide and Effort in Major Depression: A 72-Person Randomized Trial", "description": "A randomized trial in 72 adults with major depressive disorder found semaglutide reduced effort discounting on a reward task (β = -1.737, P = .03), with no change in probability sensitivity.", "hash": "73b140ee00b9edfac86d677fc773bb8c4294ccc12cd539fa13ba5ad5587cb12b", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/motivation-in-depression-a-secondary-finding.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/muscle-loss-on-glp1", "canonical": "https://thisglp.com/research/muscle-loss-on-glp1", "title": "Semaglutide Lean Mass in the SMART Trial: −2.5 kg, Interval Crossing Zero", "description": "A prespecified SMART trial analysis measured lean and fat mass on semaglutide in 101 adults: a −2.5 kg lean-mass change whose interval crosses zero, and why lean mass is not muscle.", "hash": "06f7c76d7eef3e163c404694e121d2fa21f106ec4751e6399912068b5eb64052", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/muscle-loss-on-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/ninety-three-percent-in-thirteen-weeks", "canonical": "https://thisglp.com/research/ninety-three-percent-in-thirteen-weeks", "title": "VK2735 Phase 2 VENTURE Trial: 14.7% Weight Loss in 13 Weeks | This GLP", "description": "In the 13-week VENTURE phase 2 trial, weight fell 9.1% to 14.7% on VK2735 against 1.7% on placebo, and 93% of treated participants lost at least 5% | why a 13-week figure is not a 68-week one.", "hash": "73fbb4051d75eb1b2ea10761ca5d0098786eddabd8ac19edfa1172a47bb3f75c", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/ninety-three-percent-in-thirteen-weeks.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/one-asthma-study-in-a-hundred-and-twenty-three", "canonical": "https://thisglp.com/research/one-asthma-study-in-a-hundred-and-twenty-three", "title": "Respiratory Side Effects of Weight-Loss Drugs: A Review of 123 Studies | This GLP", "description": "A systematic review and meta-analysis of 123 studies found no increase in respiratory adverse events on weight-loss drugs | 122 were in general populations and one in people with asthma.", "hash": "11bd5ebd407b355f98c79932966ebc4834fc81e08572eb5c1f604282131f91b8", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/one-asthma-study-in-a-hundred-and-twenty-three.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/oral-semaglutide-cognitive-impairment", "canonical": "https://thisglp.com/research/oral-semaglutide-cognitive-impairment", "title": "Oral Semaglutide vs DPP-4 Inhibitors and Cognitive Impairment in HFpEF | This GLP", "description": "In 246 elderly HFpEF patients with obesity and type 2 diabetes, 33 new cases of cognitive impairment on oral semaglutide against 73 on DPP-4 inhibitors, a result a larger US study did not reproduce.", "hash": "d5c5cd7d7367ebdffe4475700925bc2d3a8f48a7ce015910b8c8332cfc46186c", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/oral-semaglutide-cognitive-impairment.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/oral-semaglutide-fifty-milligrams", "canonical": "https://thisglp.com/research/oral-semaglutide-fifty-milligrams", "title": "Oral Semaglutide 50 mg in East Asian Adults: 14.3% Weight Loss | This GLP", "description": "What the 50 mg oral semaglutide trial in 201 East Asian adults found (14.3% against 1.3% on placebo), the conditions the headline drops, and why a storefront's 'oral semaglutide' is probably not this.", "hash": "160aaa156c8fe79c7388530e3229b7a01e0b7902f6cedad7f9f71370631ccae5", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/oral-semaglutide-fifty-milligrams.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/oral-semaglutide-what-the-pill-does", "canonical": "https://thisglp.com/research/oral-semaglutide-what-the-pill-does", "title": "Oral Semaglutide 25 mg: OASIS 4 Trial Results at 71 Weeks | This GLP", "description": "OASIS 4 tested oral semaglutide 25 mg for 71 weeks: −13.6% body weight against −2.2% on placebo, with GI adverse events in 74% versus 42%. Compounded oral products are a different thing.", "hash": "b3f09f056fc01505cf8474a0ba067fd51401ea5f6ed5d6c94ab060e6cc8f825f", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/oral-semaglutide-what-the-pill-does.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/overdose-depends-on-the-comparator", "canonical": "https://thisglp.com/research/overdose-depends-on-the-comparator", "title": "GLP-1 Drugs and Overdose Risk: Five Comparators in VA Data | This GLP", "description": "A VA target trial emulation found lower drug overdose risk on GLP-1 drugs against insulin (HR 0.32) and SGLT2 inhibitors, but not against metformin, sulfonylureas or DPP4 inhibitors.", "hash": "489120ade340e8f87a83ee40680d4894ae7681553d91612149f3ee28eaf4734a", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/overdose-depends-on-the-comparator.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/ozempic-teeth", "canonical": "https://thisglp.com/research/ozempic-teeth", "title": "Ozempic Teeth: What Has Actually Been Measured, and What Has Not | This GLP", "description": "Dry mouth is the oral effect most consistently reported with semaglutide, alongside taste change, reflux and caries. No study pools a prevalence, and no trial has counted cavities.", "hash": "4a513f5f3dcf360f6262d82fb746d7201353705fc4d930d2280060f36ca0ba14", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/ozempic-teeth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/preventing-it-is-not-treating-it", "canonical": "https://thisglp.com/research/preventing-it-is-not-treating-it", "title": "Parkinson's Incidence and Motor Symptoms on GLP-1 Drugs: An 82-Study Review", "description": "A systematic review of 82 studies linked GLP-1 use to lower Parkinson's incidence (HR 0.70) in observational data, with no improvement in motor symptoms in randomized trials.", "hash": "bc65913924926e26d30f3b6fb0ded5bb893693f0cc0ad1aa2085feeab8272faa", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/preventing-it-is-not-treating-it.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/rereading-glp1-prices", "canonical": "https://thisglp.com/research/rereading-glp1-prices", "title": "GLP-1 Price Changes Between Two Readings of the Same Sellers | This GLP", "description": "How often published GLP-1 prices change between two readings of the same sellers, which direction they move and by how much, measured on the sellers' own pages.", "hash": "d2f61881c4a5a2cae49f18495223143fe7cdff8d9d7a4682a8772ce1c00c6f3f", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/rereading-glp1-prices.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/retatrutide-transcend-t2d-1", "canonical": "https://thisglp.com/research/retatrutide-transcend-t2d-1", "title": "Retatrutide in Type 2 Diabetes: Why TRANSCEND-T2D-1 Reads Lower Than Phase 2", "description": "TRANSCEND-T2D-1 randomized 537 adults with type 2 diabetes to retatrutide or placebo. HbA1c fell up to 1.94 points against 0.81 on placebo, and weight 15.3% against 2.6%.", "hash": "8c7f644b031af84e73ad574796eeca1e4fe4628d0e503996d2f835864852fac2", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/retatrutide-transcend-t2d-1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/same-benefit-different-route-by-sex", "canonical": "https://thisglp.com/research/same-benefit-different-route-by-sex", "title": "Tirzepatide in HFpEF by Sex: SUMMIT Trial Results in Women and Men | This GLP", "description": "A prespecified SUMMIT analysis found tirzepatide's benefit in obesity-related HFpEF did not differ by sex (HR 0.66 vs 0.61), while weight loss tracked symptom improvement more closely in women.", "hash": "eb6e4912294978e5fb89cf7bf47dd7288ff95416ab4aa8f1427110d0261b2c86", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/same-benefit-different-route-by-sex.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-and-alzheimers", "canonical": "https://thisglp.com/research/semaglutide-and-alzheimers", "title": "Oral Semaglutide in Early Alzheimer's Disease: The evoke and evoke+ Trials", "description": "The evoke and evoke+ trials tested oral semaglutide in 3,808 people with early Alzheimer's disease and found no effect | what that means for the observational evidence that preceded them.", "hash": "97f49965e78b4523a962e827d4fcd775403ee6634a877e1400bdea67ce18f7bf", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-and-alzheimers.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-and-kidney-disease", "canonical": "https://thisglp.com/research/semaglutide-and-kidney-disease", "title": "FLOW Trial: Semaglutide 1.0 mg in Diabetic Chronic Kidney Disease | This GLP", "description": "The FLOW trial randomized 3,533 people with type 2 diabetes and chronic kidney disease to semaglutide 1.0 mg or placebo and found a hazard ratio of 0.76 for major kidney events.", "hash": "07cdce4db262551274a55d8759a7e1f49187617d4f724b2c1fec3c7ac6553d86", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/semaglutide-and-kidney-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-and-liver-disease", "canonical": "https://thisglp.com/research/semaglutide-and-liver-disease", "title": "Semaglutide in MASH: ESSENCE Phase 3 Results at 72 Weeks | This GLP", "description": "The ESSENCE phase 3 interim results for semaglutide in MASH, the 13-trial meta-analysis behind them, and the one randomized cirrhosis result that went the other way.", "hash": "f39b10a1f0da2643b2c48ce118f1edb330a91e333ac27827e623abde269a5720", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-and-liver-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-and-recorded-cognitive-signs", "canonical": "https://thisglp.com/research/semaglutide-and-recorded-cognitive-signs", "title": "Semaglutide and Cognitive Signs in Psychiatric Patients: 13,007 Records | This GLP", "description": "Among 13,007 patients with psychiatric diagnoses, semaglutide was linked to fewer recorded cognitive signs than no treatment but not versus sitagliptin | how a score built from clinical notes works.", "hash": "9b55900176e85f33433bf412f414f00663d325b375c7babc266c2f043d6d07ff", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-and-recorded-cognitive-signs.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-cochrane-review", "canonical": "https://thisglp.com/research/semaglutide-cochrane-review", "title": "Cochrane Review of Semaglutide for Obesity: 18 Trials Graded | This GLP", "description": "Cochrane's 2025 review of semaglutide for adults with obesity: −10.73% body weight against placebo at high certainty, with lower grades for quality of life, mortality and adverse events.", "hash": "ca066887f4283f3685d1dfebcc92c55f05cf353f7569754b139864703c690763", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/semaglutide-cochrane-review.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-fractures-diabetes-only", "canonical": "https://thisglp.com/research/semaglutide-fractures-diabetes-only", "title": "Semaglutide and Fracture Risk: Type 2 Diabetes vs No Diabetes | This GLP", "description": "A target trial emulation found lower fracture risk on semaglutide only in the type 2 diabetes cohort | what a null in the cohort without diabetes means for someone taking it for weight loss.", "hash": "32828fc94b3eeaa74315cefa1861bbadbd0a147ac8970a3cc647374a83c9f9e9", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-fractures-diabetes-only.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-in-type-1-diabetes", "canonical": "https://thisglp.com/research/semaglutide-in-type-1-diabetes", "title": "Does Semaglutide Help Type 1 Diabetes? What Two Small Trials Found | This GLP", "description": "In ADJUST-T1D, semaglutide cut total daily insulin 22.6% in type 1 diabetes. A crossover trial raised time in range 4.8 points without more hypoglycemia.", "hash": "7c667ed82405525bf7ff2c6561ace44636f654d05ab219316e91b81066b0cb9d", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/semaglutide-in-type-1-diabetes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-knee-osteoarthritis-phenotypes", "canonical": "https://thisglp.com/research/semaglutide-knee-osteoarthritis-phenotypes", "title": "Semaglutide in Knee Osteoarthritis: A Six-Month Cohort and Its Phenotypes", "description": "In 88 knee osteoarthritis patients, six months of semaglutide came with 10.88 kg lost and WOMAC down 22.50 points, in a retrospective cohort with no comparison group and exploratory phenotype clusters.", "hash": "b62825a46a6f9317813c98ce5851281a85daf15fe249d7375ed86eca5744aac6", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-knee-osteoarthritis-phenotypes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-lifespan-in-mice", "canonical": "https://thisglp.com/research/semaglutide-lifespan-in-mice", "title": "Semaglutide Lifespan Study in Female Mice: 742 vs 834 Days | This GLP", "description": "A Nature study found late-life semaglutide extended median lifespan in female mice from 742 to 834 days, outperforming a matched 24% calorie restriction on several measures. No human data exists.", "hash": "5d2894a44fcde44d011b1631d8351623f89950737636de4f1c5243a6eeceedf5", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-lifespan-in-mice.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-lifetime-carbon-emissions", "canonical": "https://thisglp.com/research/semaglutide-lifetime-carbon-emissions", "title": "Semaglutide Carbon Footprint: A UK Lifetime Emissions Model | This GLP", "description": "A UK disease model gave semaglutide lower lifetime carbon emissions in two groups and higher in a third (14,700 against 14,444 kg CO2e) because patients lived longer.", "hash": "95d108bdad3053744ed05131dafe9717d26a33245be7bca834b538b4a3d6aec5", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-lifetime-carbon-emissions.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-liver-japanese-subgroup", "canonical": "https://thisglp.com/research/semaglutide-liver-japanese-subgroup", "title": "Semaglutide for MASH in Japanese Patients: The ESSENCE Subgroup | This GLP", "description": "In 116 Japanese ESSENCE participants, steatohepatitis resolved in 63.1% against 36.8% on placebo, while the fibrosis endpoint gave 7.07 points, 95% CI −11.48 to 25.62.", "hash": "5b5af64dbc3db139d63eb0b3ecf09ab0f0e65110ec51dc9e962ed2092be930ef", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-liver-japanese-subgroup.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-muscle-mass-and-grip", "canonical": "https://thisglp.com/research/semaglutide-muscle-mass-and-grip", "title": "Semaglutide and Handgrip Strength: A 12-Month Body Composition Study | This GLP", "description": "Semaglutide and handgrip strength in 83 adults with obesity: 11.0 kg more weight loss and less muscle mass at 12 months, with grip strength preserved in both groups.", "hash": "a5693df257b7bb59c42258879f1921259d376f8253d14e3cfa881fc52c3f50d2", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-muscle-mass-and-grip.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-optic-nerve-by-indication", "canonical": "https://thisglp.com/research/semaglutide-optic-nerve-by-indication", "title": "Semaglutide and NAION: Optic Nerve Risk in Diabetes vs Obesity | This GLP", "description": "Pooling eight cohorts, semaglutide carried a relative effect of 1.93 for NAION, an optic nerve injury, overall and 1.68 (95% CI 0.72 to 3.91) in people with overweight or obesity.", "hash": "361bd1adbaeec8fef18e7a2646566b18fce8be1313aaeb3cf1967d25464bb439", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-optic-nerve-by-indication.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-psychiatric-risk-pooling", "canonical": "https://thisglp.com/research/semaglutide-psychiatric-risk-pooling", "title": "Semaglutide Psychiatric Risk Meta-Analysis: Trials Pooled With Report Counts", "description": "A semaglutide meta-analysis gave pooled risk ratios of 1.25 for depression, 1.22 for anxiety and 1.20 for suicidal ideation, all non-significant, with heterogeneity of 98%, 99% and 92%.", "hash": "f31942da5e50e4c291486a473930f7697a4457aecf9cebc5de1d5a9a83c7bd38", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-psychiatric-risk-pooling.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-reproduction-pair-fed-rats", "canonical": "https://thisglp.com/research/semaglutide-reproduction-pair-fed-rats", "title": "Semaglutide and Reproductive Hormones in Rats: A Pair-Fed Study | This GLP", "description": "Semaglutide in diet-induced obese rats against pair-fed controls: androgens fell on food restriction and less on the drug, while female hormones fell in a treatment-specific way.", "hash": "76787147424aef10b56689edad3169e08063ac84cf530ccaff21a8cd7ede7633", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-reproduction-pair-fed-rats.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-starting-dose", "canonical": "https://thisglp.com/research/semaglutide-starting-dose", "title": "Semaglutide Starting Dose: 0.25 mg, and What Compounding Changes | This GLP", "description": "The starting dose is 0.25 mg weekly for four weeks, escalating every four weeks to 1.7 or 2.4 mg. What compounding changes, and the measurement error that causes harm.", "hash": "23ff24a7619109199d48cd6caed334aa6fd9127a31d2653c4dde42c6a125e5ca", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/semaglutide-starting-dose.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/semaglutide-vs-sleeve-liver-stiffness", "canonical": "https://thisglp.com/research/semaglutide-vs-sleeve-liver-stiffness", "title": "Semaglutide vs Sleeve Gastrectomy: Liver Stiffness Over 72 Weeks | This GLP", "description": "Over 72 weeks, liver stiffness fell 2.8 kPa on semaglutide and 4.9 kPa after sleeve gastrectomy, with no significant difference in relative reduction between them.", "hash": "69cf54fb2a6904fd1b551d09d74c26a215c8dfa0b3ca09a7e52b385573e0378c", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/semaglutide-vs-sleeve-liver-stiffness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/should-you-stop-ozempic-before-a-colonoscopy", "canonical": "https://thisglp.com/research/should-you-stop-ozempic-before-a-colonoscopy", "title": "Should You Stop Ozempic Before a Colonoscopy? What Bowel-Prep Studies Found", "description": "Ozempic and colonoscopy: inadequate bowel prep in 125 of 503 GLP-1 users against 56 of 503 non-users | no study has tested whether stopping first improves the prep.", "hash": "95c93b4ed7f7d6deffc0422e6ca14d2f30545116e98725bfb9645a96eb9bfa1d", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/should-you-stop-ozempic-before-a-colonoscopy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/stopping-glp1-and-weight-regain", "canonical": "https://thisglp.com/research/stopping-glp1-and-weight-regain", "title": "GLP-1 Withdrawal Trials: STEP 1, STEP 4 and SURMOUNT-4 Compared | This GLP", "description": "STEP 1, STEP 4 and SURMOUNT-4 each measured what happens when a GLP-1 drug is withdrawn: the regain figures, the spread behind them, and what they mean for a prepaid plan.", "hash": "18633f28af43479ffd845356eebb0f8bd8fc962decf2af236bf21cf35d954052", "modified": "2026-10-26", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/stopping-glp1-and-weight-regain.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/survodutide-synchronize-1", "canonical": "https://thisglp.com/research/survodutide-synchronize-1", "title": "Survodutide: What SYNCHRONIZE-1 Found, and Why It Reads Weaker Than Phase 2", "description": "SYNCHRONIZE-1 randomized 725 adults to survodutide 3.6 mg, 6.0 mg or placebo. Weight fell 12.2% and 13.0% against 5.4%, with gastrointestinal events at 80.9% and 89.7%.", "hash": "7eea1539c82ed7a20429af96251aeacad60c58179ba684f93448bb5c482ec41f", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/survodutide-synchronize-1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/telehealth-glp1-program-trial", "canonical": "https://thisglp.com/research/telehealth-glp1-program-trial", "title": "Telehealth Semaglutide and Tirzepatide Program: 12.3% at 24 Weeks | This GLP", "description": "A 180-person single-arm study of telemedicine semaglutide and tirzepatide prescribing found 12.3% weight loss at 24 weeks | what the intervention included beyond the prescription.", "hash": "7bd77d7e40a1bae9e9aada714a84bf0fc936159b8f3bcf95a6713e8dcec32e80", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/telehealth-glp1-program-trial.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/the-best-losers-are-the-worst-tolerated", "canonical": "https://thisglp.com/research/the-best-losers-are-the-worst-tolerated", "title": "Obesity Drugs Ranked Across 262 Trials: Weight Lost vs Side-Effect Dropout", "description": "A network meta-analysis of 262 trials ranks tirzepatide at -14.9% and CagriSema at -14.8% against lifestyle alone, and finds four top performers also lead on discontinuation.", "hash": "fe09f6b0dcdc1764c4877b83b3897844e3d8d1770b31e81b3a891655fea83bfc", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/the-best-losers-are-the-worst-tolerated.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/the-bowels-woke-up-sooner", "canonical": "https://thisglp.com/research/the-bowels-woke-up-sooner", "title": "GLP-1 Use and Bowel Function After Lumbar Fusion: 117 Patients | This GLP", "description": "After posterior lumbar fusion, bowel function returned at 1.35 days in GLP-1 users against 1.90 in non-users, with no differences in complications or hospital length of stay.", "hash": "467d05bc2545d6ba2738695b1c5c684553847e2c3c786a80550423933bb3b137", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/the-bowels-woke-up-sooner.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-and-oral-contraception", "canonical": "https://thisglp.com/research/tirzepatide-and-oral-contraception", "title": "Tirzepatide and Oral Contraceptive Levels: 55 to 66% Lower Peaks | This GLP", "description": "Tirzepatide reduced peak oral contraceptive hormone levels by 55 to 66% and total exposure by about 20% | what that difference means for the pill, and where the evidence stops.", "hash": "5c4522347c9a6431efaeba3616ab69717662b4c2fdb828f954cbdfdae55fd1d9", "modified": "2026-09-18", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/tirzepatide-and-oral-contraception.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-dose-mix-in-japan", "canonical": "https://thisglp.com/research/tirzepatide-dose-mix-in-japan", "title": "Tirzepatide Dispensing by Dose in Japan: National Claims Data | This GLP", "description": "National Japanese claims data show tirzepatide strengths of 7.5 mg and above rising from 13.0% to 24.0% of dispensed units between June 2024 and March 2025.", "hash": "e15b0e4cd4951982cd240903975701693a85cfeee1020c8525adc2913023a21e", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/tirzepatide-dose-mix-in-japan.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-fibrosis-worst-group", "canonical": "https://thisglp.com/research/tirzepatide-fibrosis-worst-group", "title": "Switching to Tirzepatide and Liver Fibrosis Scores: 182 Patients | This GLP", "description": "In 182 patients switching to tirzepatide, a liver fibrosis index fell significantly only in the high-risk group, with baseline severity correlated to the size of the change.", "hash": "1fdc09e8cb549a664bdb54d51ea17d1bafd8e639650f6ee8356404369c506242", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/tirzepatide-fibrosis-worst-group.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-heart-failure-composite", "canonical": "https://thisglp.com/research/tirzepatide-heart-failure-composite", "title": "SUMMIT Trial Composite Endpoint: Tirzepatide in HFpEF, Broken Down | This GLP", "description": "The SUMMIT trial of tirzepatide in HFpEF with obesity: how a 38% cut in a composite endpoint splits between worsening heart failure and cardiovascular death.", "hash": "f93b674550d49a04d16a4c333ccf17474b6a15212d174b8fd2d3133445c993f1", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/tirzepatide-heart-failure-composite.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-hfpef-reverse-remodeling", "canonical": "https://thisglp.com/research/tirzepatide-hfpef-reverse-remodeling", "title": "Tirzepatide and Cardiac Remodeling in HFpEF: A 50-Patient Echo Study | This GLP", "description": "A 50-patient cohort found left ventricular mass down 12.4 g and E/e' improved by 1.45 on tirzepatide in obesity-related HFpEF, with no control group and BMI down 5.8 kg/m².", "hash": "32df78cc450b2a81ca18b30f71a404c258ade630bd9e185d3ed9db702ce48b9f", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/tirzepatide-hfpef-reverse-remodeling.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-low-dose-self-selected", "canonical": "https://thisglp.com/research/tirzepatide-low-dose-self-selected", "title": "Tirzepatide 2.5 mg vs 5 mg in Japanese Adults Without Diabetes | This GLP", "description": "In 112 non-diabetic Japanese adults, tirzepatide 2.5 mg produced 15.3% weight loss against 16.1% at 5 mg, with adverse events of 35% against 50%, and no randomization.", "hash": "4788f66d7bc5023cadf03adde75e3aa88db57aeeb5af7d2e50a350a76d6e7f6f", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/tirzepatide-low-dose-self-selected.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-vs-real-clinical-practice", "canonical": "https://thisglp.com/research/tirzepatide-vs-real-clinical-practice", "title": "Tirzepatide Against Real Clinical Practice: What SURPASS-EARLY Found | This GLP", "description": "SURPASS-EARLY randomized 794 adults to tirzepatide or intensified conventional care for two years. HbA1c fell 1.99 points against 1.32, with 60.2% vs 24.0% reaching under 5.7%.", "hash": "a4a6da345d26b2c6ef4202a90c6fb6e181c25acfff96654f47efd65b40a038a9", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/tirzepatide-vs-real-clinical-practice.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-vs-semaglutide-liver", "canonical": "https://thisglp.com/research/tirzepatide-vs-semaglutide-liver", "title": "Tirzepatide vs Semaglutide: Major Adverse Liver Outcomes in Type 2 Diabetes", "description": "A matched study found major adverse liver outcomes at 4.05 against 4.04 per 1,000 person-years for tirzepatide and semaglutide in adults with obesity and type 2 diabetes, hazard ratio 1.04.", "hash": "b7f38cc602f9dfafd28693daf367d595a822ea8ea9196be079e347252297360e", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/tirzepatide-vs-semaglutide-liver.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/tirzepatide-vs-semaglutide-which-works-better", "canonical": "https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better", "title": "Tirzepatide vs Semaglutide: Which Works Better for Weight Loss? | This GLP", "description": "In the randomized SURMOUNT-5 trial, weight fell 20.2% on tirzepatide and 13.7% on semaglutide at 72 weeks | routine-care studies found a three-to-four-point gap.", "hash": "a273184647bc30ceb331ccad99c03a8e046bb44937e4b003ab1e6344a9791632", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/tirzepatide-vs-semaglutide-which-works-better.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/triple-agonist-first-in-human", "canonical": "https://thisglp.com/research/triple-agonist-first-in-human", "title": "UBT251 Triple Agonist: First-in-Human 12-Week Weight Loss Trial | This GLP", "description": "A phase 1 study of the GLP-1/GIP/glucagon agonist UBT251 reported mean losses of 8.96 to 13.48 kg in 12 weeks against a 1.57 kg gain on placebo.", "hash": "ea62e02cb36cdc2a49a53ee39725ff268c720a8fd3919d4eabafd3c7941126d9", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/triple-agonist-first-in-human.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/twenty-two-thirteen-seventeen", "canonical": "https://thisglp.com/research/twenty-two-thirteen-seventeen", "title": "FLOW Trial Cardiovascular Subgroups: Semaglutide's Numbers Needed to Treat", "description": "FLOW cardiovascular subgroup analyses give numbers needed to treat of 22, 13 and 17 over three years to prevent one kidney outcome, with null interaction tests across cardiovascular status.", "hash": "15947a3fa78143a8f6933248ebd04c342343077bb26184bf88efa4b67483a107", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/twenty-two-thirteen-seventeen.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/type-1-diabetes-stopping-semaglutide", "canonical": "https://thisglp.com/research/type-1-diabetes-stopping-semaglutide", "title": "Stopping Semaglutide in Type 1 Diabetes: Time in Range After Withdrawal | This GLP", "description": "After semaglutide stopped, time in range fell a median 3.6 points against a 1.5-point rise on placebo in adults with type 1 diabetes using an insulin pump.", "hash": "a464a774d4cc438ccf7058acfff5cc19515f63f17f87b07400619f1b98c31224", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/type-1-diabetes-stopping-semaglutide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/uric-acid-fell-and-most-of-it-was-weight", "canonical": "https://thisglp.com/research/uric-acid-fell-and-most-of-it-was-weight", "title": "Tirzepatide and Serum Uric Acid: A SURMOUNT-1 Post Hoc Analysis | This GLP", "description": "A SURMOUNT-1 post hoc analysis found serum uric acid fell up to 0.95 mg/dL on tirzepatide against 0.18 on placebo, with 72.7% of the reduction attributed to weight loss.", "hash": "6ec529d3cc6458c99f790c6227308a9f641f0564968d2739d5f88eddf2cf5457", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/uric-acid-fell-and-most-of-it-was-weight.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-bmi-do-you-need-for-a-glp1", "canonical": "https://thisglp.com/research/what-bmi-do-you-need-for-a-glp1", "title": "What BMI Do You Need for a GLP-1? The Cut-Off Is a Convention | This GLP", "description": "What BMI do you need for a GLP-1? STEP 12 enrolled at 24 to 30 and found 12.1% against 2.2%, while only 10.6% of hospitalized adults over BMI 30 were coded for obesity at all.", "hash": "83b2707a5da9590608f4e0a84a3f90401e56aeda97a60a63cb60d473255355a8", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/what-bmi-do-you-need-for-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-else-comes-back-when-you-stop-a-glp1", "canonical": "https://thisglp.com/research/what-else-comes-back-when-you-stop-a-glp1", "title": "What Else Comes Back When You Stop a GLP-1? Almost Everything | This GLP", "description": "What a meta-analysis of eighteen discontinuation trials found returning after GLP-1 treatment stopped, how it differed by drug, and why its heterogeneity limits every figure in it.", "hash": "c1c67c3b0f2f31e47eafc4752c4e433af0f5287bf1956a61f340517f758463d1", "modified": "2026-09-17", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/what-else-comes-back-when-you-stop-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-glp1-sellers-do-not-publish", "canonical": "https://thisglp.com/research/what-glp1-sellers-do-not-publish", "title": "GLP-1 Seller Disclosure Gaps: Dose Pricing, State Coverage, Formats | This GLP", "description": "How many GLP-1 sellers leave dose pricing, state coverage and catalog breadth unpublished, counted across several hundred sellers, and three questions to ask one before ordering.", "hash": "fbd9fc57f5dc7344ea942e2462f35e438c788ceff35e712f113a971417ba61be", "modified": "2026-10-28", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/what-glp1-sellers-do-not-publish.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-happens-when-you-stop-drinking-on-it", "canonical": "https://thisglp.com/research/what-happens-when-you-stop-drinking-on-it", "title": "Alcohol Admissions After Stopping a GLP-1: Swedish Within-Person Data | This GLP", "description": "A Swedish within-individual study of 167,026 people found alcohol-related hospital admissions fell on GLP-1 drugs (RR 0.55), and the benefit faded within a year of stopping.", "hash": "7c100ff394b533900f7e131c1ca35a8031f5baa1859349131f3fd15243f5ae76", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/what-happens-when-you-stop-drinking-on-it.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-happens-when-you-stop-tirzepatide", "canonical": "https://thisglp.com/research/what-happens-when-you-stop-tirzepatide", "title": "What Happens When You Stop Tirzepatide? SURMOUNT-4 Says 14% Comes Back", "description": "In SURMOUNT-4, people who stopped tirzepatide regained 14.0% over a year while those who continued lost a further 5.5%. What returned depended on how much weight came back.", "hash": "effc1a2bd2bbdd0c88cdf530f7bfa8815853ef1645ba1f93581298f1e6102b9e", "modified": "2026-10-26", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/what-happens-when-you-stop-tirzepatide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-is-ecnoglutide", "canonical": "https://thisglp.com/research/what-is-ecnoglutide", "title": "What Is Ecnoglutide? A Phase 3 Result You Cannot Compare to the Others | This GLP", "description": "A phase 3 trial of ecnoglutide in 664 Chinese adults found 13.2% weight loss at week 40 against 0.1% on placebo | and entry criteria well below Western obesity trials.", "hash": "000c3e400e30b5a90cd0d1a454b0e53c12e5171c8878b982843424e324216da0", "modified": "2026-09-17", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/what-is-ecnoglutide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-is-orforglipron", "canonical": "https://thisglp.com/research/what-is-orforglipron", "title": "What Is Orforglipron? A Daily GLP-1 Tablet That Is Not a Peptide | This GLP", "description": "What orforglipron is, what ATTAIN-1 found at 72 weeks in 3,127 adults, and why a small-molecule tablet is chemically different from oral semaglutide | plus its tolerability.", "hash": "f531bc580ab92bd4316af14ef9c54925609e6fc7ed088f6b076ad42fc53164d6", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/what-is-orforglipron.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-new-weight-loss-drugs-are-coming", "canonical": "https://thisglp.com/research/what-new-weight-loss-drugs-are-coming", "title": "What New Weight Loss Drugs Are Coming? Retatrutide Leads at 22.1% | This GLP", "description": "What new weight loss drugs are coming? Retatrutide, CagriSema, VK2735, UBT251 and ecnoglutide, with the trial length behind each figure | and what is buyable.", "hash": "428763702fc88c12b38d081b519bbe5346c6e8323e521c1f9988f07ec30f4186", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/what-new-weight-loss-drugs-are-coming.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-should-a-glp1-provider-actually-do", "canonical": "https://thisglp.com/research/what-should-a-glp1-provider-actually-do", "title": "What Should a GLP-1 Provider Actually Do? Five Pillars | This GLP", "description": "The EASO position statement on integrating incretin-based therapies names five pillars of good care — and a reader can hold any seller to all five.", "hash": "27293f2f558758d9d42553b8a42c529c112cb47b6b137b898563c088200a2df3", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/what-should-a-glp1-provider-actually-do.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/what-weight-loss-drugs-are-there-besides-ozempic", "canonical": "https://thisglp.com/research/what-weight-loss-drugs-are-there-besides-ozempic", "title": "What Weight Loss Drugs Are There Besides Ozempic? Six Have Evidence | This GLP", "description": "What weight loss drugs are there besides Ozempic? Six have randomized evidence across 56 trials and 60,307 patients | only two exceeded 10% of body weight.", "hash": "0ad0008d63727da26a83b5da4ecaec3db53c521ab12085a09bb3540117a96909", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/what-weight-loss-drugs-are-there-besides-ozempic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/when-a-drug-improves-everything", "canonical": "https://thisglp.com/research/when-a-drug-improves-everything", "title": "GLP-1 Drugs and ERCP Complications: A TriNetX Cohort of 21,818 | This GLP", "description": "A matched TriNetX analysis of 21,818 ERCP patients found every 30-day complication roughly halved with GLP-1 exposure | why uniform improvement signals selection, not effect.", "hash": "74d657d8fa52fdf0e9aa205df200c85c92d15f4c6704dedd3caac64fb11e3d9f", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/when-a-drug-improves-everything.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/where-should-you-inject-ozempic", "canonical": "https://thisglp.com/research/where-should-you-inject-ozempic", "title": "Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure", "description": "Where to inject Ozempic: abdomen, thigh or upper arm | the label reports similar exposure at all three, and 1,612 trial patients showed no site effect.", "hash": "1f81ace54ed052e740f217f078de576ac77af653fff37f86d5352444a3e880dd", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/where-should-you-inject-ozempic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/which-glp1-has-the-worst-side-effects", "canonical": "https://thisglp.com/research/which-glp1-has-the-worst-side-effects", "title": "Which GLP-1 Has the Worst Side Effects? It Depends on the Outcome | This GLP", "description": "A meta-analysis of ten studies found tirzepatide produced 4.28 points more weight loss than semaglutide — and a higher rate of serious adverse events.", "hash": "c37eedf46cadf43c03a4934aff3bf4268683cba72a3b66c1221b5ea2837a8318", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/which-glp1-has-the-worst-side-effects.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/who-publishes-a-glp1-dose-ladder", "canonical": "https://thisglp.com/research/who-publishes-a-glp1-dose-ladder", "title": "GLP-1 Sellers That Publish a Dose Price Ladder, Counted | This GLP", "description": "How many GLP-1 sellers publish a dose price ladder rather than an opening figure, counted across the whole roster, and why a printed ladder beats a promise that the price rises.", "hash": "775a3b676547a52248ce2974a6030870f761ae6e9f29b3160d8308eb522606b7", "modified": "2026-10-28", "published": "2026-09-15", "markdown": "https://thisglp.com/ai/research/who-publishes-a-glp1-dose-ladder.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/who-publishes-the-states-they-serve", "canonical": "https://thisglp.com/research/who-publishes-the-states-they-serve", "title": "GLP-1 Seller State Coverage: Who Publishes Where They Ship | This GLP", "description": "A census of which GLP-1 sellers publish the states they serve, how many states those lists cover, and why an absent list is not a coverage claim.", "hash": "300782eb71a822c34b7f74e098c3d413ee5e7184bb63b691e60d874d3e54e963", "modified": "2026-10-26", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/who-publishes-the-states-they-serve.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/research/who-qualifies-for-semaglutide-for-liver-disease", "canonical": "https://thisglp.com/research/who-qualifies-for-semaglutide-for-liver-disease", "title": "Who Qualifies for Semaglutide for Liver Disease? Fibrosis Stage F2 to F3 | This GLP", "description": "Who qualifies for semaglutide for liver disease? The conditional approval covers MASH with fibrosis stages F2 to F3, without cirrhosis | staging requires a test.", "hash": "0e5c2d5d1fd837d8d2fbd6ba3aa24bac85722f67cadd6b4b6ef365cf7cb95b0b", "modified": "2026-09-18", "published": "2026-09-17", "markdown": "https://thisglp.com/ai/research/who-qualifies-for-semaglutide-for-liver-disease.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/why-do-glp1-drugs-cause-nausea", "canonical": "https://thisglp.com/research/why-do-glp1-drugs-cause-nausea", "title": "Why Do GLP-1 Drugs Cause Nausea? And Why It Does Not Predict Weight Loss", "description": "Why do GLP-1 drugs cause nausea? They act on the brainstem's area postrema. In STEP 1 to 3, weight loss was similar with or without it | under 1 point ran through it.", "hash": "e30966b90ab277ea0fda42cf25cad701b18a46241fa708aff238e5a9132cc34e", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/why-do-glp1-drugs-cause-nausea.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/why-does-ozempic-cause-sulfur-burps", "canonical": "https://thisglp.com/research/why-does-ozempic-cause-sulfur-burps", "title": "Why Does Ozempic Cause Sulfur Burps? What the Adverse-Event Data Show", "description": "Why does Ozempic cause sulfur burps? Burping hit 2.7% on Ozempic and 7% on Wegovy vs 1% or less on placebo | the smell itself has never been measured.", "hash": "c03f88ae1ac116bbecd5e42447576467181e21819eaca0a92ca8fdab8bb2574d", "modified": "2026-09-18", "published": "2026-09-18", "markdown": "https://thisglp.com/ai/research/why-does-ozempic-cause-sulfur-burps.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/why-does-weight-loss-plateau-on-a-glp1", "canonical": "https://thisglp.com/research/why-does-weight-loss-plateau-on-a-glp1", "title": "Why Does Weight Loss Plateau on a GLP-1? The Drug Is Still Working | This GLP", "description": "Why does weight loss plateau on a GLP-1? Appetite feedback catches up | median plateau came at 24 to 36 weeks on tirzepatide, and intake stayed lower at week 60.", "hash": "a114991f92835fa077f7c6960908a893b46491c1d0fef998a3df24441e2a7ec2", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/why-does-weight-loss-plateau-on-a-glp1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/research/why-isnt-obesity-in-your-medical-record", "canonical": "https://thisglp.com/research/why-isnt-obesity-in-your-medical-record", "title": "Why Isn't Obesity in Your Medical Record? One in Ten Had It Written Down", "description": "Why isn't obesity in your medical record? Among 42,243 adults with BMI 30 or more, 10.6% had it documented at discharge vs 59.7% for diabetes | four studies.", "hash": "9b714672364e2bd0c12bb1680d839f96624ff38b2f4fa8679fc475cc0f429889", "modified": "2026-09-18", "published": "2026-09-16", "markdown": "https://thisglp.com/ai/research/why-isnt-obesity-in-your-medical-record.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ListItem", "MedicalScholarlyArticle", "Organization", "PropertyValue", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews", "canonical": "https://thisglp.com/reviews", "title": "Provider reviews: honest, evidence-first telehealth assessments | This GLP", "description": "Independent reviews of the GLP-1 sellers we track — compounded semaglutide and tirzepatide, injection and oral. What the plan term really is, what it costs month to month, and who each seller is for. No fabricated scores.", "hash": "fbb81659af1c9df3cd6a7cc9c0a25687048e6a6b6c3fd4e73ceebd4137a5a829", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews.md", "schemaTypes": [ "BreadcrumbList", "ItemList", "ListItem", "Organization", "WebPage", "WebSite" ] }, { "path": "/reviews/10rx", "canonical": "https://thisglp.com/reviews/10rx", "title": "10Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "10Rx advertises a quarterly package that holds its price across available strengths. Its terms make the selected subscription period and prescription stage important when stopping treatment.", "hash": "5d6d0c9638a57b4e4cbbd933e485823e45773845ec6bb79a0f44c8325a13a92c", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/10rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/1st-optimal", "canonical": "https://thisglp.com/reviews/1st-optimal", "title": "1st Optimal reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A lab-led coaching membership with GLP-1 prescribing inside it, where the membership has a price and the drug does not.", "hash": "dd2dbe5af6ad5d6c0b19dcf19e5ab1854ff5fafbaf96018faf6717bba51ffc74", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/1st-optimal.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/24hrdoc", "canonical": "https://thisglp.com/reviews/24hrdoc", "title": "24hrDOC reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A general online clinic with a weight-loss page that prints two semaglutide figures and never says what period either covers.", "hash": "2996d56ec4dc2503a852449a2a8938957254e01fd429d7a2373845e82bda3580", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/24hrdoc.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/abundrx", "canonical": "https://thisglp.com/reviews/abundrx", "title": "AbundRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two starting figures for compounded semaglutide and tirzepatide, and a signup screen that talks about a first-month discount without saying what month two costs.", "hash": "9d7be3ac79f7dc7b03109440f4d21cb9015608ace8a56e70fce0889d93f4c98a", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/abundrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/actin", "canonical": "https://thisglp.com/reviews/actin", "title": "Actin reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every commitment length is printed on the product page, but the help center says the dose can move the cost.", "hash": "9f5b9d0f163b1801d059e79d42a783aa89e81426b5acfabde20a575550d82bbe", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/actin.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/agelessrx", "canonical": "https://thisglp.com/reviews/agelessrx", "title": "AgelessRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The $139 semaglutide figure already has a first-term coupon applied; the same option reads $239 without it.", "hash": "971ce86c4d19c654d5f281149a1a77dfddddf7ec3b2749822c32036d8c4a41c9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/agelessrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ahbarx", "canonical": "https://thisglp.com/reviews/ahbarx", "title": "AHBARx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide and tirzepatide in one, three and six-month supplies, with a physician founder named and no prescriber.", "hash": "b8633d0ae955726ed0a848eb8de3c4289278c6605f740ea97e9c80a186de07b5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ahbarx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/aj-peptide", "canonical": "https://thisglp.com/reviews/aj-peptide", "title": "AJ Peptide reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "AJ Peptide presents its GLP-1 products as patient prescriptions. Its testing claims need to be connected to the actual dispensed product.", "hash": "5691a62136a863e57042df5cab70f1c8c1385c68f9ab21ed98f0e3f71863afe6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/aj-peptide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/alan-meds", "canonical": "https://thisglp.com/reviews/alan-meds", "title": "Alan Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Full-dose lines priced as six-month prepayments, beside cheaper microdosing lines.", "hash": "602d1d95bbd6e5a89f5c706a730816018f89df84fa5a832cf9290da0584ec1d0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/alan-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/alegro-health", "canonical": "https://thisglp.com/reviews/alegro-health", "title": "Alegro Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The figure buys eight weeks outright, and the page stops before saying what week nine costs.", "hash": "e0f5923102b4e7e0506686bda65edf1f99a57034061035dc63c335ab7e3d1150", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/alegro-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/alinwell", "canonical": "https://thisglp.com/reviews/alinwell", "title": "Alinwell reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A GLP-1 service for women whose homepage advertises a new-patient offer, while both product pages say the price is set at consultation.", "hash": "a0e232dd836afd961b832569f683a6cf36e4b2713e380539fae7640084404565", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/alinwell.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/allara-health", "canonical": "https://thisglp.com/reviews/allara-health", "title": "Allara Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A women's hormone and metabolic practice that prescribes branded GLP-1s and prices only its own care.", "hash": "33f62bebedf1f1256a174d0b8c151b68e59426a9f85de576e7ef00080dc59d7e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/allara-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/alloy", "canonical": "https://thisglp.com/reviews/alloy", "title": "Alloy reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every figure at this seller is a medication rate plus a $99 monthly care fee charged alongside it.", "hash": "caf25606c25b5e6ce36ebbeb1a3e6a97d7e8407c5ca07a10e75a4ed4e26d8df3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/alloy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/alternate-health-club", "canonical": "https://thisglp.com/reviews/alternate-health-club", "title": "Alternate Health Club reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The rate reads per month and the vial is stated to cover twenty-eight days.", "hash": "4bf3dc438b7bce28a90375258f0aa1fc6df62321eb1ef656cafc39df73cfbe8c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/alternate-health-club.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/altrx", "canonical": "https://thisglp.com/reviews/altrx", "title": "altRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide and tirzepatide with named dispensing pharmacies, a published dose schedule, and monthly product prices.", "hash": "c09c29402b9bc613aedda9fdef271c476c4f7a881ee3d2b25c59563ac19e4092", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/altrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/always-wellness-and-recovery", "canonical": "https://thisglp.com/reviews/always-wellness-and-recovery", "title": "Always Wellness and Recovery reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three-month titration bundles priced stage by stage, and single-month vials priced by strength.", "hash": "9625502f185c7dd1a87b3d2d6e2fdaaca37c0c2591ed82dc0f4e74f1ab6782ef", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/always-wellness-and-recovery.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/alyverx", "canonical": "https://thisglp.com/reviews/alyverx", "title": "AlyveRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tirzepatide comes as an injection and as needle-free sublingual drops, and the two are priced as different products.", "hash": "647635dd79943368c8613ab1d66bbfad18936e589cd7e26a15cf7ca50288762f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/alyverx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/amazon-one-medical", "canonical": "https://thisglp.com/reviews/amazon-one-medical", "title": "Amazon One Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Pay-as-you-go prescribing for branded GLP-1s, where the visit, the medication and the labs are three separate bills.", "hash": "f6ed0f30662a293d8e48ad4361442294a1215eadd1a5821c59f7e708808ee134", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/amazon-one-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ambiante-health-wellness", "canonical": "https://thisglp.com/reviews/ambiante-health-wellness", "title": "Ambiante Health & Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Ambiante combines metabolic, longevity and aesthetic marketing with independent clinician access. Its semaglutide page and terms give different cancellation notice periods.", "hash": "45a0f4d522b9e1557fbb7c1bb4fd33dd7568e81560dc53ffe0150e2d26adcf97", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ambiante-health-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/amble", "canonical": "https://thisglp.com/reviews/amble", "title": "Amble reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two compounded lines, three plan lengths each, and one rate that holds at every dose.", "hash": "e838888b18ff39f38dff788b1caceb24c94c41a67bb2c8c263f0f7351b71b55d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/amble.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/amrx", "canonical": "https://thisglp.com/reviews/amrx", "title": "AM Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Insurance coordination for brand-name drugs, plus a cash route for compounded semaglutide and tirzepatide.", "hash": "edcca620080fc5d266f064935caad68db2c7ab766d47ba9918bb082f4fcd7cc5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/amrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/andrew-meds", "canonical": "https://thisglp.com/reviews/andrew-meds", "title": "Andrew Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide and tirzepatide at four plan lengths, prescribed through an independent medical practice the footer names.", "hash": "f795d04451f8a70b8ac743ede3efca85b7aad12e07786664e207acee2633a9ed", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/andrew-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/apex-md", "canonical": "https://thisglp.com/reviews/apex-md", "title": "Apex MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The weekly injection is sold with three additives, and what those additives do was not measured in the trials behind the drug.", "hash": "dd18e5a71b51d29d2b471dae47d967985a7c5f7d0e2090699147311a27749adb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/apex-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/aquavita-nextgen", "canonical": "https://thisglp.com/reviews/aquavita-nextgen", "title": "AquaVita NextGen reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each molecule is sold as a one-month supply at a single published price, with no dose named beside it.", "hash": "0330da05f45948a037309d6698ca96686e8f1d7a6b12c51519fe12176f65c112", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/aquavita-nextgen.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/arc-1", "canonical": "https://thisglp.com/reviews/arc-1", "title": "Arc-1 reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide and tirzepatide sold as dose-priced variants on a longevity storefront, with checkout before the intake.", "hash": "1f9274d10061ef23e216c9a53c5b54726d653fbb124f620406773fd28f673937", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/arc-1.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ark-health", "canonical": "https://thisglp.com/reviews/ark-health", "title": "Ark Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three bundled monthly GLP-1 plans, and an oral option whose page does not name the drug inside it.", "hash": "bcf5c587e2242d03162e9fd9e5c25239e442ef3e16ae6eae0153e455eb7f6870", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ark-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/arsynl-rx", "canonical": "https://thisglp.com/reviews/arsynl-rx", "title": "ARSYNL Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One of these figures has already moved once, which makes either worth confirming on the day.", "hash": "e7da8c186397958c6354391083d82f02ddecac9661e6805acbe8534ed25e4eb3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/arsynl-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ascend-medical", "canonical": "https://thisglp.com/reviews/ascend-medical", "title": "Ascend Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two package prices are published and neither states what period they cover.", "hash": "9547d9eff1eefcb4b1e247092e9d7d643d8ddb90d86b4a2ce42da557785e7360", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ascend-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ascend-vitality", "canonical": "https://thisglp.com/reviews/ascend-vitality", "title": "Ascend Vitality reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The tirzepatide tablets page prints the semaglutide price panel.", "hash": "941770403e31a2cb1bb5b17906874fc56cc7c3d9805735dbdee99dc0dbc48c31", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ascend-vitality.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ask-rx", "canonical": "https://thisglp.com/reviews/ask-rx", "title": "AskRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Brand-name Wegovy and Zepbound billed at pharmacy cost, plus a flat monthly care fee shown on its own line.", "hash": "009bf5346cb88a1a871d9a7c4a3ef1f883ea216cc47c8c104f968d1ac0ce7462", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ask-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/aspen-health", "canonical": "https://thisglp.com/reviews/aspen-health", "title": "Aspen reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both molecules cost the same here, every dosage costs the same, and the vial carries an additive the trials never measured.", "hash": "d5a901c169d66bd2f9504fd0c64c5db0dc78324d02386291547e020d8d2e9a36", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/aspen-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/aspire-health", "canonical": "https://thisglp.com/reviews/aspire-health", "title": "Aspire Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The vial is measured in weeks and the care fee in months, so neither published number is a month of treatment.", "hash": "4d7d269778177420c944ed156f9ea01ceb887ae76b596873dd389f89b970f3d9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/aspire-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/aurelius-health-group", "canonical": "https://thisglp.com/reviews/aurelius-health-group", "title": "Aurelius Health Group reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Aurelius markets clinician-monitored, compounded tirzepatide microdosing. Its promised check-ins are distinct from the evidence needed to support its broader wellness claims.", "hash": "4dede537207da27b040ab5b8746b8860fd617902abf6c2094b3eb1eacbe69195", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/aurelius-health-group.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/auren-rx", "canonical": "https://thisglp.com/reviews/auren-rx", "title": "Auren Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tirzepatide costs $80 a month more than semaglutide, and both commitment rates are published.", "hash": "d9cf57985cd73284fdf39f672adb98eead8f691c936ba652baaef5f65b06fa2b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/auren-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/avara-rx", "canonical": "https://thisglp.com/reviews/avara-rx", "title": "AVARA Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The lower tirzepatide figure requires a discount code, which makes it a condition rather than a standing rate.", "hash": "fb7e7a205df7a4326203fcfa75c47db810162e30457ad50991ff610911982c7c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/avara-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/avarx", "canonical": "https://thisglp.com/reviews/avarx", "title": "AVArx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "AVArx identifies Arora Health & Aesthetics as its clinical organization and describes real-time visits when state rules require them.", "hash": "7340ff217797936f25ed781882ed6980dd59977efcb5d63f20d3ffb835e27ee5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/avarx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/avono-health", "canonical": "https://thisglp.com/reviews/avono-health", "title": "Avono Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide and tirzepatide at flat monthly rates across two dose programs, with the prescribing team and the pharmacies named.", "hash": "c2bf28cdd749b2b54b44dc245774923f85182dedeca8ff2066597070ee8ae0d4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/avono-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/az-health", "canonical": "https://thisglp.com/reviews/az-health", "title": "AZ Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One tirzepatide injection carries two monthly figures on the same page, and screening is a nurse practitioner phone call.", "hash": "18343ee670b990749dafdfcf0d831c782d85785c818be29a23d172ffb1b77365", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/az-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/balanced-hormone-health", "canonical": "https://thisglp.com/reviews/balanced-hormone-health", "title": "Balanced Hormone Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A package here is a quantity of drug rather than a length of time, so how long it lasts is decided by the dose a buyer titrates to.", "hash": "182527a1708d9af7cc75ab1b011d9053b30443ee3183788fc4f7f0a86db729b3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/balanced-hormone-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/basal-health", "canonical": "https://thisglp.com/reviews/basal-health", "title": "Basal Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Basal’s GLP-One offers clinician-prescribed compounded tirzepatide in microdose and weight-loss plans. Those programs should be assessed separately rather than treated as interchangeable.", "hash": "2f18a988addc5152917cd37baf8147844e016ce0f8952f77de04b6da1d683817", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/basal-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bayan-health", "canonical": "https://thisglp.com/reviews/bayan-health", "title": "Bayan Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An injection and an oral drop carry the same monthly figure here, which is the reverse of the usual pattern.", "hash": "61dca7f2edc71919d3e940aa85819bbb425b1c511d60d3656ebedeb373ffc00f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bayan-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/believe-health", "canonical": "https://thisglp.com/reviews/believe-health", "title": "Believe Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tirzepatide and semaglutide cost the same to the dollar, at every dose.", "hash": "1771386114d3c1dfd8543160f02e20a1af1084bc2e3896d386205f9548da0908", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/believe-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/belle-health", "canonical": "https://thisglp.com/reviews/belle-health", "title": "Belle Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Belle includes clinician oversight, nurse support and group dietitian coaching in its compounded injection plans. Longer supplies lower the advertised monthly equivalent, but the one-month rates remain higher.", "hash": "88e0da28aef56ac40221926788eda5ff226720efd5885f9fe32938174cf5c7f1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/belle-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/better-medspa", "canonical": "https://thisglp.com/reviews/better-medspa", "title": "Better MedSpa reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Better Med Spa offers supervised semaglutide and tirzepatide care in Chicago, with Illinois telehealth described. Its aesthetic memberships are a separate financial decision.", "hash": "c4c0b489f71c2d33654c467783cabb26a1c00faafe2e54312b3dae70ce5153ad", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/better-medspa.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/better-u-care", "canonical": "https://thisglp.com/reviews/better-u-care", "title": "Better U Care reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A mental-health telehealth practice whose checkout charges one monthly figure for compounded GLP-1s, medication and consultation together, at every dose.", "hash": "24b218c8a7aad7f3c2be0dcaa4673791c9ce5a507e242a8048224ebe14c2fb6c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/better-u-care.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/betterme-rx", "canonical": "https://thisglp.com/reviews/betterme-rx", "title": "BetterMe Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised rate holds while a sitewide sale runs, and the pricing page carries no notice of what happens when it stops.", "hash": "06f37f74f1899b802da8dd405fefc3357da654cfa59b3dde5dcb8c864359eb0b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/betterme-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/beyondmd", "canonical": "https://thisglp.com/reviews/beyondmd", "title": "BeyondMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A peptide practice that added GLP-1 programs, with starting figures that name no billing period.", "hash": "369c269ab9a51d7d5a014fd40f1469c591a0dce9f5a29df154b092c37dc2e8ad", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/beyondmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/big-easy-weight-loss", "canonical": "https://thisglp.com/reviews/big-easy-weight-loss", "title": "Big Easy Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Dividing a twelve-week package by three understates every figure here, because twelve weeks is 2.76 calendar months.", "hash": "563f0bccef7ab7021f5451e51729bd3e1b550aba63e97548fc3061259fee7a65", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/big-easy-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/biltrx", "canonical": "https://thisglp.com/reviews/biltrx", "title": "BiltRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Card prices for two compounded drugs, with a membership and a consultation billed separately.", "hash": "d9303624dcfaac387aceccc456ac7475ae42d25ddfe6544734ec6bd456eff8c8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/biltrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bionomy-health", "canonical": "https://thisglp.com/reviews/bionomy-health", "title": "Bionomy Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "There is no subscription to cancel here, which matters more than it sounds when most people stop within a year.", "hash": "ebd4e5f53218e96bccc2bc6ecf8d95cf9a9def3857ea9c33698fdba47370e944", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bionomy-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bioverse", "canonical": "https://thisglp.com/reviews/bioverse", "title": "Bioverse reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The struck-through figures imply a fifty-five percent cut on one line and eleven on the other, with nothing explaining either.", "hash": "ade214a4d73aa2fc1b7b426589d504d722fab6c596fd00fa841f01009d121462", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bioverse.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/blis-md", "canonical": "https://thisglp.com/reviews/blis-md", "title": "Blis MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each rung is a one-month vial, with the weekly dose it delivers printed beside the price.", "hash": "e3f836d067cd069094f599c6f79eed50e74ab2b3c298e998d5b5a9b500faf947", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/blis-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bliv", "canonical": "https://thisglp.com/reviews/bliv", "title": "Bliv reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An asynchronous GLP-1 service whose headline figures depend on plan structure and eligibility.", "hash": "3c5131e5d5414054a8d85ee62c82d29432e584825719da69e919d8370f279613", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bliv.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bloommd", "canonical": "https://thisglp.com/reviews/bloommd", "title": "Bloom MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide at one price for any dose; tirzepatide priced step by step, with each weekly dose printed.", "hash": "c732a61b66d319042298e668658f9898043d6218ac064bb7302fad187bad14b0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bloommd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bloomwell-rx", "canonical": "https://thisglp.com/reviews/bloomwell-rx", "title": "BloomWell Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Monthly figures on both molecules, with the dispensing pharmacy and the provider network named in the FAQ.", "hash": "6ddc8dca744538dfcb54a00bca677b5f265c469a1565cbc86fce5984583e90ed", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bloomwell-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/blue-haven-rx", "canonical": "https://thisglp.com/reviews/blue-haven-rx", "title": "Blue Haven RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The card states that the rate buys four weeks and then advertises that same rate as a month, which are two different things the page itself distinguishes.", "hash": "512dc9f80df46f7fe54a21df32ba51361da8293b121e34308373bfd90e42fa99", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/blue-haven-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/blue-sky-md", "canonical": "https://thisglp.com/reviews/blue-sky-md", "title": "Blue Sky MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The weekly figures are stated plainly and neither can be reached without joining a program whose cost the practice declines to publish.", "hash": "f485fe0139df775e3421e5b40d68c370ddf9b75c8b0f9f5467855f3a6b8e3431", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/blue-sky-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bmimd", "canonical": "https://thisglp.com/reviews/bmimd", "title": "bmiMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both products are sold explicitly as microdose lines, which puts them below the doses every trial in this field used.", "hash": "6183f8c1818114f2718a12bb3e8a1567dc3a55a25534947d5bbfb0ee5dc161c9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bmimd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bodi-envi", "canonical": "https://thisglp.com/reviews/bodi-envi", "title": "Bodi Envi reviews (2026): care and monthly plans | This GLP", "description": "Bodi Envi identifies Wasef Health for clinical care and VialsRx for dispensing. Its cancellation and replacement rules need attention before enrollment.", "hash": "79aeb8f5162f3c7f7e243d10da6c91a250cf042f87ddc166b9f0b163c202ab3c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bodi-envi.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bodybuilding-health-plus", "canonical": "https://thisglp.com/reviews/bodybuilding-health-plus", "title": "Bodybuilding Health+ reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Nothing here has a term attached, so the advertised number is the one an uncommitted buyer pays.", "hash": "d2171fdb788e9b107f068f66214aeec2f0b5a6b917f71945cd79f21779563599", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bodybuilding-health-plus.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bodylogicmd", "canonical": "https://thisglp.com/reviews/bodylogicmd", "title": "BodyLogicMD reviews (2026): weight-loss clinics | This GLP", "description": "BodyLogicMD offers practitioner-led weight assessment within a broader hormone-focused network. Its semaglutide discussion should lead to a specific prescription and monitoring plan.", "hash": "18127314ddf6cc02aac4b35543338be4758ee646c8432a60310a2282e96d541e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bodylogicmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/bon-health", "canonical": "https://thisglp.com/reviews/bon-health", "title": "Bon Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four term lengths are published for each molecule, and the coverage list runs to every state.", "hash": "047713585c2d69bcc3c4f18cee8dfe5d5d56c4650221ba8f24996ad0d155c157", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/bon-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/boostagerx", "canonical": "https://thisglp.com/reviews/boostagerx", "title": "boostAGErx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Ninety-five dollars is three months paid at once, divided by three. No invoice ever reads that figure.", "hash": "3458798b40f24701a7b5db9ad90b80829bc1376d30eff360703fb6586b0a85de", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/boostagerx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/boston-medical-group", "canonical": "https://thisglp.com/reviews/boston-medical-group", "title": "Boston Medical Group reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A men's health telemedicine brand selling compounded GLP-1s on a four-rung plan ladder, with the one-month plan selected by default.", "hash": "d512447f924c17345f79f00064a88c72f5bef080796bf9cec9dd19485187baf6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/boston-medical-group.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/breeze-meds", "canonical": "https://thisglp.com/reviews/breeze-meds", "title": "Breeze Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide starts at $199 by injection, and the oral tablet is priced above it rather than below.", "hash": "e2111b16a3ec7e3281fb4f9defb7b11d3d95cd1274c63178c0acc36d0147e3f1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/breeze-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/brello-health", "canonical": "https://thisglp.com/reviews/brello-health", "title": "Brello Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The card advertises a monthly figure. Renewals bill every eleven weeks, not every three months.", "hash": "8c278211ce6d140d73095cf5489c96e1968374f5723fe4194ffb536d0daaadd9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/brello-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/brightmeds", "canonical": "https://thisglp.com/reviews/brightmeds", "title": "Brightmeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A flat price at any dose, stated to apply to patients who are new to GLP-1 treatment.", "hash": "c042f2bb1ba9a0c2bd584a65ccb277616e455be248896f33ad43bff2a2e8d661", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/brightmeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/broose-wellness", "canonical": "https://thisglp.com/reviews/broose-wellness", "title": "Broose Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Broose separates oral semaglutide, injectable semaglutide and tirzepatide. The follow-up plan needs to fit the supply term.", "hash": "851dd7d81d27f888d53f4e4067f48148c0a74f2f8e2a60c183315a687885fb9c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/broose-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/cabana", "canonical": "https://thisglp.com/reviews/cabana", "title": "Cabana reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Cabana names its supervising physician and its pharmacy, and prices its weight-loss plans from one figure.", "hash": "91669dfffc11288d25a7f60e35dd760083351977f6e5f2cf76c1c71ec1e4673f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/cabana.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/caliberrx", "canonical": "https://thisglp.com/reviews/caliberrx", "title": "CaliberRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A single starting figure covers both molecules, and billing splits across three parties.", "hash": "bc009798653fe5c4844a2cf50c22032c1b9041551e5f625b28c85de06b2657d8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/caliberrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/calibrate-health", "canonical": "https://thisglp.com/reviews/calibrate-health", "title": "Calibrate Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The program fee is fixed and published; the medication figure beside it depends on an insurance plan.", "hash": "4d2889cc4fc03cdb842886b9e25741d3cb3428c2887378b050f615cfd5849e40", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/calibrate-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/california-trim-clinic", "canonical": "https://thisglp.com/reviews/california-trim-clinic", "title": "California Trim Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Westlake Village clinic that now treats by video, with its prices kept on a page of their own.", "hash": "43ba05333228f1c55db244d12c721d82cfa135325a82c480bac12a6ddcf48a97", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/california-trim-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/call-on-doc", "canonical": "https://thisglp.com/reviews/call-on-doc", "title": "Call-On-Doc reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An online prescriber that now sells an all-in home-delivery GLP-1 program beside its care-only plan.", "hash": "680ae2fe34f8ffaeadece690b80534e523be4d5c468185d40d5bbf5c0fee9467", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/call-on-doc.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/candor-rx", "canonical": "https://thisglp.com/reviews/candor-rx", "title": "Candor Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The promise of a rate that never moves with the dose is the rare kind worth wanting, and both molecules carry it.", "hash": "1dd26f43f481cebd941c19a4becdaa5b95aef7059ae1e186282a8f925ac5d2be", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/candor-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/capo-health", "canonical": "https://thisglp.com/reviews/capo-health", "title": "CAPO Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "CAPO identifies The Pharmacy Hub and describes monthly check-ins. Confirm the medical practice responsible for the prescription.", "hash": "369e23994d69e762c07cd13c48c7ea5dfa0a2a9d54f1475868a9f65e51a80db0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/capo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/care-bare-rx", "canonical": "https://thisglp.com/reviews/care-bare-rx", "title": "Care Bare Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide and tirzepatide cost the same $199 here. That is unusual.", "hash": "156f939826e42fd22eedb6fd6b337d6be3925a930bb36db2bcbccb0024ac9887", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/care-bare-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/care-clinics", "canonical": "https://thisglp.com/reviews/care-clinics", "title": "Care Clinics reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The price never moves as the dose climbs, because the number of weeks does instead.", "hash": "ea2d64f4e2c0bb3c6093e0da454aaeacfc3164fd77548ab37298d18d407f74a4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/care-clinics.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/carocare-wellness", "canonical": "https://thisglp.com/reviews/carocare-wellness", "title": "Carocare Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Houston clinic that prints the milligram dose beside every monthly price for the first six months.", "hash": "0ff3ebfa2870ac5f583935c030919d6e87a96c8adc5a543136e1b41f32e88950", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/carocare-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/celia-rx", "canonical": "https://thisglp.com/reviews/celia-rx", "title": "CeliaRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The per-month figure is arithmetic on a four-month vial. The charge is the whole vial, once.", "hash": "be93e3bfbc9ff58e953ea89d58a04e798b2b1568179fc54e7ce2d12536d461e4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/celia-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/center-for-medical-weight-loss", "canonical": "https://thisglp.com/reviews/center-for-medical-weight-loss", "title": "Center for Medical Weight Loss (CMWL) reviews (2026): GLP-1 telehealth sellers", "description": "Both product pages open with the three-month plan already chosen.", "hash": "93db1db2442d2c1e81c3d6b00fc60dcfdc4b2ceb0d0eab8927e32fc69c48b9c1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/center-for-medical-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/chia-health", "canonical": "https://thisglp.com/reviews/chia-health", "title": "Chia reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Chia combines weight-loss prescribing with a wider longevity menu. A focused care plan matters more than adding extra protocols.", "hash": "06561be601e8d92df1ae8cca4d01cad1251c8f377008ee097e34e6bffee753a5", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/chia-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/chronos-bhw", "canonical": "https://thisglp.com/reviews/chronos-bhw", "title": "Chronos Body Health & Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Chronos offers in-person weight care in Metairie and telehealth pathways for Louisiana and Texas. Its GLP-1 pages explain individual assessment and optional compounded treatment.", "hash": "84c12956d15cea24bb09b33254b580a4afadc881554f9fbe24355a902395aed3", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/chronos-bhw.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/cielo", "canonical": "https://thisglp.com/reviews/cielo", "title": "Cielo reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The asterisk on the home page card does the work most sites leave out.", "hash": "20d3b8a4eb0f25abc1c57949c29698be6497d451af1d029b9c2e00511b7f1901", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/cielo.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/citizen-meds", "canonical": "https://thisglp.com/reviews/citizen-meds", "title": "Citizen Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The entry figure is stated, and so is the fact that it rises with the dose. Most sellers state only the first half.", "hash": "40306153eb151944fa6fcc7002e55ffb3b47d91187ac7504afb5d23e7524191a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/citizen-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/claya", "canonical": "https://thisglp.com/reviews/claya", "title": "Claya reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The homepage advertises one semaglutide rate and the product page charges another.", "hash": "fc93b10d2b4dc4a88f8d9cd8b76959e80efa4ab83dc85879e8b42c2a407a7410", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/claya.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/clinic-secret", "canonical": "https://thisglp.com/reviews/clinic-secret", "title": "Clinic Secret reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The bold figure is the first month. The struck figure beside it is every month after.", "hash": "c0230ae6c5fbec7e8fd9475c6a952d1534417080c7378cbe7d9fcf641bde50a7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/clinic-secret.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/clume-health", "canonical": "https://thisglp.com/reviews/clume-health", "title": "Clume Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both molecules carry one monthly figure, and the lower advertised figure requires a twelve-week prepaid term.", "hash": "ffee1a820315957c8537e53948ea89bd4b9f8b88b66b9684d7b806517fa1ae75", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/clume-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/clyr-health", "canonical": "https://thisglp.com/reviews/clyr-health", "title": "CLYR Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The charge rises with the dose, and every tier is published before the intake.", "hash": "bb89ff472c2bc5488a9bd7682fe3554737f2118dca5140297ad54befe6f4b60c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/clyr-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/coby-health", "canonical": "https://thisglp.com/reviews/coby-health", "title": "Coby Health reviews (2026): care and dose costs | This GLP", "description": "Coby connects patients with independent prescribers for compounded injections. The care relationship deserves as much attention as the starting price.", "hash": "c68b2bef13f3f444aed517e40e070a9cc0ed75f3824f0fd3ae391eb93dd435c1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/coby-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/coivas", "canonical": "https://thisglp.com/reviews/coivas", "title": "Coivas reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One monthly number is published. Almost nothing surrounding it is.", "hash": "b466735aafcc6bb9504238fb091019218a1e15cd899a44ad1c58eb4ebec6a83d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/coivas.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/collective", "canonical": "https://thisglp.com/reviews/collective", "title": "Collective reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised rate is $59 a month, and the required annual membership brings the monthly figure to $76.", "hash": "07e401ce40c7a845e7312c5b413b446eb4462007eb8332f952577adcd6b29b63", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/collective.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/concierge-md-la", "canonical": "https://thisglp.com/reviews/concierge-md-la", "title": "Concierge MD LA reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly figure is a membership that includes the medication, and the page disagrees with itself about how often it ships.", "hash": "4d9aa5efd2c73a9461d62aa66a91d0a85579882c7f619535fa00c6f313f811e8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/concierge-md-la.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/contour-health", "canonical": "https://thisglp.com/reviews/contour-health", "title": "Contour Health reviews (2026): care and vial pricing | This GLP", "description": "Contour Health offers a free video consultation, continued access to the same provider and medication ordered by vial rather than automatic monthly refills.", "hash": "bc3fb9ad0c0680b4fc384b22dc972d4a0997016714c209da75c906acef86a78f", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/contour-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/cora-health", "canonical": "https://thisglp.com/reviews/cora-health", "title": "Cora Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every prescriber, both pharmacies and all four commitment terms are printed where a buyer can read them.", "hash": "4acaed8366401362c3139bbb56ae641d29a229dc4db45b8b2b50ec5c6318d519", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/cora-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/coradoc", "canonical": "https://thisglp.com/reviews/coradoc", "title": "CoraDoc reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "There is no monthly option here, and the headline figure is half a year.", "hash": "f183a78090264dc50c22a395719c9f23434306bdddb8f763c989e8c4c233bbbf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/coradoc.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/coreage-rx", "canonical": "https://thisglp.com/reviews/coreage-rx", "title": "CoreAge Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide is advertised at $99 a month, on a row checked earlier than the rest of this group.", "hash": "2a5fcf9ffd01e795ff5880435afa3ea65e0802745e9bad41b071f246e4d39d4a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/coreage-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/corsica-health", "canonical": "https://thisglp.com/reviews/corsica-health", "title": "Corsica Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both advertised figures sit inside a three-month plan paid in advance, and the monthly rate is printed beside each.", "hash": "f13abc24c51ab36a1358aef798c56c321bb83a05c7a1851db36deb2a1be7b003", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/corsica-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/curex", "canonical": "https://thisglp.com/reviews/curex", "title": "Curex reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An oral line at $199 across forty-five states, with no injection offered at any price.", "hash": "5873435c52a9e1d212441de24e34e6c28a04d1a36832326552672b5516436303", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/curex.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/cvs-minuteclinic", "canonical": "https://thisglp.com/reviews/cvs-minuteclinic", "title": "CVS MinuteClinic reviews (2026): weight-management clinical care | This GLP", "description": "CVS MinuteClinic offers a $29 online GLP-1 eligibility consultation with later medication support. The first assessment, ongoing visits and pharmacy purchase are separate decisions.", "hash": "ac54d330a23329ef6299dc118646201d22842bd88413c743311041615aeef770", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/cvs-minuteclinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/dadvantage-mens-health", "canonical": "https://thisglp.com/reviews/dadvantage-mens-health", "title": "DadVantage Men's Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Nothing here is sold by the month, and two charges sit outside whichever block a buyer picks.", "hash": "5924d38627cf8683a4c83b8afa4969e24aedb3aac44006236f11cd6e0e45286d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/dadvantage-mens-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/defy-medical", "canonical": "https://thisglp.com/reviews/defy-medical", "title": "Defy Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Defy places GLP-1 treatment within a broader medical weight-management practice. Its consultation and follow-up model deserve more attention than the list of available therapies.", "hash": "1f93c297c8ed3f37668b11405bedb1ccf2d02a0912e611402aab50bf871620f1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/defy-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/direct-meds", "canonical": "https://thisglp.com/reviews/direct-meds", "title": "Direct Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Everything is sold by the quarter and quoted by the day. One of the daily figures is the other molecule's.", "hash": "dd16794c1baffb90eb57108477969384ed49ed670734e5d317f13cdce63352df", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/direct-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/docberry", "canonical": "https://thisglp.com/reviews/docberry", "title": "Docberry reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Docberry’s supply commitments deserve as much attention as its clinical intake.", "hash": "f6669fb4131e2143227039f835af128efa7122d70e595d957b30fdc386283fbb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/docberry.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/doctoradam", "canonical": "https://thisglp.com/reviews/doctoradam", "title": "DoctorAdam reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide costs the same in either form, and the tirzepatide tablet costs less than its injection.", "hash": "de093fd2785502440dcc538408ea9c9a00274dc0b1a1d3ed05d9f2831a55d4a2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/doctoradam.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/dollar-dad-club", "canonical": "https://thisglp.com/reviews/dollar-dad-club", "title": "Dollar Dad Club reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One injection price at every dose, a printed oral price, and a card charged when the plan is picked rather than after the doctor has looked at the case.", "hash": "1e15d672c6d4aaec2edd6394dcf1828dba025fa128819a46a6674b233307e8a8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/dollar-dad-club.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/dr-arevitalize", "canonical": "https://thisglp.com/reviews/dr-arevitalize", "title": "Dr. Arevitalize reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The injection figures are twelve-month bundle rates; the capsules are quoted month by month.", "hash": "e1b90e70a80cd78e627b11077006873b536ba42f053d0f5c7a27bf061ddd5eb7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/dr-arevitalize.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/dr-gillis-wellness-center", "canonical": "https://thisglp.com/reviews/dr-gillis-wellness-center", "title": "Dr. Gillis' Wellness Center reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A physician-owned clinic in Oakland, Maine, with walk-in consultations and no contracts.", "hash": "f7f56f3ba3d2548968631eee4abb9951f60eb67a108ab54a452300d88c80f1b3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/dr-gillis-wellness-center.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/drbrainrx", "canonical": "https://thisglp.com/reviews/drbrainrx", "title": "DrBrainRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A single medication price per molecule, and a required monthly care fee that sits outside it.", "hash": "fd06f6f759c28e99e51fcb506b59a00717251aa0c7854781067f6acce50a79c5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/drbrainrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/dreamhug-medical", "canonical": "https://thisglp.com/reviews/dreamhug-medical", "title": "DreamHug Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both figures are the longest-plan tier. The one-month rate is higher and is not published.", "hash": "87628a84241e43cf84c00bb1b9d9f342eb79e53163716efd19aa82e7d8a914b6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/dreamhug-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/dudemeds", "canonical": "https://thisglp.com/reviews/dudemeds", "title": "DudeMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each lower figure is a commitment kit that strikes the month-to-month rate through beside it.", "hash": "b135403de371fee7ab421c737f0f4aea67d82541fe536ae1ac8ca7dc801512bc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/dudemeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/eclipse-medical-wellness", "canonical": "https://thisglp.com/reviews/eclipse-medical-wellness", "title": "Eclipse Medical Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Colorado nurse practitioner's weight-loss practice that prices the care and sends the prescription to a pharmacy the patient pays directly.", "hash": "987e95c6db3366a743aee2d3abbf91e29394315d320d4eb4c0fa10e46fc1bc9b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/eclipse-medical-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/eden", "canonical": "https://thisglp.com/reviews/eden", "title": "Eden reviews (2026): GLP-1 sellers by price | This GLP", "description": "The membership costs the same on either molecule, so the hundred dollars between them is the medication and nothing else.", "hash": "3debe9e04e61f683672a769227507a9d91e5fae879c32996540ee32ceca9f29e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/eden.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/edessa", "canonical": "https://thisglp.com/reviews/edessa", "title": "Edessa reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The number on the front of the site is the six-month rate. A single month costs forty-four dollars more.", "hash": "2cf4627622f9885e3584c02c34c778ab3dfa3f82d0867a9a8c1099c1a7f4698c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/edessa.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/edgerx", "canonical": "https://thisglp.com/reviews/edgerx", "title": "EdgeRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A seller that names who compounds its medication also says its protocols are not currently available to buy.", "hash": "6c201c20c2f2f8f7270dd878b8a69fe4452e04c655555d1056d48351e7b08b37", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/edgerx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/effecty", "canonical": "https://thisglp.com/reviews/effecty", "title": "Effecty reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide is sold at four plan lengths. Monthly billing is the dearest rung.", "hash": "d040ce9f7c8ee880648dd4fe2042a2a9d2828f9a444776ebc5b7a2585c772f75", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/effecty.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elara-health-and-wellness", "canonical": "https://thisglp.com/reviews/elara-health-and-wellness", "title": "Elara Health and Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two figures sit on every card, and the lower one is a prepayment for thirteen months.", "hash": "9f11b2f571922ce75f44629cab52cf5c4d8c7150708ea65259d680739317141d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elara-health-and-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elara-md", "canonical": "https://thisglp.com/reviews/elara-md", "title": "Elara MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Elara MD publishes dose-linked prices for personalized GLP-1 products, but generic product labels leave the exact medicine and a conflicting starting-price claim unresolved.", "hash": "9d9142566db100ad6833b79b0fd7d7dc020603b153e371237cc105c440523f66", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elara-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elevate-health", "canonical": "https://thisglp.com/reviews/elevate-health", "title": "Elevate Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The checkout starts on the monthly plan, and every cheaper line beneath it asks for months in advance.", "hash": "40ea3ff62b4a9d3fc11e09219186486acc08df9b49c9e11e8aa9e523a86d965f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elevate-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elevated-health", "canonical": "https://thisglp.com/reviews/elevated-health", "title": "Elevated Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four plan lengths on each molecule, with every figure printed rather than revealed at checkout.", "hash": "150d9d3af43f6c5eb75fa0a333d52c72013735acafddf7ee578672015850cf50", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elevated-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elitephysiqmd", "canonical": "https://thisglp.com/reviews/elitephysiqmd", "title": "ElitePhysiqMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The headline is a member rate; the $89 monthly membership that unlocks it is priced separately.", "hash": "7dff985be750c3008b9a6ae0c6ffb1073255aa15ba01c87e84552d362dac6761", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elitephysiqmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elixamd", "canonical": "https://thisglp.com/reviews/elixamd", "title": "ElixaMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "ElixaMD offers compounded injections and branded GLP-1 treatment. Clarify the medication bill, prescribing decision and refund conditions before paying.", "hash": "ea3e6ef47edd149ecee743a8385fcd6d60570f8c3de5e56e322e5a7054a0ba04", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elixamd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elles", "canonical": "https://thisglp.com/reviews/elles", "title": "ElleS reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four monthly GLP-1 rates, two named physicians, four named pharmacies, and one price at every dose.", "hash": "a0a3f1c539000dca6698f2a12d17af5b57a239ccbcd9fdf7b2c41d0f1d45bea0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elles.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/elliemd", "canonical": "https://thisglp.com/reviews/elliemd", "title": "EllieMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A build-your-own formula that ships twelve weeks of injections at once and bills for them month by month.", "hash": "fc76f27bb3acd37d2afbf19cdec5e1c1d13d9c426fb9e0fbf80e344a79f12e7b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/elliemd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/eloria", "canonical": "https://thisglp.com/reviews/eloria", "title": "Eloria reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The headline rate covers a first month, and the figure that follows it lives only in the FAQ.", "hash": "214fa01c095b5411c0881920598d8123a0613bbf6fccc930502e14a7abbc0cc6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/eloria.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/embody", "canonical": "https://thisglp.com/reviews/embody", "title": "Embody reviews (2026): care, dosing and costs | This GLP", "description": "Embody names its clinical network and dispensing partners. Its promotion and monthly Flat terms still describe different purchase decisions.", "hash": "0cc304e8069686b18da28a30a237c15a0607846f4103ca106c2d790a7b23a8fb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/embody.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/embrace-rx", "canonical": "https://thisglp.com/reviews/embrace-rx", "title": "EmbraceRX reviews (2026): GLP-1 care platforms | This GLP", "description": "EmbraceRX lists compounded injections and oral capsules, with medical services through independent networks including Samaritan MD. Formulation and follow-up need a careful review.", "hash": "5cdefdc67573487bf6ab74b612e546492f1c31a699633c3f0e131ff51186974f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/embrace-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/emed", "canonical": "https://thisglp.com/reviews/emed", "title": "eMed reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "eMed combines its own screening kit with licensed-clinician review, monthly consultations and brief weekly check-ins. Employer access and the public patient pathway should not be treated as identical programs.", "hash": "c6501c17168448df9c30f1082e29513dcad921e7af9a0d621e598b2e7061095e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/emed.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/emerge-weight-loss", "canonical": "https://thisglp.com/reviews/emerge-weight-loss", "title": "Emerge Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A tirzepatide-only clinic that prints every dose's price and bills every four weeks, not every month.", "hash": "50f5a5ef9047f3c6e81a3ba76e087c3c6df94b5d7e44ace28a18d985429cb3f3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/emerge-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/emi-aesthetics", "canonical": "https://thisglp.com/reviews/emi-aesthetics", "title": "eMI Aesthetics reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four plan lengths on offer and one starting figure, with no way to tell which plan the figure belongs to until a gated intake has been completed.", "hash": "3e0eb2e52861df54085b914f8850f384edc269f5b4f6f6606686b656d05d54fa", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/emi-aesthetics.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/enara-health", "canonical": "https://thisglp.com/reviews/enara-health", "title": "Enara Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Enara combines medical weight management with dietitian, movement and behavioral support through partner clinics. Medication is one part of the program rather than its entire purpose.", "hash": "23572a6da018dda48033611a94e1ed85d5680dead19d17e3aa6995dafa3034c5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/enara-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/enhance-md", "canonical": "https://thisglp.com/reviews/enhance-md", "title": "Enhance MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Everything here is billed in four-week cycles, so a plan advertised by the month lands thirteen times a year rather than twelve.", "hash": "2f5bb06de429a2317c5da0647bb1f1517513574ae06f236280eec7f9b2e9ae5a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/enhance-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/enhanced", "canonical": "https://thisglp.com/reviews/enhanced", "title": "Enhanced reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Enhanced now lists clinician-guided semaglutide and tirzepatide within its Weight Rx pathway. Prescription assessment and the supplement storefront are different services.", "hash": "9b1bc29342f086de7f1a431a18a371ba4dc1161a422f6d682d540b955c3df849", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/enhanced.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/eos", "canonical": "https://thisglp.com/reviews/eos", "title": "EOS Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each plan shows what it costs now and what it costs when it renews.", "hash": "09901367695967412080f0542c0e386b26350cbb5473f91a91f7b4cc0035ad07", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/eos.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/eve", "canonical": "https://thisglp.com/reviews/eve", "title": "Eve reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An unpriced GLP-1 program and three branded names, behind an intake that asks for an email before the first health question.", "hash": "10067e019a8678c6e6b4d0303ce8f84339d5bb02ba4a7cf32c207b53f19b80f1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/eve.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/everfit-medical", "canonical": "https://thisglp.com/reviews/everfit-medical", "title": "EverFit Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "EverFit combines an Ohio clinic with online weight-management evaluation. Its public program names semaglutide and tirzepatide, with treatment conditional on a clinician’s assessment.", "hash": "247d8593196f8e9f99e2a2a5b99edd5b0ab79da3a053eec7fe81906345fe8fc9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/everfit-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/evergreen-telehealth", "canonical": "https://thisglp.com/reviews/evergreen-telehealth", "title": "Evergreen Telehealth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Evergreen Lean describes continuing GLP-1 care through a team, while the terms name NVP Medical Group and impose a seven-day cancellation deadline.", "hash": "667ffbed4949a0a40b098ace9a92198bbba3a54bb27266ea50a9ca7469036973", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/evergreen-telehealth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/everlywell-weight-care-plus", "canonical": "https://thisglp.com/reviews/everlywell-weight-care-plus", "title": "Everlywell (Weight Care+) reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A monthly membership on a three- or twelve-month term. The brand medication is billed by a pharmacy.", "hash": "9e2f813307ee7b62210668c4209041ddfa6f4081f2ebb179cd7659a9f6b604fe", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/everlywell-weight-care-plus.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/evernow", "canonical": "https://thisglp.com/reviews/evernow", "title": "Evernow reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Evernow places GLP-1 assessment within menopause-focused care, with membership or individual visits. Medication costs and suitability remain separate from access to the care team.", "hash": "36212fd86c187dc14c9a8b82e38da9c506564579588a3fb8031777bf3cd3c6aa", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/evernow.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/everprime", "canonical": "https://thisglp.com/reviews/everprime", "title": "EverPrime reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Named clinical groups, video visits and ongoing support; confirm the pharmacy and the full cost of your chosen care plan.", "hash": "8a4e8dda5a3a3279037d8e2262ec30f49eaa5696661024b9e58adb9844d18179", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/everprime.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/everslim", "canonical": "https://thisglp.com/reviews/everslim", "title": "EverSlim reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly figure covers the medication, the provider visit and the shipping, and it does not move as the dose does.", "hash": "20b4cbbf3a51d630d341bb3b69aa7e55d6ee117babf1160a267388bd0b15d39b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/everslim.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/eviora-md", "canonical": "https://thisglp.com/reviews/eviora-md", "title": "Eviora MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three GLP-1 programs, each marked available by consultation, from a Virginia telehealth practice that quotes a flat rate only after a provider has reviewed the case.", "hash": "3e0ec59bcfb981248b5ea13857316a8b6e2208d3256d367030ad98bcd6d9ff82", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/eviora-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/evolve-telemed", "canonical": "https://thisglp.com/reviews/evolve-telemed", "title": "Evolve Telemed reviews (2026): weight-care programs | This GLP", "description": "Evolve discusses semaglutide within men’s weight-management care. Its separate women’s page emphasizes hormones, so clarify the actual treatment pathway before enrolling.", "hash": "ea1e7dfb5bef1b49f58917136e090426736b048c0c50a92bd442a84546317ee2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/evolve-telemed.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/factor-health-md", "canonical": "https://thisglp.com/reviews/factor-health-md", "title": "Factor Health MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A flat price at every dose, with the lowest headline figure belonging to a twelve-month plan.", "hash": "1bba0934e01fe6a6f610a0802787da7c2a424f0be6b2d76a3c549dcddd7c6ba4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/factor-health-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/feelgood-meds", "canonical": "https://thisglp.com/reviews/feelgood-meds", "title": "FeelGood reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "FeelGood offers compounded weight-care products and branded options through independent medical groups. Its round-the-clock support claim should be separated from access to the clinician managing treatment.", "hash": "546d41355f296d146f679be0b5bc0924255b466d37b421e4815357326f13a974", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/feelgood-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fella-health", "canonical": "https://thisglp.com/reviews/fella-health", "title": "Fella Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A men's weight-loss program that states its cost per day, not per month, and backs it with a conditional six-month refund.", "hash": "83d6955d6845120f8b153482f22526f1576cb10d6456ed6b656ff2de76f66224", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fella-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fidelity-medical-clinic", "canonical": "https://thisglp.com/reviews/fidelity-medical-clinic", "title": "Fidelity Medical Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each order buys four doses over four weeks, so thirteen of them land in a calendar year.", "hash": "1a5757dd5e5b4446fb18f072b42e9aaa7c853c516f9e4d3242680c26d44ab53e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fidelity-medical-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fierce-health", "canonical": "https://thisglp.com/reviews/fierce-health", "title": "Fierce Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The order is paid before the medical intake, and a nurse practitioner sets the dose afterward.", "hash": "208048404a0fd81beaebb34935bff0b1a20d324c02ae79ca9c18d86d667a35c8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fierce-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fifty-410", "canonical": "https://thisglp.com/reviews/fifty-410", "title": "Fifty 410 reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A page with three starting-at figures on it, only one of which is a GLP-1.", "hash": "b77b99724df56e1f32127f10ebe1d8a0dff90fda4d8b4bda7fcdaef2a94c6a7c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fifty-410.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fitflow", "canonical": "https://thisglp.com/reviews/fitflow", "title": "FitFlow reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The rate in the browser tab is the twelve-month plan paid upfront.", "hash": "cbe273d96d7ed76f358d7c477a62ad0958fb2301d177c45a65c08bd3551b6a11", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fitflow.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fitish", "canonical": "https://thisglp.com/reviews/fitish", "title": "Fitish reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two lanes per molecule, one monthly supply price each, and a microdose lane that stays at one dose.", "hash": "94d29174d75ca3565f1fef48773a7736b6378acff3e94953c0bb86e47efe2738", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fitish.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fitness-rx", "canonical": "https://thisglp.com/reviews/fitness-rx", "title": "Fitness RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A subscription GLP-1 service that prints one medication-inclusive floor and leaves the product behind it to the intake.", "hash": "191e0b17f8588f9f535f1d551f461ccc6ab425547589a11961480105841814e1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fitness-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fitrx", "canonical": "https://thisglp.com/reviews/fitrx", "title": "FitRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An insurance-first service with a bundled cash plan for compounded GLP-1s and a cheaper route that adds a membership.", "hash": "3527a886fbe7b5581cac74e4851678cbb8e019af36f67d10c15bc2b7c365c666", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fitrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fitstry", "canonical": "https://thisglp.com/reviews/fitstry", "title": "Fitstry reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The cards start at $149, the FAQ bills $249 every four weeks, and a clinician reads a long profile before anything ships.", "hash": "25e43c3dfbd0caf1064cf61a112df0f0da59da0064f3ff424a022de20c14233c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fitstry.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/florida-weight-loss-md", "canonical": "https://thisglp.com/reviews/florida-weight-loss-md", "title": "Florida Weight Loss MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Florida Weight Loss MD presents care through Florida Surgery & Weight Loss Center, with separate branded-drug and compounded-treatment pathways.", "hash": "98e27997a0e3583673f26dc9c7e79afa7fd726f751bc5684b77df0f9b54ceb0c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/florida-weight-loss-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fmmeds", "canonical": "https://thisglp.com/reviews/fmmeds", "title": "FMmeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The whole pricing section is two figures and a pharmacy name.", "hash": "eed0014854f6c59b75217bfe3a0f692fab0ee0cb3b86f63b20cf1dd0c8d070b5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fmmeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/form", "canonical": "https://thisglp.com/reviews/form", "title": "FORM reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four lines, four published figures, and not one of them is the price of a medication.", "hash": "0dcdf257d094f399b9a50ae5055b8bb52d5967db022ea5f6f67450f940cff7e5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/form.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/form-health", "canonical": "https://thisglp.com/reviews/form-health", "title": "Form Health reviews (2026): clinicians and coverage | This GLP", "description": "Form combines medical visits, nutrition support and primary-care coordination. Medication is one part of the program, with eligibility and coverage assessed separately.", "hash": "905015ced360231b0928b3054de4c8aa4f688aa664cc97961e1c7dd41cb531c3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/form-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/formblends", "canonical": "https://thisglp.com/reviews/formblends", "title": "FormBlends reviews (2026): prescribing and pharmacy | This GLP", "description": "FormBlends describes clinical screening, check-ins before dose changes and shipment replacement rules alongside its public plan prices.", "hash": "c7602ccef807dd673cff8d3209db476d930f1ac2d9da8e601bcd76e95f407d35", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/formblends.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/formidablemd", "canonical": "https://thisglp.com/reviews/formidablemd", "title": "FormidableMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A priced ladder for each molecule, a paid visit at every dose change, and medical care in four states.", "hash": "35b0532f900399e6af7d805fd8d38acdc98d76ba2da425ac420714825d50a912", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/formidablemd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/found", "canonical": "https://thisglp.com/reviews/found", "title": "Found reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each molecule has its own four-rung ladder, and every rung is billed per 28-day cycle rather than per month.", "hash": "cc66ca4656bff49d4978cbdcc86990102c8f04491c573dcce2d7fe70b32806de", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/found.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/found-youth", "canonical": "https://thisglp.com/reviews/found-youth", "title": "Found Youth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Found Youth describes weekly compounded GLP-1 programs with provider-directed adjustments. Its editorial guide is more informative than the storefront’s broad price ranges.", "hash": "1245ddd645e039474bd4cf28264f64b257456d9d19a57d99640f8981ce09d1d9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/found-youth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/framework", "canonical": "https://thisglp.com/reviews/framework", "title": "Framework reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A figure quoted by the week reads cheaper than the same money quoted by the month.", "hash": "95e13a0ae806f640bb86c9dc406a3b144638d34c515ad1046c2da42ca14e6eff", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/framework.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/freeley", "canonical": "https://thisglp.com/reviews/freeley", "title": "Freeley reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Freeley publishes more of its care process than a simple medication storefront, but its long-plan pricing needs clarification.", "hash": "cc5811769342ff262f0fde90b95074e89493eda15c0e57b979273a4706f10d08", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/freeley.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fresh-day", "canonical": "https://thisglp.com/reviews/fresh-day", "title": "Fresh Day Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The low storefront figures are three-month plans, and the one-month plans renew every 23 days.", "hash": "4d62ec078ac0b340c44fea7f392adb94383aa427ecb96aac88af984a781aff00", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fresh-day.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/freya-meds", "canonical": "https://thisglp.com/reviews/freya-meds", "title": "Freya Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Monthly plans cost more than the quarterly figures, and the dose does not change the price.", "hash": "6e47cf8db45876002503d065ac8fcbfd11c67932b1dd69fe5b0fb139a6c05509", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/freya-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/fridays", "canonical": "https://thisglp.com/reviews/fridays", "title": "Fridays reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The pricing page and the treatment page give different annual rates for the same plan, and the discount figure needs a coupon.", "hash": "36776bdf5c09027ae271b1defb2f027fee783d7fa217a97f46bf101109bb3ecc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/fridays.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/futurhealth", "canonical": "https://thisglp.com/reviews/futurhealth", "title": "FuturHealth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "FuturHealth brings clinical prescribing and nutrition tools together. Before enrolling, distinguish ongoing clinical follow-up from the app’s everyday food and activity features.", "hash": "ee2a6ce27bce7620495ddb615a31a6ab75bf4891cf44bca7b48e47336f3db6eb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/futurhealth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/g-plans", "canonical": "https://thisglp.com/reviews/g-plans", "title": "G-Plans reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "G-Plans offers prescription treatment alongside nutrition tools. Confirm the exact medicine and clinical follow-up rather than relying on the quiz’s metabolic-type framing.", "hash": "465bab4cd6bf41c656a3e368d4e20d5d46559680a70f62ea000ef12e62ed2d08", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/g-plans.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/gala", "canonical": "https://thisglp.com/reviews/gala", "title": "Gala reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A brand cash price near thirteen hundred dollars sits beside a compounded yearly plan at a fraction of it.", "hash": "cd393a37d408b70ca0b7076605d43fd36ee10e372c16ba263556fbbf108f52d7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/gala.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/garcia-weight-loss", "canonical": "https://thisglp.com/reviews/garcia-weight-loss", "title": "Garcia Weight Loss, Aesthetics & Hormone Therapy reviews (2026) | This GLP", "description": "A Tampa Bay clinic group that runs GLP-1 injections through weekly or monthly office visits and prices them only at a consultation.", "hash": "a3d96ffc14189ca8b601c7dd9acdd1759d4b412c61579f6f62dd8752e39d6162", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/garcia-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/gatlan", "canonical": "https://thisglp.com/reviews/gatlan", "title": "Gatlan reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Gatlan describes individualized care and ongoing contact. Ask for the exact prescription, treating practice and monitoring plan before judging the program.", "hash": "6fcbef2e4393e027d5518be27182df6a0177b5bcf627e687e926fb4817dcc6d0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/gatlan.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/gaya-wellness", "canonical": "https://thisglp.com/reviews/gaya-wellness", "title": "Gaya Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A physician-led midlife program with the medication priced inside one tier, in five states.", "hash": "4d0a699c5b0f30c7d881a7b4a474528e9f4e43dd1ab2b5a77311132c6af2cbe4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/gaya-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/genesis", "canonical": "https://thisglp.com/reviews/genesis", "title": "Genesis Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every commitment length is priced and every total is printed beside it.", "hash": "c8a7505dc55ea02d4a67389fe2e7b411e396e1f98a89fff23ff69fa7d3141ceb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/genesis.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/genesis-lifestyle-medicine", "canonical": "https://thisglp.com/reviews/genesis-lifestyle-medicine", "title": "Genesis Lifestyle Medicine reviews (2026): medical weight-loss clinics | This GLP", "description": "Genesis Lifestyle Medicine combines weight-management assessment, laboratory review and adjustable follow-up. Its brand-name and compounded pathways need separate pharmacy and cost checks.", "hash": "ffc957c77c5dc23d628db6b696787cbc5755cf846ce1d532a70c387a7b16a24c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/genesis-lifestyle-medicine.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/get-thin-md", "canonical": "https://thisglp.com/reviews/get-thin-md", "title": "Get Thin MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The sale figures apply to the first month of a three-month plan, not to a month bought alone.", "hash": "f458945131fe52523f8cddcadcc0956ca43ac0ca3221d9fede15fab950138b31", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/get-thin-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/getrelief-rx", "canonical": "https://thisglp.com/reviews/getrelief-rx", "title": "GetRelief Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A daily liquid held under the tongue, sold on two-month plans at prices that move with the dose.", "hash": "2d16a3795a432f090ccc07c69f3038dd4a40a66fb9cc994d66715155558d5a4a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/getrelief-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/gide-health", "canonical": "https://thisglp.com/reviews/gide-health", "title": "Gide Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Gide identifies a provider-network partner, while its broad GLP-1 labels leave the exact ingredient and formulation unclear.", "hash": "86a59d115f6995b530a338a988dcfadd61710a320258cd66cc4b63849468023f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/gide-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/gimme-care", "canonical": "https://thisglp.com/reviews/gimme-care", "title": "Gimme Care reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each product card prints a monthly rate and a three-month rate, and states the price holds at every dose.", "hash": "f3a3165a7e2b607799d51f55137afce335afe049ae01a12008962180ddf5c233", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/gimme-care.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/glam-health", "canonical": "https://thisglp.com/reviews/glam-health", "title": "Glam Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two floors are published with B12 formulations named. Almost nothing else is.", "hash": "aec3f1f905ce5de2d40a0e2af80b4abd9418cd56dba9fe85aaf0d01c613eab50", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/glam-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/glow", "canonical": "https://thisglp.com/reviews/glow", "title": "Glow reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Glow combines an AI-led diet service with a separate clinician-reviewed prescription program. Medical decisions and pharmacy responsibilities need to remain clear.", "hash": "e9efb5b33b6a933243efc652bb5703e2b49f582d6c7bddf9efcaf1750c0a7a80", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/glow.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/go-vida-plena", "canonical": "https://thisglp.com/reviews/go-vida-plena", "title": "Go Vida Plena reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Spanish-language program whose advertised figures are annual rungs, with installment plans offered on top.", "hash": "b2571a286e89be7663eb119603231dd93cc75c83c5a479302a5c32c9545e56d4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/go-vida-plena.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/goal-md", "canonical": "https://thisglp.com/reviews/goal-md", "title": "GOAL.MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Physician supervision, nutrition coaching and a phone-accessible team are included. The question is how that support translates into your own follow-up plan.", "hash": "d87b0d4292af5971386e97514466ba67508b89d7178da0bb5ab25f950ce2a011", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/goal-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/gobymeds", "canonical": "https://thisglp.com/reviews/gobymeds", "title": "GobyMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A one-month price at any dosage, beside a starter bundle with its inclusions spelled out.", "hash": "beee71277bc69c02936b9bd7c2446efc0a5b3ff1fc0b9cf69d162e2f91bfd249", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/gobymeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/goldspan-health", "canonical": "https://thisglp.com/reviews/goldspan-health", "title": "Goldspan Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The word monthly appears beside a supply that arrives every four weeks, and the price is not on the seller's own site.", "hash": "a7f8be99ab9e14f145d234c57de01400f9481a7a25cdc829ffb4914d1f68841c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/goldspan-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/good-girl-rx", "canonical": "https://thisglp.com/reviews/good-girl-rx", "title": "Good Girl Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each \"from\" figure is the twelve-month rung of a prepaid plan, and the one-month rate sits on the same selector.", "hash": "3f03529640f6b0d434de713404259ed17ed59e27a59ca62547120323a8e7ce6b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/good-girl-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/good-life-meds", "canonical": "https://thisglp.com/reviews/good-life-meds", "title": "Good Life Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One figure holds across every dose level, with no membership and no fees stated on top.", "hash": "bdb4c992e094188a24b84863585f64b1d50f28222b239a2bcf1a01e9f9a99bb8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/good-life-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/goodlife-health", "canonical": "https://thisglp.com/reviews/goodlife-health", "title": "GoodLife Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "GoodLife puts repeated lab review and cardiometabolic care ahead of a medicine-only offer. The monthly membership and the pharmacy prescription remain separate.", "hash": "9fa36902f176f6d83f5f36371b776345d25c9a59898a37e3c781aad730000a3a", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/goodlife-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/goodrx", "canonical": "https://thisglp.com/reviews/goodrx", "title": "GoodRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The prescription-coupon company's telehealth plan, which prescribes FDA-approved GLP-1s only and bills a monthly membership apart from the medication.", "hash": "ab488dede339cbfa141c4180ce041f443959031b3c2769625e7756ec286a0d37", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/goodrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/green-cap-health", "canonical": "https://thisglp.com/reviews/green-cap-health", "title": "Green Cap Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two unusually low published figures, available in a single state.", "hash": "826c808a6e8f686fea1854df6d3e57f8f749cf7cfdbe7fd1afe11c96ab5d1e71", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/green-cap-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/happy-care-meds", "canonical": "https://thisglp.com/reviews/happy-care-meds", "title": "Happy Care Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Happy Care Meds identifies a clinical-service platform and offers weekly compounded weight-loss protocols.", "hash": "c35307a64e7d56464c56d1cf7d593f9d4f095c2293ff90e49a83f474708c5a76", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/happy-care-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/harbor", "canonical": "https://thisglp.com/reviews/harbor", "title": "Harbor reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each plan states what it covers. Each figure carries the words as low as.", "hash": "7aeaa8509fb9cf131a9d374e82593cfcae4027a0b3a03201f6cd9db60be9a8d5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/harbor.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/harmony-wellness-clinic", "canonical": "https://thisglp.com/reviews/harmony-wellness-clinic", "title": "Harmony Wellness Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Five priced levels on one molecule and six on the other, printed on the services page rather than discovered later.", "hash": "6dafd54024bc94a8b1ab92b019d59c46a1749e020ca03f2e89a7e3ea4d7669d4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/harmony-wellness-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/harper-meds", "canonical": "https://thisglp.com/reviews/harper-meds", "title": "Harper Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One charge covers the consultation, the prescription and the shipping, and the fill it buys runs four weeks rather than a calendar month.", "hash": "219447afbe04822c388b160883a7c3d4e86c073fa7bc22395081c36ec1df579d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/harper-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/he-and-she-md", "canonical": "https://thisglp.com/reviews/he-and-she-md", "title": "He & She MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both injection rates are annual plans billed in a single payment, and the oral figure is an introductory rate that renews twenty percent higher.", "hash": "b5bbca119bed2ee7ac8a55d91f12471d1ab7cd5a96ddd5007d27c3b83398ab58", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/he-and-she-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/healfast", "canonical": "https://thisglp.com/reviews/healfast", "title": "HealFastRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "HealFastRx includes supplies, clinical care and shipping in its compounded injection offer, with separate introductory, monthly and prepaid prices.", "hash": "4473046069a2f8844cb81ae721c4e06f2780f83e2da8d8f19770fe4ec6a0b7b7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/healfast.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/heally", "canonical": "https://thisglp.com/reviews/heally", "title": "Heally reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A telehealth marketplace that prescribes brand semaglutide and tirzepatide after a live video visit, with no membership and no compounded option.", "hash": "fbf28994509d3e1865e634cfadb901ef7e9eac8e54e9915873d3d15d3960976f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/heally.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/healthhub", "canonical": "https://thisglp.com/reviews/healthhub", "title": "HealthHub reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The homepage tile quotes more than the injection behind it actually costs.", "hash": "981ac092fcf140735a3fe77570260f4c41d8396bdecbcf8519bfe128c15b28d8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/healthhub.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/healthicare", "canonical": "https://thisglp.com/reviews/healthicare", "title": "Healthicare reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two injections at low monthly rates, with the charge broken into its parts and a three-month plan beside it.", "hash": "981d70ab5ba5ac5672d822c7b0cc17162bfe2f3723d441df9cf91becc6328f50", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/healthicare.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/healthon", "canonical": "https://thisglp.com/reviews/healthon", "title": "HealthOn reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The product pages lead with a twelve-month figure. The monthly plan in the cart bills differently.", "hash": "aa9f51d977f6900cd5066f03808490072ce2673e23a4a062ae81099b359828a3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/healthon.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/healthrx", "canonical": "https://thisglp.com/reviews/healthrx", "title": "HealthRX reviews (2026): GLP-1 sellers by price | This GLP", "description": "Both molecules are stated flat at every dose, which on a medication designed to be escalated is the disclosure worth more than the headline.", "hash": "1c5c04241def408ebcdf8ce4c69eebd886ecf48f1372c3971441e394f7dbabbc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/healthrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/healthsource", "canonical": "https://thisglp.com/reviews/healthsource", "title": "HealthSource reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every figure is quoted per four weeks rather than per month, and the dispensing pharmacy type is stated.", "hash": "ec5796f73fac015663e32d2b9bae314ea02f6f9fba22defb5eb2a63739d51701", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/healthsource.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/helimeds", "canonical": "https://thisglp.com/reviews/helimeds", "title": "HeliMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every plan runs twelve weeks, and every monthly figure beside one divides by three.", "hash": "7383562c2772c8f1ef0c290fd16f1ccfdeb25183e59be6aa7eed6b1adecca6c6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/helimeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/helix-wellness-rx", "canonical": "https://thisglp.com/reviews/helix-wellness-rx", "title": "Helix Wellness Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Helix Wellness Rx describes direct clinician messaging and flat-rate semaglutide care. Its public pages disagree about how much cancellation notice is required.", "hash": "458ec15ff5c06d8ba3695752036dc634c832434b9d55859a178367051b75208d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/helix-wellness-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/hello-alpha", "canonical": "https://thisglp.com/reviews/hello-alpha", "title": "Hello Alpha reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Everything Alpha dispenses has an FDA approval behind it. Nothing it dispenses has a published cost.", "hash": "be1fa26e374f9479d241bb85da9918c7c4baccc83eaa091cf8bd1c491a7350bc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/hello-alpha.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/hellowellness", "canonical": "https://thisglp.com/reviews/hellowellness", "title": "HelloWellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A longevity-branded online seller of compounded semaglutide and tirzepatide, sold as three-month plans that renew every eleven weeks and are paid before any intake.", "hash": "aba09c1fc2262f07316358fe5c07675974af6419dd2bcdf1d140970bbfac5817", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/hellowellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/henry-meds", "canonical": "https://thisglp.com/reviews/henry-meds", "title": "Henry Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A monthly rate here buys a quantity of drug per shipment window, and the window stretches as the allowance grows.", "hash": "7d8c96795ce82cb36da5cdf669b196d8b0fe76c8df380f34207a77aa41f77b7b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/henry-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/heros-health", "canonical": "https://thisglp.com/reviews/heros-health", "title": "Heros Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The program names its prescribing physicians and publishes dose check-ins at weeks 2, 4 and 8.", "hash": "0306ed5f77c0d0e38015e3b2a8cc9016ad189aa17f0ae4239b411b4f3454e5b7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/heros-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/hers", "canonical": "https://thisglp.com/reviews/hers", "title": "Hers reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every medication price here is missing $149, and Hers states plainly that the membership behind it is not optional.", "hash": "9042a68cc5a940f622901c69b6897b6ed74ffff56d7976a7e8be85d4c36e6436", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/hers.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/heva-health", "canonical": "https://thisglp.com/reviews/heva-health", "title": "Heva Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A functional-medicine practice that sells compounded semaglutide and tirzepatide at a flat rate across doses, with the month-to-month rung printed beside the commitment discounts.", "hash": "6f7c89abd932f4d33a73df18948e42540149b138aa8efe4d1a29503ed3503b6a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/heva-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/hims", "canonical": "https://thisglp.com/reviews/hims", "title": "Hims reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every GLP-1 price is medication only. The membership is billed separately and cannot be skipped.", "hash": "9a5a41d773c6848f24137364cd844b8116ef696bdd0b62b1b2be089a8a398508", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/hims.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/hone-health", "canonical": "https://thisglp.com/reviews/hone-health", "title": "Hone Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Hone Health combines biomarker testing and physician visits with a separate medication bill. Its listed GLP-1 option is compounded liraglutide, within a broader hormone and longevity service.", "hash": "61c57df3eb94160211159bcd2293c7f68ef5c54be63268db5b36e398971d96b9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/hone-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/hormonally-balanced", "canonical": "https://thisglp.com/reviews/hormonally-balanced", "title": "Hormonally Balanced reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Hormonally Balanced lists a monthly tirzepatide program with a physician-assistant consultation, medication delivery and coach check-ins. Pharmacy and stopping terms need clarification.", "hash": "513f19e84cbf153efb3a51dea5ee39fb61a743d070b6a324cfd70c2bde472d59", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/hormonally-balanced.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/humecare", "canonical": "https://thisglp.com/reviews/humecare", "title": "HumeCare+ reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The rate is stated to hold at every dose, and what it covers includes a physical device as well as the medication.", "hash": "709d2745d554c00950930519adb10a77b147149e07d78ba78f5d750bc8eeb8d3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/humecare.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/idgie-health", "canonical": "https://thisglp.com/reviews/idgie-health", "title": "Idgie Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "This seller calls its own microdosing approach off-label on the page that sells it, which few in this category do.", "hash": "a82a3fddb6e5a1c459a0845e25343498ad2012de578d8c9f6976d0d001d707f5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/idgie-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/immortals", "canonical": "https://thisglp.com/reviews/immortals", "title": "Immortals reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every monthly figure on the GLP-1 pages is a share of a three-month charge taken at the start.", "hash": "d490cc3d59815c69fcc83e0d01100145229271c2fb1b4455853afcf7aeeee258", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/immortals.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/independent-wellness", "canonical": "https://thisglp.com/reviews/independent-wellness", "title": "Independent Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A single-provider telehealth practice selling compounded semaglutide and tirzepatide, with a semaglutide rate its own pricing page states two ways.", "hash": "a21249ce24783241248822c32ffd9734b49c32249fa7ae8e9b884a378553ad01", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/independent-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/injectco", "canonical": "https://thisglp.com/reviews/injectco", "title": "Injectco reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A monthly subscription for each molecule, beside long packages quoted only at the starting dose.", "hash": "6b636a14480a1117222ef31fbd285c3d236ddb72a350497ba8cafe62d6d391cb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/injectco.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/instarx", "canonical": "https://thisglp.com/reviews/instarx", "title": "InstaRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One flat price is stated for both molecules. Only the first month carries a figure.", "hash": "2e8673af269fe0df65b7f92aec6c2f6d535706ca499c32a43205726e7ec1e60f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/instarx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/intimate-rose", "canonical": "https://thisglp.com/reviews/intimate-rose", "title": "Intimate Rose reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One advertised floor covers both molecules, and the prescribing is done by a named clinician network.", "hash": "8d241cb9ebd0180f885c734109277c238b01a2a0823c10a82d2ccd3120d35396", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/intimate-rose.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/invigor-medical", "canonical": "https://thisglp.com/reviews/invigor-medical", "title": "Invigor Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The plan pages say GLP-1 and GLP-1 + GIP. The checkout bills every four weeks.", "hash": "f8002e92aa2130df798be5ec405e61570faf8c2e274a9a7bdf2488d45fbb374d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/invigor-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/invyncible", "canonical": "https://thisglp.com/reviews/invyncible", "title": "Invyncible reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every step up the dose ladder is a separate program with its own higher price.", "hash": "d06afa4dda82bb4d4a0f86432878be22d7ad8f7b68cf9dde4dab0a362ec1c15a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/invyncible.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/iron-med-rx", "canonical": "https://thisglp.com/reviews/iron-med-rx", "title": "Iron Med RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An injection from $149 and a tablet from $196, each printed under a list of three plan lengths that the page never matches to a price.", "hash": "c8f7315c3b7c19f7d4a44ac1887fd0db77e389a729ade953290f2547dc6f951f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/iron-med-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ithrivemd", "canonical": "https://thisglp.com/reviews/ithrivemd", "title": "iThriveMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A clinic network in two states, with a flat price at every dose and a 28-day billing cycle.", "hash": "f2d577bcc1b89d7bb608a925bb31f339129268cab1a3bb50838d3ffa9587f8af", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ithrivemd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ivim-health", "canonical": "https://thisglp.com/reviews/ivim-health", "title": "Ivim Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Ivim charges for care and for the drug on separate lines, and says so on its own pricing page.", "hash": "953968db02aa298afb26138dd9bf1e19344c0541e3bae5d0a5d6a9692170542a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ivim-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ivologist", "canonical": "https://thisglp.com/reviews/ivologist", "title": "Ivologist reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The paid-in-full plan runs eleven weeks and is priced as though a quarter had gone by.", "hash": "de961561616fff58a7a0f7a3f7d1fb9ab6d84e8a6e17bc3b0a85720c4876525c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ivologist.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ivy-rx", "canonical": "https://thisglp.com/reviews/ivy-rx", "title": "Ivy Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every figure Ivy Rx prints is a floor, and the floor depends on which page a buyer lands on.", "hash": "ce083f1fe9f09c51d11c972e2c7ee02c0a41deb839f1b7569ecbcf964a270aab", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ivy-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/jently", "canonical": "https://thisglp.com/reviews/jently", "title": "Jently reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A New York telehealth platform that names its compounding pharmacy and opens on a no-commitment month.", "hash": "7a9dadf1205e3215bbbeb328f9693230fa113fbda1130d37c51cbee471b7f5a5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/jently.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/jm-integrated-health", "canonical": "https://thisglp.com/reviews/jm-integrated-health", "title": "JM Integrated Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "JM Integrated Health makes the cost boundary clear: its program fee pays for care, while the pharmacy charges separately for medication.", "hash": "98c77abe35d9a18b8ee08b3100519776633ab1c3f3c44e206850670492034789", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/jm-integrated-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/joey-med", "canonical": "https://thisglp.com/reviews/joey-med", "title": "Joey Med reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two GLP-1 plans priced per four weeks, with the drug in each named only on the hub page.", "hash": "8df9e59ad726af2d99f9b79a6a9900603c469e3d3c8969fb9ccb3c31d00a7f8e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/joey-med.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/joi-and-blokes", "canonical": "https://thisglp.com/reviews/joi-and-blokes", "title": "Joi + Blokes reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The card prints the introductory rate and the standing one in the same line.", "hash": "e865e8ce75909873ec8c02be185c0be886a7004c5e8d976fe78b6432258310b2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/joi-and-blokes.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/jrnys", "canonical": "https://thisglp.com/reviews/jrnys", "title": "JRNYS reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A coaching membership with a published price, and brand-name drugs priced after a consultation.", "hash": "430312ef2bcd1b0d1edc162e8b6d2f117eae164cee8e7c04e603b6cfd5c88205", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/jrnys.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/jumpstartmd", "canonical": "https://thisglp.com/reviews/jumpstartmd", "title": "JumpstartMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A California clinic network that prices the act of joining and leaves the medication to be priced after the clinician visit.", "hash": "c00fc76ea33d01f4246809919881a93aa7139f4d9847e9e9b925de9860fea0b9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/jumpstartmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/june-health", "canonical": "https://thisglp.com/reviews/june-health", "title": "June Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each line publishes its whole tier structure, and the milligram doses are stated on the oral ones.", "hash": "377c40dea715346462752ae416328fbb524b28d310b700e327321462a64523fa", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/june-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/justanswer-weight-loss", "canonical": "https://thisglp.com/reviews/justanswer-weight-loss", "title": "JustAnswer Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both published figures are annual-plan rates, and the monthly plan is priced behind a sign-up form.", "hash": "b6ea753932567e47cb7df42498626ab8f1bfb1cbac204be32a2f1462ce584833", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/justanswer-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/jyra-health", "canonical": "https://thisglp.com/reviews/jyra-health", "title": "Jyra Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A flat price that holds through every dose step, from a seller that names all three of its pharmacies.", "hash": "a96c12465aeb670f48d8f353cc78f672437711ae1774ad1ca06e30605cc4e2f5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/jyra-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kairorx", "canonical": "https://thisglp.com/reviews/kairorx", "title": "KairoRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "KairoRx offers clinician-reviewed weight treatment and a separate AI health-advisor feature. Its branded-drug access fees are distinct from the medication bill.", "hash": "2808f7a959b8eba52329915f9fd215bf9fb048cc715fa9aab7071ba650d72af2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kairorx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kernx-health", "canonical": "https://thisglp.com/reviews/kernx-health", "title": "KERNX Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The consultation is priced as three named tiers and is charged only when treatment is approved.", "hash": "24a1fef6aa1b3d38c14ab9cab175e300d57111daa9e31dd43d03afabec306c27", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kernx-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kin-health", "canonical": "https://thisglp.com/reviews/kin-health", "title": "KIN Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "KIN advertises a single price including medication, provider care and messaging. Its GLP-1 menu groups several formulations without fully defining every drug-and-form option.", "hash": "01b4c998f98d7293f31c2a83bb744204c0e0ba34c212b696aff4794267ab3cf0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kin-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kin-meds", "canonical": "https://thisglp.com/reviews/kin-meds", "title": "Kin Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One figure can be checked against a manufacturer's own published price. Two cannot, and sit at about half cash-pay.", "hash": "1f786924819ab601c1b53ba697897d948af68962cc9b6e2749c6e3c01b42503a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kin-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kina", "canonical": "https://thisglp.com/reviews/kina", "title": "Kina reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One population, four delivery routes, and the clinical provider named with a street address.", "hash": "46aea6d2c1f2de5672510b205c5a7bc7a167e7873d72148e407faa0cf6ddf064", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kina.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/klarity-health", "canonical": "https://thisglp.com/reviews/klarity-health", "title": "Klarity Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Klarity Health offers a choice of independent weight-loss clinicians, insurance or self-pay visits and medication assessment. Continuity depends on the particular practice selected.", "hash": "b426eed8d7f4c46fb2519e4cd241f070d4bb56e9750a3c937896b6f2f8273c1c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/klarity-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/klinic", "canonical": "https://thisglp.com/reviews/klinic", "title": "Klinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Klinic connects patients with independent medical practices for weight-management assessment. Consultation fees, prescription costs and insurer access are separate decisions.", "hash": "fa3219c8a47f976d289e85e3131683b736dad1ee5f5f4ee1f2ccb0034f00befb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/klinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/knownwell", "canonical": "https://thisglp.com/reviews/knownwell", "title": "Knownwell reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An obesity-medicine practice that bills insurance for visits and prescribes brand-name drugs only.", "hash": "c79a41d9198d81009cf455c085dcf291989f61b50b75d468c3115980084200e4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/knownwell.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kongo", "canonical": "https://thisglp.com/reviews/kongo", "title": "Kongo reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two all-inclusive monthly rates, no membership, and a provider review within a day.", "hash": "41ec7abfb0c25e8164475aa2fbd4a11fb09cedaf2a96e93e5b51e92cfd4e31ec", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kongo.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/kova", "canonical": "https://thisglp.com/reviews/kova", "title": "Kova reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Kova combines clinician-reviewed treatment with an app for tracking progress. Its plan billing can continue independently of refill and review timing.", "hash": "6827499e07c032f73d9f884db7bc8e3cf72a065dca58bb80baf9133ad99965d3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/kova.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lasara", "canonical": "https://thisglp.com/reviews/lasara", "title": "LaSara Medical Group reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each step down the price ladder is bought with the whole term's money at the start.", "hash": "1c1671f4d68fe8f62666de783eb20c2b8b843c8b4da2c2dfe5f3ceae41efdab6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lasara.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lavender-sky-health", "canonical": "https://thisglp.com/reviews/lavender-sky-health", "title": "Lavender Sky Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every compounding pharmacy is named beside its own price, and a new patient's first order is a one-month starter plan.", "hash": "693d5d4b69cd4f84cc24d1798506081df999eaf8be54c84d5e22e91df3d26af0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lavender-sky-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/layla", "canonical": "https://thisglp.com/reviews/layla", "title": "Layla reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Oral semaglutide drops at $237 a month after a discounted first month, beside a footnote about a different form.", "hash": "2e8c466e45786ddfc668fe1c3b6de31e60ae8b1702d0dd07f2e5db6d3c60272f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/layla.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lean-rx", "canonical": "https://thisglp.com/reviews/lean-rx", "title": "Lean Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every plan is billed in four-week fills. The one rung without a lock-in adds shipping.", "hash": "b9a2c77ef7180138d52f84f5a1fff44eb11cc107fe29a34e05baf1d34391781b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lean-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/leandose", "canonical": "https://thisglp.com/reviews/leandose", "title": "LeanDose reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both published figures are labeled first-month prices, and no ongoing rate appears anywhere.", "hash": "6e7e76da4a08fb90d891a3cf976821f8dd17c4c782e5bbffda5c93aea2bc4041", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/leandose.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/leanmeds", "canonical": "https://thisglp.com/reviews/leanmeds", "title": "Lean Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Leanmeds describes clinician review and coaching, but its current starting offer does not identify a separate price for each molecule.", "hash": "cabfbdc13f26bd135ce90112670dcb3a677ac0c6e9f4b2e88d14732d37249f1b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/leanmeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lemonaid-health", "canonical": "https://thisglp.com/reviews/lemonaid-health", "title": "Lemonaid Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Medication at $299 a month plus a required $49 membership, from a clinic that names its clinicians.", "hash": "ccee5a8ebb00f7ba4c4bf685f82aafce0beec89aa1ec68828d9bf08f64149761", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lemonaid-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/levelsrx", "canonical": "https://thisglp.com/reviews/levelsrx", "title": "LevelsRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two starting prices on a seller whose cost rises with the dose, and no ceiling published.", "hash": "4f1b6022337b498c416d75d19e3de0e95d5831348382595ec9508c0882d0dcab", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/levelsrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/levelup-rx", "canonical": "https://thisglp.com/reviews/levelup-rx", "title": "LevelUp Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every plan length is priced as a total, and the rate is stated flat across doses.", "hash": "022f588224b4600180718871bb419261b47c7bc091d44c722da2798a3d41ca50", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/levelup-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/levers-health", "canonical": "https://thisglp.com/reviews/levers-health", "title": "Levers Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each advertised figure buys a capped weekly dose, and the next band up costs more.", "hash": "e92f975c24102c06e4942b124efff48fc01e393876ff4ec067aee8b1dd8db65f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/levers-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/liberty", "canonical": "https://thisglp.com/reviews/liberty", "title": "Liberty reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The preparation is sourced from a 503B outsourcing facility, which is a different regulatory category from a retail compounding pharmacy.", "hash": "5d89d37d6696c5c33ce041e1e5fdd53ff111b302fca7896fe92eb9c7ae0c1e5f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/liberty.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lifemd", "canonical": "https://thisglp.com/reviews/lifemd", "title": "LifeMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each published figure is medication only, with a $149 monthly program fee charged alongside it.", "hash": "f95ed94436662caec614d4694ee5100aed57a66cbef0302c2f07a31ddf2f2736", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lifemd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/liferx", "canonical": "https://thisglp.com/reviews/liferx", "title": "LifeRx.md reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One starting figure for a GLP-1 plan, a pledge not to charge more as the dose climbs, and a refund policy with no exceptions for dispensed medication.", "hash": "4945dfe62293f9fc502ddd5e8165ee9ababaacdab4c9436af6619adacbe2b999", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/liferx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lifespanningrx", "canonical": "https://thisglp.com/reviews/lifespanningrx", "title": "LifespanningRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Miami peptide and longevity platform whose weight-loss program is sold through a clinician evaluation, with no GLP-1 price on the program page.", "hash": "48d19e7e9046e7d1de170486dc4974426624895f625198097ec452e79ae4c403", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lifespanningrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lifevine-wellness", "canonical": "https://thisglp.com/reviews/lifevine-wellness", "title": "LifeVine Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "LifeVine’s nurse-founded identity sits alongside a clear legal distinction: independent medical groups provide treatment. Renewal charges may be processed early.", "hash": "18826fff13dc1c7f425c9b449c370bc0661493ae786a991bed3a39c094b47966", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lifevine-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lighter-you", "canonical": "https://thisglp.com/reviews/lighter-you", "title": "Lighter You reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Lighter You combines medication access with advertised support. Verify the plan’s clinical follow-up and the conditions behind its satisfaction guarantee.", "hash": "5b35ca9ffe6c9c227a7eb9b279c03d0b7367e5969862ee31af29e77f6b87c7f4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lighter-you.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lillydirect-foundayo", "canonical": "https://thisglp.com/reviews/lillydirect-foundayo", "title": "LillyDirect Foundayo reviews (2026): manufacturer direct pharmacy | This GLP", "description": "Eli Lilly's direct pharmacy channel for its orforglipron tablet, with a self-pay price for every strength and a separate insured figure.", "hash": "cbe8c4217f3004c12c857901f4b357a32351837b2a952177a6f33e96f26ff613", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lillydirect-foundayo.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/liv-body", "canonical": "https://thisglp.com/reviews/liv-body", "title": "Liv Body reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "No membership and no contract, and an asterisk saying the real price depends on what is prescribed.", "hash": "2fe57277cbbff58abbc061c861e612b57b203ae6d2978c10845671a7cd57fe43", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/liv-body.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/liv-by-wellnow", "canonical": "https://thisglp.com/reviews/liv-by-wellnow", "title": "LIV by WellNow reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One compounded semaglutide membership at $195 a month, sold in five states, with its dose schedule printed on the page.", "hash": "cb24faa563ca5110612d69e5dab974b432d6b16ed8ef0a8437f5786a67573b87", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/liv-by-wellnow.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/livbetr", "canonical": "https://thisglp.com/reviews/livbetr", "title": "Livbetr reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A care coach and AI-assisted check-ins accompany clinician-reviewed treatment. Ask which contacts involve the prescriber.", "hash": "0df02bf3c5004a87fe5504dd5aced2c56aa07f4d7f7299accb6301ac18d4393e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/livbetr.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/live-vital", "canonical": "https://thisglp.com/reviews/live-vital", "title": "Live Vital reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both plans are ten-week protocols, and the page's own framing calls one of them a three-month program.", "hash": "5a25874310e65821e220489a4b593d7fcdb7ae7c2288b455f5541114d3529973", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/live-vital.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/livea", "canonical": "https://thisglp.com/reviews/livea", "title": "Livea reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The medication figure and the program fee live on different pages, and the site says the relationship between them is settled at a consultation.", "hash": "1c0a2cd2efef425d8fe571b15868c9e7ac0b2a393374ef86e26dbab00088b708", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/livea.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/livv", "canonical": "https://thisglp.com/reviews/livv", "title": "50 Stars Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide is $146 on the monthly plan, the same at every dose.", "hash": "8d8cc051fb345631a506bd3ece3d41209ac7a6fe6d4567a12e953e880d88e7f7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/livv.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/longevity-meds", "canonical": "https://thisglp.com/reviews/longevity-meds", "title": "Longevity Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Longevity Meds names compounded semaglutide and tirzepatide, lists available strengths and describes care-team support. Its public screening shows the information requested before evaluation.", "hash": "640e457a2bc0d899fecce507c014d5cdb432afb2253eb7b847b68a7f66a1862a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/longevity-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/longevixx", "canonical": "https://thisglp.com/reviews/longevixx", "title": "Longevixx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both prices sit on one treatment menu, flat across doses, with no anchor beside them.", "hash": "fc53799483c78c68e515c7f65ea02fb278ba278c69f2d0b3499ee56b5ac9560a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/longevixx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/loop-health", "canonical": "https://thisglp.com/reviews/loop-health", "title": "Loop Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A peptide community whose membership is free for now, with GLP-1 prescriptions priced flat at every dose and sold on top of it.", "hash": "08d12f674ec5150a44131ef522ed9a3cdc73fc2169ac99d11f31f234e59c408f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/loop-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/loozy", "canonical": "https://thisglp.com/reviews/loozy", "title": "Loozy reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Loozy’s approachable storefront describes asynchronous support, while its terms establish a prepaid three-month telehealth membership.", "hash": "e409abe6e832bb5618fdc0289699c804ecbe95760f0687ba4ce80bf8531498d1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/loozy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lovelymeds", "canonical": "https://thisglp.com/reviews/lovelymeds", "title": "LovelyMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Compounded semaglutide at $175 and tirzepatide at $235 on one-month plans, each flat across doses.", "hash": "98bd0ebafd8a3010c701191376fa139134ba4076209c9ab174ba534e5c1ca7bb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lovelymeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lttl", "canonical": "https://thisglp.com/reviews/lttl", "title": "Lttl reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every line publishes a four-rung prepay ladder, and the low-dose and standard-dose products are priced separately rather than blended.", "hash": "4df34c621217b38617b6287044b7b372fc86ee64d02929e60fa7914d8c0d4c19", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lttl.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/luci", "canonical": "https://thisglp.com/reviews/luci", "title": "Luci reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four figures, all of them asterisked. The seller's own note says the real monthly cost may be higher.", "hash": "e40def3f950981cf09e006d72ff85773de235a8b90180140e66505ef4d3867be", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/luci.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/luma-health", "canonical": "https://thisglp.com/reviews/luma-health", "title": "Luma Health Co reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A price for every milligram strength, each buying four weeks, with no subscription attached.", "hash": "27dec027d896ed12d9de7582ba465e00916689e634f0c403ff536d4e93a04d7d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/luma-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/luma-meds", "canonical": "https://thisglp.com/reviews/luma-meds", "title": "Luma Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The headline figure requires being new and paying for three months, and a continuing patient on monthly billing pays half as much again.", "hash": "8ae72eb0e2203c718d9ad9ac81b6a540141f5e52b305172a3aa22b75a556e68e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/luma-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lumen-meds", "canonical": "https://thisglp.com/reviews/lumen-meds", "title": "Lumen Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two compounded programs at flat monthly rates that hold at every dose, with no membership fee and no term to sign.", "hash": "a1420d3a50d40ef6cdecf2a64693e1290f665ed7525385cdc854fc02189e7e92", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lumen-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lumimeds", "canonical": "https://thisglp.com/reviews/lumimeds", "title": "LumiMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The ingredient, route and pharmacy type are all stated; the plan behind the price is not.", "hash": "dba42791af26dab1d4d3009d512b3c2c4326774975fac604b1ed273dc5b7c90b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lumimeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lumora", "canonical": "https://thisglp.com/reviews/lumora", "title": "Lumora reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The site promises to show visit fees, medication, labs and follow-up before you commit, and publishes an amount for none of them.", "hash": "7b3bc6cc15888fc4fb893042e6e50d092d08561a0525b1243f12f1e28290fb6a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lumora.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lunarx-health", "canonical": "https://thisglp.com/reviews/lunarx-health", "title": "LunaRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One headline figure spans three bundled stacks, and the page never says which stack it prices.", "hash": "6ad6172bcd5df154041acf96aa9848f8e6b0a27f1f1ac769daa7826a2988a309", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lunarx-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/luvo-health", "canonical": "https://thisglp.com/reviews/luvo-health", "title": "Luvo Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Everything is priced per four weeks and per week at once, with twelve, twenty-four and fifty-two week blocks published beside it.", "hash": "24925d37a434606238b78ce9270fe401e0f1d8f7775334f5b102581663573e93", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/luvo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lvng-rx", "canonical": "https://thisglp.com/reviews/lvng-rx", "title": "LVNG RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The card figures are stated to be confirmed after a provider review, which makes them provisional.", "hash": "09c682932bb41f1aa45a04ecb6ca8e64e3c17a43f6ac8c10afd2f561bde7d55f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lvng-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/lyfe-rx", "canonical": "https://thisglp.com/reviews/lyfe-rx", "title": "Lyfe Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each price includes the provider review, medication, supplies and shipping, with no membership fee.", "hash": "ab6c36fd0d5b7a4cb1f2954f64009b3b69f6cfa9caa327b64607af1700dfc316", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/lyfe-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mademed", "canonical": "https://thisglp.com/reviews/mademed", "title": "MadeMed reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised figure belongs to the six-month plan, and every line publishes the shorter term's rate beside it.", "hash": "b6e8f95c9d0d4f5ad513fea544fcbfd20dcc64d05a52176d1118de9bfd9274b1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mademed.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/male-excel", "canonical": "https://thisglp.com/reviews/male-excel", "title": "Male Excel reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Male Excel includes GLP-1 options within a broader men’s hormone and metabolic program. Regular provider reviews are described, while the drug-specific costs need clarification.", "hash": "978fa3a5fb4982ffe52640d01342d4d81646e79432c2beb56478aac649926c76", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/male-excel.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mangorx", "canonical": "https://thisglp.com/reviews/mangorx", "title": "MangoRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "MangoRx offers Slim, a compounded semaglutide dissolving tablet. Its clinical process, pharmacy terms and formulation deserve separate consideration from the low starting price.", "hash": "00ce9ed46d9cbc6edbd1b0497e8e0dca2ba717282a2de476b649bd7d1794af30", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/mangorx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/manu-telehealth", "canonical": "https://thisglp.com/reviews/manu-telehealth", "title": "MANÜ Telehealth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two plans per molecule, split by dose rather than by term, with both figures published.", "hash": "49b840d20f3fc74ab15f66bd6f1e8e1457c34645eb51018c001ed322d8b301af", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/manu-telehealth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/marek-health", "canonical": "https://thisglp.com/reviews/marek-health", "title": "Marek Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A lab-led optimization service that tests before it prescribes, and publishes no price for the GLP-1 medication itself.", "hash": "5b0da2c72519a2fe2de17595e1001ff1b1c5c09856b844e72185a19d9b1a654c", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/marek-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/maves", "canonical": "https://thisglp.com/reviews/maves", "title": "Maves reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The $89 on the page is a first month with a $100 discount applied, and every month after it costs $189.", "hash": "c4087063034445ece4bb34fbaa773ba90ad5acfd94a453f6cab770b78df58396", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/maves.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/maximus-tribe", "canonical": "https://thisglp.com/reviews/maximus-tribe", "title": "Maximus reviews (2026): sellers of the branded GLP-1 products | This GLP", "description": "Compounded preparations and the manufacturers' pens are listed side by side on this seller's plans.", "hash": "d8d370a5ae63d662e72cb3c5d590ea75eba6b092192468874018c71bd31923bb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/maximus-tribe.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/maxlife", "canonical": "https://thisglp.com/reviews/maxlife", "title": "MaxLife reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both headline figures are asterisked to a Starter Kit Plan that the page never describes.", "hash": "36e60c256cb754ff760dc579bb241961106aca209869281619eb10db09b5e326", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/maxlife.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/md-trim-clinic", "canonical": "https://thisglp.com/reviews/md-trim-clinic", "title": "MD Trim Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "MD Trim Clinic offers physician-directed semaglutide and tirzepatide assessment with a free screening call. Its dose-based payment model and dispensing details need a direct conversation.", "hash": "d307a531d707c4cb2e48c422c8066b138760feff4ae3834f848cb9bfdec195da", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/md-trim-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mdexam", "canonical": "https://thisglp.com/reviews/mdexam", "title": "MDExam reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The same product carries different figures on two of the seller's own pages, and only one of them is ever given a billing period.", "hash": "8bc9c55ee5f84ad09b8ccaa3bbc3cc5817ba60891bb082cedaa8488c88b04c06", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mdexam.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mdlive", "canonical": "https://thisglp.com/reviews/mdlive", "title": "MDLive reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "MDLIVE offers anti-obesity prescriptions through eligible Primary Care Routine Care visits. Its urgent-care service and wellness screening are different pathways.", "hash": "eed5fd207ecb62f9c9ab3f0b967f53d1f16fe5e4e6f26f08642ba5af0df44bdb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mdlive.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mdtw", "canonical": "https://thisglp.com/reviews/mdtw", "title": "MD Total Wellness reviews (2026): medical weight-loss clinics | This GLP", "description": "MD Total Wellness offers in-office GLP-1 care in Brea, California, with monthly visits, body-composition tracking and direct clinical messaging in its published package.", "hash": "efb28203069c9630d420fbfbb3ca5975c74038d4d33b8532fb0343882ff676d5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mdtw.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/measured", "canonical": "https://thisglp.com/reviews/measured", "title": "Measured reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The lead figure is a twelve-month rate, and the struck figure beside it is the monthly one.", "hash": "b72fdc3929013ff32fab0cd10686bf43c9461064f2b0344bc7e5bab47a9c5d66", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/measured.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medgm", "canonical": "https://thisglp.com/reviews/medgm", "title": "MEDGm reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "All three figures are memberships. The medication cost is written as a word, not a number.", "hash": "2f8424d28e99733b9b2ba4890b3d83eb23b3dc474d022c3d78f64002f0f84c44", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medgm.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medi-weightloss", "canonical": "https://thisglp.com/reviews/medi-weightloss", "title": "Medi-Weightloss reviews (2026): in-person weight-loss clinics | This GLP", "description": "A franchise of in-person clinics. Only the first month of medication is priced online.", "hash": "2ac13fb5a92b1d91e76ca1ab463cbaef6af284f43a2a71c0ccae6d54dfef230d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medi-weightloss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medical-health-institute", "canonical": "https://thisglp.com/reviews/medical-health-institute", "title": "Medical Health Institute reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Medical Health Institute describes laboratory-guided GLP-1 care and ongoing monitoring. Its general program page leaves the exact medicine, pharmacy and complete cost to assessment.", "hash": "f371a91468aa262d4fbb9be9fdbd4760d690f4d08d3ca8b1b9b0d2e4ee0241c1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medical-health-institute.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medirx", "canonical": "https://thisglp.com/reviews/medirx", "title": "MediRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The same two products are priced twice on one page, at different rates.", "hash": "db31c46f5cb342ea09188389fcaf6bc3e36a3100cdb0d374dcc29f3ee22b142f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medirx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medivive", "canonical": "https://thisglp.com/reviews/medivive", "title": "Medivive reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Medivive starts with an AI conversation, then assigns prescribing decisions to TrueEval Medical Group. The weight program describes 30-day monitoring.", "hash": "3768cba5b1740f10de06e2e63be20c97fd5ddafd0cc8b18fbb7b56fe29638faf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medivive.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medleanrx", "canonical": "https://thisglp.com/reviews/medleanrx", "title": "MedLeanRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The pricing is reasonable and the catalog is sensible. Forty-nine states cannot reach either.", "hash": "a34ebfa65bd17edc07d9fa575d7e5954d81ee5dfcb59df9876720a62b786b86f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medleanrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medro", "canonical": "https://thisglp.com/reviews/medro", "title": "Medro reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The lead figure has a one-time code applied. The standing rates are $199 and $299.", "hash": "584500c0166820afc51a9b34e7483382a531394fc1d7c559d78add48307c2ff3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medro.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medsol-rx", "canonical": "https://thisglp.com/reviews/medsol-rx", "title": "Medsol RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Month-to-month semaglutide is $199 after a $169 first month, and three prepaid plans trade the whole term up front for a lower monthly figure.", "hash": "aa143576fef7ca884043d3487dbcc2371a8521a2627773318c75e6726590e88b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medsol-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medvi", "canonical": "https://thisglp.com/reviews/medvi", "title": "MEDVi reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Only one of three lines publishes what the medicine costs; on the other two the figure on the card is the membership and the drug is unpriced.", "hash": "316434526beea099716d1d4838b9164fd534bf0e5fa8cb2ae22d9f4befd7a05e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medvi.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/medvidi", "canonical": "https://thisglp.com/reviews/medvidi", "title": "MEDVidi reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "MEDvidi offers scheduled online assessment and follow-up, with a weight-care page naming branded GLP-1 options. It is not a bundled medication storefront.", "hash": "b4c045973ad27537962dc84e0ab339366f87012027f906bdf4d47bbf4ed6fbb3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/medvidi.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/meli-health", "canonical": "https://thisglp.com/reviews/meli-health", "title": "Meli Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Meli identifies an independent clinician network and a dispensing pharmacy for its compounded weight-care service. The platform itself does not practice medicine.", "hash": "ef08c6f3224779ccd4d09272e0cc29a9fb126ae555c66b672d2fa539bb1729ae", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/meli-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/metabolic-rx", "canonical": "https://thisglp.com/reviews/metabolic-rx", "title": "Metabolic Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Metabolic Rx describes provider check-ins and direct messaging for compounded weight care. Its product FAQ and general terms give different cancellation notice periods.", "hash": "45d1575dd51e73e9af3b2548c01f5b4ccd6707037d8c16755deedc71a7855bc9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/metabolic-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/metabolyz", "canonical": "https://thisglp.com/reviews/metabolyz", "title": "Metabolyz reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Metabolyz combines clinician review with nutrition, movement and lifestyle coaching, but keeps program prices inside consultation.", "hash": "640148b237eefcccb95b2e1f525d42482fe41c51302d7172a95e1dd88b54b85e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/metabolyz.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/metaboost-rx", "canonical": "https://thisglp.com/reviews/metaboost-rx", "title": "Metaboost Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An Oklahoma City telehealth brand whose headline GLP-1 figures sit under a new-patient banner, with nothing on the page saying what follows the offer.", "hash": "e809ec1a6099d5b9469b80a929a06c1f5357efe1d36a83550e6047c78ab6222b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/metaboost-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mevo-health", "canonical": "https://thisglp.com/reviews/mevo-health", "title": "Mevo Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both figures read as low as. The plan length each one prices is not stated.", "hash": "69bbf112641cc7b5481b4a01774a4bdef7f9b40286a34bc99a6e9d2eaa9f20b8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mevo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/midi-health", "canonical": "https://thisglp.com/reviews/midi-health", "title": "Midi Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "All four lines publish a complete dose ladder with the milligram beside each rung — and every table is a four-week supply rather than a month.", "hash": "6a49c3fff5427ab64a15cdb01b453c2342277372bd1197d52a2ca66f19ccc910", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/midi-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mint-med", "canonical": "https://thisglp.com/reviews/mint-med", "title": "Mint Med reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly figure is written into the product name, and the listing says it holds at every dose for as long as the order runs.", "hash": "71cd2e672f3dcc4785cd4975dc735e49ce054633faa7a4b315b35276778888ed", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mint-med.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mint-medical", "canonical": "https://thisglp.com/reviews/mint-medical", "title": "Mint Medical Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Utah clinic prints one starting price for both molecules, and the GLP-1 page itself carries no price at all.", "hash": "81d042b3c839f62b764c8320a90dd0496a9d839508eabfb595038047aa6d3ce6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mint-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mixx-health-and-wellness", "canonical": "https://thisglp.com/reviews/mixx-health-and-wellness", "title": "Mixx Health & Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Mixx Health & Wellness identifies a medical director and pharmacy for its compounded GLP-1/GIP pathway. Confirm the actual ingredient, prescription and cancellation conditions.", "hash": "43ed41545af2980f862717294bd33a58215ed570055b2b88925c266ca5eef37e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mixx-health-and-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mochi-health", "canonical": "https://thisglp.com/reviews/mochi-health", "title": "Mochi Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The full dose ladder is published in milligrams, and the care fee is billed separately from it.", "hash": "4eec60c1008fd324578cef3ea1a34e2846e4181f3827d848a958047d4b43bee4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mochi-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/modern-age", "canonical": "https://thisglp.com/reviews/modern-age", "title": "Modern Age reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Modern Age describes assessment-led weight management with a six-month support program and separate medication costs. Clarify current availability and the proposed prescription first.", "hash": "0b57fc052ab3e223eedeb77273912cb6a50a2fd78110b63df67d55e5a36d7379", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/modern-age.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mojoon", "canonical": "https://thisglp.com/reviews/mojoon", "title": "Mojoon reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Chinese-language telehealth service prices each monthly course by dose, from a starting figure up to a published ceiling.", "hash": "5bc660b614bc4ee394e41accdcbdc442b265d81d2ff8d6e6a758d43ba99c0cbe", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mojoon.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mondae", "canonical": "https://thisglp.com/reviews/mondae", "title": "Mondae reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Among the lowest published compounded rates here, on pages that state very little else.", "hash": "9ca00e35a78de8c196f25c78ec261900bef3850aadf0b386551213107e2f6b49", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mondae.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/multimedrx", "canonical": "https://thisglp.com/reviews/multimedrx", "title": "MultiMedRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The single published figure is a refundable consultation fee, and the medication is billed elsewhere.", "hash": "4836e2e111e489b3e86813fccadc6b7c47a65f7ecde3ea27ce56da8f4a72cc8e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/multimedrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mydrhank", "canonical": "https://thisglp.com/reviews/mydrhank", "title": "MyDrHank reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three compounded GLP-1 products, each blended with a second ingredient, and a starting monthly figure on every one with no plan length printed beside it.", "hash": "b4c295f37e8b1c2375bf8119c26d03c1e44771d70ea40134defc71593884556b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mydrhank.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/myfastrx", "canonical": "https://thisglp.com/reviews/myfastrx", "title": "MyFastRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An introductory first month sits on top of each product page, and the rate for every month after it is printed on the same card.", "hash": "a509354a23c7e8237cd68404e57fb80bbb087b621ee31b6af502e2aa9b8feadb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/myfastrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/myrnk", "canonical": "https://thisglp.com/reviews/myrnk", "title": "RNK Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The headline rate carries a $50 coupon that the seller's own data applies once.", "hash": "59ad9c327ee018ea3d549cce64a68ed0aeaea9012617691fb8a85cbfa198bd48", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/myrnk.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/mystart-health", "canonical": "https://thisglp.com/reviews/mystart-health", "title": "MyStart Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The price is guaranteed never to rise, and the month it applies to is four weeks.", "hash": "c938c07d77c804dfd396bcf292818b0f236dfa043e6fc82d49a77bc831f30df1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/mystart-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/naky", "canonical": "https://thisglp.com/reviews/naky", "title": "Näky reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The rate on each injection card is the six-month plan, not the monthly one.", "hash": "af5a9a8a5763e0cb3cd061bbdb95ac7f477dc984093c07db75de6bf52e998291", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/naky.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nativemed", "canonical": "https://thisglp.com/reviews/nativemed", "title": "NativeMed reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two compounded injections, priced monthly, with a three-month plan that costs the same per month.", "hash": "16fc0f87e00f844bc130f833333d72b403af310e8b4c82d01fe1c752f4eee152", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nativemed.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/navio-md", "canonical": "https://thisglp.com/reviews/navio-md", "title": "Navio MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two tirzepatide figures, one compounded and one branded. Both are floors, and the dose that earns either is never named.", "hash": "35cab26515a4d7d2a4265e0fa7d1e3f931617694fb26ea40ce2550173468a53e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/navio-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/neo-soma-healthcare", "canonical": "https://thisglp.com/reviews/neo-soma-healthcare", "title": "Neo Soma Healthcare reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Texas clinic that publishes its full semaglutide dose ladder, names its compounding pharmacy, and prices refills by dose band.", "hash": "f7a8045d810e376fbcd113285f528a78ad7007d05da83699ac17bafbc01ffdcf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/neo-soma-healthcare.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/neuve-md", "canonical": "https://thisglp.com/reviews/neuve-md", "title": "NEUVÉ Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Whether the medication is inside the program fee depends on which part of the page you read.", "hash": "0be93dceedbc938ed7e3a2218a8d0178e62ff313962f75e3ec2aa7001830660c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/neuve-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/new-wave-health", "canonical": "https://thisglp.com/reviews/new-wave-health", "title": "New Wave Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two compounded injections from a Virginia Beach storefront, with no monthly price shown before an intake.", "hash": "63bc4b938af288089ce15f8f39d907695c178cf750211e112ac825887820fad6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/new-wave-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/newself", "canonical": "https://thisglp.com/reviews/newself", "title": "NewSelf reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every milligram step is listed on the homepage, and the seller says each one costs the same.", "hash": "34b831e6973d5f75bd61cd631e00b819ca1f04e6324a2a7481696a598baa5abf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/newself.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nex-gen-health-rx", "canonical": "https://thisglp.com/reviews/nex-gen-health-rx", "title": "Nex Gen Health Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four supply lengths on one selector, each with a strength and an upfront total beside it.", "hash": "3bc08e4dda84a32a3e909bb4ea923e41924c9b10aed179de5ef9f02386cd7191", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nex-gen-health-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nexlife", "canonical": "https://thisglp.com/reviews/nexlife", "title": "NexLife reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The rate set in the largest type belongs to a year-long plan, and the asterisk beside it says so.", "hash": "c553a654170a560c2facee04539d091a218a1de7252f361e3b3a782df275d69c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nexlife.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/next-vial", "canonical": "https://thisglp.com/reviews/next-vial", "title": "Next Vial reviews (2026): care, dosing and costs | This GLP", "description": "The selector opens on the twelve-month card, and the month-to-month rate sits at the top of the same ladder.", "hash": "fd2e36261fe688de493ddc875a55329190547bc702742a761347509f04cdc18d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/next-vial.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nextmeds", "canonical": "https://thisglp.com/reviews/nextmeds", "title": "NextMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The membership here is the product rather than a fee charged beside one, and it bundles four services.", "hash": "fb0dc3522315da599e2841b83b2f026e65ed152bf900a70d88548aecfa1f3dbb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nextmeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nicerx", "canonical": "https://thisglp.com/reviews/nicerx", "title": "NiceRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each product card prints a discounted opening month and, on the same line, the monthly rate that replaces it.", "hash": "e2e59dc65ad790af74eca17f72af40325d49470c24176ffcf711372fb3075e05", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nicerx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nirwana-health", "canonical": "https://thisglp.com/reviews/nirwana-health", "title": "Nirwana Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each product page prints two price blocks, and one of them calls the monthly figure introductory.", "hash": "bdc2573c8cfadcd29d517bafbde7c97b9bc305a3d3ba84513269a9e1bb7ba05f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nirwana-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/no-bs-rx", "canonical": "https://thisglp.com/reviews/no-bs-rx", "title": "NoBsRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every program is named low-dose, and all three twelve-week blocks cost the same regardless of molecule.", "hash": "7a08e0596e723f01ff1f7a4feae0531702dcc8f2427f89a38fb87e68beea515f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/no-bs-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nolu", "canonical": "https://thisglp.com/reviews/nolu", "title": "Nolu reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every line came down a month apart, and every line is labeled per four weeks by the seller itself.", "hash": "c986e2c28b62c00749ebffa85e66cbe580745921cccd2247ff5624e8dacb35ac", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nolu.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/noom", "canonical": "https://thisglp.com/reviews/noom", "title": "Noom reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The intro runs three weeks, the medication four, and the recurring charge answers to twelve.", "hash": "1ed096c4df5263289092c3aaeded47c260c666009a17675df90761ae5f976fab", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/noom.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nova", "canonical": "https://thisglp.com/reviews/nova", "title": "Nova reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every figure includes a required care fee, and each oral is priced below its injection.", "hash": "7a72bc14280325d49f80ba4b179aa404dfdb02a482930d2e6c57804577afa216", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nova.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nova-md", "canonical": "https://thisglp.com/reviews/nova-md", "title": "Nova MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four plan lengths per drug, with the twelve-month prepay already chosen when the page loads.", "hash": "30821ad7b90ea4f4de3f8ec641873108e95bba3f4ae9920349486147ab9e7d22", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nova-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/novera-md", "canonical": "https://thisglp.com/reviews/novera-md", "title": "Novera MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Novera MD promotes testing and ongoing optimization, while its terms identify independent providers affiliated with WizDoc as the clinical decision-makers.", "hash": "5cf4b71d5b38838d2ffdcdc568b44f4b7410cdb5150578bf3f042af9ff51da48", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/novera-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/novi", "canonical": "https://thisglp.com/reviews/novi", "title": "Novi reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A billing-cycle table on each product page, with the one-month rate listed first and no membership charged on top.", "hash": "552f2fe93d965f8a40208fbd1e9dd8c366d212c6a5858b19113e3950b197c122", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/novi.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/novocare-pharmacy", "canonical": "https://thisglp.com/reviews/novocare-pharmacy", "title": "NovoCare Pharmacy reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "This is the drug company selling its own approved product, and the month it quotes is twenty-eight days.", "hash": "0018efc0a5843e83f19e152dae2127a58189828f9677bb6825b8326af6932c7e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/novocare-pharmacy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nowpatient", "canonical": "https://thisglp.com/reviews/nowpatient", "title": "NowPatient reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four manufactured products priced by pack, each with a shipment-and-duties charge that sits in the buy box rather than the headline.", "hash": "68fc93ef1a5eda4682660665f06712e904823602caf2d54c1b9f94a6529c8013", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nowpatient.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/np2go", "canonical": "https://thisglp.com/reviews/np2go", "title": "NP2GO reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An Oklahoma nurse practitioner practice that prints a separate price for every month of the dose ladder.", "hash": "c929083cfe7e90f05da7d5bb9170cd6976cd54af9686840d8008031740615737", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/np2go.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nu-image-medical", "canonical": "https://thisglp.com/reviews/nu-image-medical", "title": "Nu Image Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four products sit on one page, and the figure that draws the eye is a year bought at once.", "hash": "771936019251ddf5d4ee575750ebcfa3a68674fbb9c9c389840908c1c6020532", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nu-image-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nubloom", "canonical": "https://thisglp.com/reviews/nubloom", "title": "NuBloom reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Six dose strengths are listed on the product page and every one of them costs the same.", "hash": "362215aa8c99f48234d3eccbb015c6a25e0979756cb01fdd46520afe1f67d4ba", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nubloom.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nucore-health", "canonical": "https://thisglp.com/reviews/nucore-health", "title": "Nucore Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three figures, all floors, with no membership fee and health-account eligibility stated.", "hash": "df57a9fd3bd3dcf3b1a5b834ff95cfc2b96e525c09f19eaad0339c2102346062", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nucore-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nuday-rx", "canonical": "https://thisglp.com/reviews/nuday-rx", "title": "NuDay Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The semaglutide tablet matches the injection, and the tirzepatide tablet costs seventy dollars more.", "hash": "a21b7b32036328c811506bd0b7585c5ecc798a7e3049fff070653d5a912f4383", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nuday-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nuform-health", "canonical": "https://thisglp.com/reviews/nuform-health", "title": "Nuform Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Nuform describes an assigned provider and follow-ups every four weeks. Its multi-month kits make a slower dose increase or early treatment change worth discussing first.", "hash": "6e2ddead33839d54f9e154cd7a962fd6e3a6a4973d18ebf98716fbf514fea642", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nuform-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nurx", "canonical": "https://thisglp.com/reviews/nurx", "title": "Nurx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Nurx offers a licensed-provider relationship and ongoing messaging. Injectable medication fulfillment is separate from its familiar home-delivery model.", "hash": "ccd12075ee1481367d5671cd1777c13e79db580857efeeb9a2e3da60f29b629c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nurx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nuuvim", "canonical": "https://thisglp.com/reviews/nuuvim", "title": "NuuVim reviews (2026): GLP-1 sellers by price | This GLP", "description": "Injection and oral cost the same on each molecule, which is unusual. The seller states no membership and one price at any dose.", "hash": "6f40e0e152f871d232a189ebab09643d15c74f737ace55a07a80ee7f078511f3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nuuvim.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/nuviarx", "canonical": "https://thisglp.com/reviews/nuviarx", "title": "NuviaRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The product page prices the annual plan; the checkout prints every term, a single month included.", "hash": "a37f9344ebe7ff78ecb2435151841e89bfb333847223784c18ad1f1aa3872771", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/nuviarx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/oak", "canonical": "https://thisglp.com/reviews/oak", "title": "Oak reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Flat at every dose with no subscription, beside an advertised figure whose terms are never published.", "hash": "32c6a001dfac8081ddbb28c25e4251089c3fc9381b51726cfae019a8413b197e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/oak.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/obu-health", "canonical": "https://thisglp.com/reviews/obu-health", "title": "Obu Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The homepage card and the product tile print the same figure, which several sellers here cannot manage.", "hash": "7822a4561d02f3d36632fab46948fdc78a3100d03eff28103a0f43f25093fc8b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/obu-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ollevecare", "canonical": "https://thisglp.com/reviews/ollevecare", "title": "Olleve Care reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Olleve Care offers scheduled virtual consultations and names semaglutide and tirzepatide as possible treatment options. Prescriptions can go to a preferred pharmacy when appropriate.", "hash": "52abd303ce7e83149dcab4e698a17224cd864a16d7425b7a5240ac49c894c6b2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ollevecare.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/omada-health", "canonical": "https://thisglp.com/reviews/omada-health", "title": "Omada Health reviews (2026): weight-management care programs | This GLP", "description": "Omada pairs GLP-1 support with behavior change, coaching and selected prescribing through a provider partner. The exact employer or health-plan benefit determines access.", "hash": "e59c0e7d6ea2c75a09c199783011115cf9212643e04a62bfed98184ccc123d1a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/omada-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/omnia-telehealth", "canonical": "https://thisglp.com/reviews/omnia-telehealth", "title": "Omnia TeleHealth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A general telehealth practice in coastal Alabama that prescribes GLP-1s through a flat-fee visit and leaves the medication price unpublished.", "hash": "2bdd2389590e1565b98d919d24dd47c79425a9a705cca0eaa1f2847e2cb7db87", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/omnia-telehealth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/omzo", "canonical": "https://thisglp.com/reviews/omzo", "title": "Omzo reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two GLP-1 rates are published, and four of the six advertised categories are not open yet.", "hash": "c4ae5226b0b557720bc459a391491f2ea0b524db2ca9c3d550e711271f5b76dd", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/omzo.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ondra-health", "canonical": "https://thisglp.com/reviews/ondra-health", "title": "Ondra Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The rate in the page title is a year bought in a single payment.", "hash": "515c9a4e2c8370cfc1b57228aa569bdd29876ab9762695cab61490bdb5c14dca", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ondra-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/one80rx", "canonical": "https://thisglp.com/reviews/one80rx", "title": "One80Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One80Rx describes a supervised semaglutide program. Its product FAQ and general terms need to be reconciled before enrollment.", "hash": "0db8036192689bc8a6928e806e9b1beb3c1cf01d3060ce23d3816e60ff770449", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/one80rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/onlinesemaglutideorg", "canonical": "https://thisglp.com/reviews/onlinesemaglutideorg", "title": "Raeliva reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Raeliva prices each product at one monthly rate, whatever the dose.", "hash": "ee3d40a4670ccca2d45714fcd625ff73940fdc353b00067fd97f1d512f02ba76", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/onlinesemaglutideorg.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/onlyrx", "canonical": "https://thisglp.com/reviews/onlyrx", "title": "OnlyRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The promotional banner offers the price the product card already charges.", "hash": "3ebceff6a5ec37cbb0458d4228df817c1631f31872128fcdef9e6fc1c946fddf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/onlyrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/onyx-weight-loss", "canonical": "https://thisglp.com/reviews/onyx-weight-loss", "title": "Onyx Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The ninety-nine dollar plan on the weight-loss page is a different medication entirely.", "hash": "ee5565e9a294b3a5658970476417fbf682b6a39b4d7aeb6251891fd1d39aef80", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/onyx-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/open-water-rx", "canonical": "https://thisglp.com/reviews/open-water-rx", "title": "Open Water Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both figures are stated as flat monthly prices, and no code is needed to reach either.", "hash": "449f7b2611425d3e6e9545838348610a06ff7be797752d1b39c2f7d7b54571dc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/open-water-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/optimized-health", "canonical": "https://thisglp.com/reviews/optimized-health", "title": "Optimized Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Missouri clinic with a named prescribing clinician, lab panels when indicated, and telehealth in five states.", "hash": "6089f21527cf1cd8de094673cf6ff4a8f4936d4fcb6910da1fb385ad978d4bb7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/optimized-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/options-medical-weight-loss", "canonical": "https://thisglp.com/reviews/options-medical-weight-loss", "title": "Options Medical Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The only semaglutide figure is a twelve-month plan paid in full, so no monthly rate exists to rank at all.", "hash": "7a5525d44009b7f94dba23bec2f8b54a3ff16669f924c738e1c53c88aa09e85d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/options-medical-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/orderlymeds", "canonical": "https://thisglp.com/reviews/orderlymeds", "title": "OrderlyMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised figures belong to a new-patient starter program. The monthly plans are printed on the same page.", "hash": "134bc3d4dcaddf9e017a9dcd35f771bcddf97342beacc9c673bb8f639888a71e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/orderlymeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/oria-meds", "canonical": "https://thisglp.com/reviews/oria-meds", "title": "Oria Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The tirzepatide figure belongs to a six-month prepay, and the line ships quarterly rather than monthly.", "hash": "9cd499f3622ccdbbeb0710e5ce53bd66cce9b2456c824b8c2ba7b2696518ffe1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/oria-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ourview-health", "canonical": "https://thisglp.com/reviews/ourview-health", "title": "OurView Health reviews (2026): care and follow-up | This GLP", "description": "OurView offers dose-independent monthly pricing, an authorization before clinical approval, and a patient portal for follow-up.", "hash": "effb133aaa8426e6d1b030df5253a470c9d5d56d91b45892882254839604972d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ourview-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ozari-health", "canonical": "https://thisglp.com/reviews/ozari-health", "title": "Ozari Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The lowest figure is a starter block for people new to GLP-1, and the full plan table sits behind it.", "hash": "e89040f98e2716b28bac73096bf5e53955da8feb22081861afc1bc035c60eba6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ozari-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pallas-health", "canonical": "https://thisglp.com/reviews/pallas-health", "title": "Pallas Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly figure is an average the seller publishes itself: one discounted first month, then a charge every twelve weeks.", "hash": "2ffa234ae8c325662e7f55a5b31b58c720dfdec2158f14bb900b72e5d0b57aa7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pallas-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pauserx", "canonical": "https://thisglp.com/reviews/pauserx", "title": "PauseRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide carries one price for all doses. Tirzepatide is worded two ways.", "hash": "7ce7ec70b0d8c78404d902bae90157bf14d867578b6030b281fe4b06379b7060", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pauserx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pcos-sisters", "canonical": "https://thisglp.com/reviews/pcos-sisters", "title": "PCOS Sisters reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A nurse practitioner clinic for polycystic ovary syndrome, where a GLP-1 prescription requires an active membership.", "hash": "03b8762390e2146407a614ba27937f088baedaf962171cd14695819b353dfd43", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pcos-sisters.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/peak-wellness", "canonical": "https://thisglp.com/reviews/peak-wellness", "title": "Peak Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly plan quotes a first month. The rate after it is printed on the same card.", "hash": "ac91a2505c1c3fb2ec51fc0d0609eec8466be1cf733dc325e492b0cf095e77f5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/peak-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pephaus", "canonical": "https://thisglp.com/reviews/pephaus", "title": "PepHaūs reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The semaglutide rungs are clear. The tirzepatide line carries two prices and nothing says which applies.", "hash": "6e0e35ecf001cac9d6a7bbb619825e116af70e7571cc7d418fd261791ca59379", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pephaus.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pepti", "canonical": "https://thisglp.com/reviews/pepti", "title": "Pepti reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each fill runs 28 days, so a year carries thirteen charges rather than twelve.", "hash": "1847f8addc1b507cc4b35b259074bcc9b03ebdf4a423e85df32a6fe77c27ac81", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pepti.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pepton-health", "canonical": "https://thisglp.com/reviews/pepton-health", "title": "Pepton Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The two cheaper products are sold as GLP-1 without saying which one, and refill pricing needs an account.", "hash": "d4ae7f38fd68026e8faa37606fcd6f541c3feba2ef7b8e9fdc0f49e204b2ab5f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pepton-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/petermd", "canonical": "https://thisglp.com/reviews/petermd", "title": "PeterMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both molecules have a cancel-anytime monthly product, while the tirzepatide landing page leads with a quarterly plan.", "hash": "0f65fb091286e75ece6da9be5ebc256b97fdb12eb73160251933a71725b36018", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/petermd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pillar-health", "canonical": "https://thisglp.com/reviews/pillar-health", "title": "Pillar Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Pillar Health’s plan type affects both the care included and the payment commitment.", "hash": "9483e9f777155c7e2010778ea10628b172e19c601c29c6e97bad674e8fa92fb6", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/pillar-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/piper", "canonical": "https://thisglp.com/reviews/piper", "title": "Piper reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The brand has changed; the company behind it and the prices have not.", "hash": "866a16b1e54763c645491e931334d7490790d201c1e24120b49761d63d82debf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/piper.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/plexusdx", "canonical": "https://thisglp.com/reviews/plexusdx", "title": "PlexusDx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The lowest figure is a microdose protocol where the provider chooses both the molecule and the route.", "hash": "563cf53903471f7e8040f86c55165960286dff10baed6838b950e8906abf7cb3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/plexusdx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/plushcare", "canonical": "https://thisglp.com/reviews/plushcare", "title": "PlushCare reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised cash-pay figure buys the 0.25 mg starting dose, and every maintenance dose is priced above it.", "hash": "621ecabe9107ce330f5f69244d6c1694326877466f063c265e00210d770ea6bf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/plushcare.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/pomegranate-health", "canonical": "https://thisglp.com/reviews/pomegranate-health", "title": "Pomegranate Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each product page quotes one starting figure; the pricing app behind it changes the price with the pharmacy, the dose tier and the package.", "hash": "c533f236d21d269313fb801737633f47e2852cccbc0ddc634a9565c0bf4e7f51", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/pomegranate-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/potere-health-md", "canonical": "https://thisglp.com/reviews/potere-health-md", "title": "Potere Health MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The clinic sells a vial and then divides its price by three to reach a monthly figure.", "hash": "15a265289952ff99da00abbaded58b2744eae3a116b0373faee0e346789097c6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/potere-health-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/precision-telemed", "canonical": "https://thisglp.com/reviews/precision-telemed", "title": "Precision Telemed reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both product pages publish the full dose range and name the clinicians, down to their NPI numbers.", "hash": "23a8f6f152026112c03acba0d3cabaf8c8c079d0e3ef7bf89162392d3c4308a2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/precision-telemed.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/premium-health", "canonical": "https://thisglp.com/reviews/premium-health", "title": "Premium Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A monthly membership that includes medication. A higher dose adds a stated monthly charge.", "hash": "dc97916d47182b01dcff685c4f6221241456a9cd17562d8477f226cb3f913fb6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/premium-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/prescribedrx", "canonical": "https://thisglp.com/reviews/prescribedrx", "title": "PrescribedRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Provider messaging and included supplies are described, but the three-month plan renews every ten weeks.", "hash": "9c31fd7b6fe0c75eb3e7d8f93e196e786fd376cacd7d0c274b32ab6f343eb0c6", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/prescribedrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/prescriva", "canonical": "https://thisglp.com/reviews/prescriva", "title": "Prescriva reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Prescriva separates standard weight-loss treatment from low-dose longevity programs and describes ongoing provider support.", "hash": "5a3d1d521ab08b94d692a6ecd4b007a424fede286e954fdb4200f9122b731de1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/prescriva.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/prescrybe", "canonical": "https://thisglp.com/reviews/prescrybe", "title": "PrescrYbe reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "PrescrYbe offers online GLP-1 assessment through independent clinical partners. Its program page and general terms describe recurring billing differently.", "hash": "d8ae940ffb6fa649ca66a069e39397f9486aee41d1ac34a54655fbc0033eeef4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/prescrybe.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/preventivemd", "canonical": "https://thisglp.com/reviews/preventivemd", "title": "PreventiveMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "It carries orforglipron alongside the usual pair, and its lowest figures are twelve-month plans paid up front.", "hash": "f24aa72c0c8605a3d7a9091894cc2a29e53e8f9c6b74e266ccb2e9384bba6986", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/preventivemd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/priderx", "canonical": "https://thisglp.com/reviews/priderx", "title": "PrideRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three approved products routed through the manufacturers' own channels, each with a required monthly membership beside it.", "hash": "f572799e829dff2ce516b554c96cf41bfeed2848cb0144665a4a5482785e68a4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/priderx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/primary-clinic", "canonical": "https://thisglp.com/reviews/primary-clinic", "title": "Primary Clinic (Direct GLP) reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The medication tables carry a condition printed across them: active members only.", "hash": "7501f4522ad27affaa61de23780826f44d17f4a1398eeeb3b4da3ef2a6bb9438", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/primary-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/prime-doctor-rx", "canonical": "https://thisglp.com/reviews/prime-doctor-rx", "title": "Prime Doctor RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The published figure is charged every four weeks, which is thirteen times a year rather than twelve.", "hash": "a199cfa5c9fc3f0719b9c19592782166158112dbd1608a2dd4e43c9ad5499896", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/prime-doctor-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/prime-health", "canonical": "https://thisglp.com/reviews/prime-health", "title": "Prime Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The program ships four weeks at a time, which is one more charge a year than the figure implies.", "hash": "9072143ea4ce8073168e437406651dd8243418364a925dd21adc10b56d5e006b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/prime-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/primo-health-partners", "canonical": "https://thisglp.com/reviews/primo-health-partners", "title": "PRIMO Health Partners reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "PRIMO offers online weight-loss plans alongside virtual primary and urgent care. Its semaglutide page describes monitoring but leaves the plan price and visit cadence unspecified.", "hash": "b4a971736dca3912a383f23b33ca433ad7b8f0986989e1315a51b5126323ad64", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/primo-health-partners.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/push-health", "canonical": "https://thisglp.com/reviews/push-health", "title": "Push Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Push Health connects patients with independent prescribers and sends approved prescriptions to a chosen pharmacy. Its GLP-1 pathway is not an all-inclusive medication subscription.", "hash": "bdfa055f46a661c89e2b4df0adf6f3f7c087fb9e90f3beee3239db9a2ba914b6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/push-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/queen-rx", "canonical": "https://thisglp.com/reviews/queen-rx", "title": "Queen RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "There is no monthly plan to choose, because the catalog holds a single quarterly one.", "hash": "0f357b4301ff573f25c729c31a03d48279875a603a754455946f65abf526864b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/queen-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/quickmd", "canonical": "https://thisglp.com/reviews/quickmd", "title": "QuickMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "An online clinic that charges per visit and sends brand GLP-1 prescriptions to the patient's own pharmacy, after withdrawing its compounded versions.", "hash": "5d320d75ed4547afccd497411c736194e0fcab5aa39dc7d6a9cc77e6938ce9fb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/quickmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ravia-health", "canonical": "https://thisglp.com/reviews/ravia-health", "title": "Ravia Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Ravia’s Florida psychiatric practice and its Lyv Health weight-care partnership are different routes. Confirm which team will manage the GLP-1 assessment.", "hash": "b9ea66d8c18f1c797ef5beabfc2d4776e5dd7916f24aca886db463bb2b9497a8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ravia-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/readyrx", "canonical": "https://thisglp.com/reviews/readyrx", "title": "ReadyRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A discounted first month, then a flat rate that ReadyRx applies to every dose.", "hash": "f5766a519d479a8a314b4c3c7bbc1d1b446a5a9db09adaec6a5c502935ed513e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/readyrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/recovery-delivered", "canonical": "https://thisglp.com/reviews/recovery-delivered", "title": "Recovery Delivered reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A seller that prints the expensive end of its own price ladder is telling you something about itself.", "hash": "21a3d51e35ddcf39b71edc65159849a4a0368615e15c4dc6ec52821ba0867671", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/recovery-delivered.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/red-mountain-weight-loss", "canonical": "https://thisglp.com/reviews/red-mountain-weight-loss", "title": "Red Mountain Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Red Mountain Weight Loss offers clinician-guided GLP-1 care through regional offices and telemedicine. Promotional pricing needs to be separated from the individual treatment plan.", "hash": "5f28bccb550a4ff45c40360d514731d6ad4639c405cac44a4c0cdd4c415b845a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/red-mountain-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/refills", "canonical": "https://thisglp.com/reviews/refills", "title": "Refills reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two compounded injections, a daily rate labeled as low as, and plans behind a date-of-birth question.", "hash": "4bd514c21d1aaf4ddfc7d341d5a8d8a4d68c4c6fbcf437e52db4343a66b0e346", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/refills.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/reflexmd", "canonical": "https://thisglp.com/reviews/reflexmd", "title": "ReflexMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three products, three flat rates, and one of them never says what is in it.", "hash": "c3437f18f430b32edc3fbc648b6c12c8a5ff44f81c194e9954e353d4b186ba86", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/reflexmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/regencen", "canonical": "https://thisglp.com/reviews/regencen", "title": "RegenCen reviews (2026): medical weight-loss clinics | This GLP", "description": "RegenCen offers several weight-management and maintenance programs with clinician check-ins. Distinguish GLP-1 prescribing from the additional injections included in some packages.", "hash": "87199f1ea97ebd7436387e0ebd8d1795dcd8652181ccd030e778b5884bb4033a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/regencen.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/regenics", "canonical": "https://thisglp.com/reviews/regenics", "title": "Regenics reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A required membership renews on a four-week clock, which is thirteen charges a year on top of the medication.", "hash": "b590bf0030bd73bd28e4a29e938d59841d78a4ab2aacc88951de114e3792d934", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/regenics.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rehydra-plus", "canonical": "https://thisglp.com/reviews/rehydra-plus", "title": "Rehydra+ Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three dose tiers on each molecule, each with its own figure, and a separate price for buying without a subscription.", "hash": "6f3ba1eeec023a7fd2893921bfe133aa378470d4f3500919683a8da4df0c32e9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rehydra-plus.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rejuve-meds", "canonical": "https://thisglp.com/reviews/rejuve-meds", "title": "Rejuve Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The label says Most Affordable and the figure under it needs twelve months paid up front.", "hash": "36d47b20458c5dbd164e40308ad2a07f7efcb50ff687e844982acdd607eefd89", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rejuve-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/remedy-meds", "canonical": "https://thisglp.com/reviews/remedy-meds", "title": "Remedy Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A four-week fill billed monthly, and no figure a reader can see before the quiz.", "hash": "44fc91fd1ffda3ce692e735bb857104c92dd832097c0374eba7ca44f41751c61", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/remedy-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/remevi", "canonical": "https://thisglp.com/reviews/remevi", "title": "REMEVi reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised rates belong to a fifty-two week plan, and the site promises no titration hikes.", "hash": "d7ad96f6561d5c772f43e4217ff48eca2d4cb5ce7bef6d36139fbe72cf7d301a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/remevi.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/remi-meds", "canonical": "https://thisglp.com/reviews/remi-meds", "title": "Remi Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two dose selectors, five priced steps on each, and every step up costs more.", "hash": "d421e65b63acb7cbd19c6038d5180f2ea5a0a8930d75df57d0c77d61245a5750", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/remi-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/remote-pharmacy", "canonical": "https://thisglp.com/reviews/remote-pharmacy", "title": "Remote Pharmacy reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The same number appears on two of this seller's pages meaning two different things, so no rate can be established at all.", "hash": "e0accc00c9eba0fd9b54c1f051d8539efbef587e8d7a63b5874ea4f508377b92", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/remote-pharmacy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/renlo-health", "canonical": "https://thisglp.com/reviews/renlo-health", "title": "Renlo Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each dose tier is listed with the same price beside it, which is a stronger claim than the word flat.", "hash": "1b61624b831bd8a8c003a587199f9056dfeb078871710bac83bd32c3cfc6d749", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/renlo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/renn-health", "canonical": "https://thisglp.com/reviews/renn-health", "title": "RENN Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The homepage and the semaglutide page give different figures for the same product.", "hash": "dcec31b387b29be26f0696557c54a7a484e654ad9cbdf7fd8df3bc303347813c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/renn-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rese-wellness", "canonical": "https://thisglp.com/reviews/rese-wellness", "title": "Rese Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Rese combines portal support with a three-month medication shipment and no automatic reorder.", "hash": "5eebdea78d7448092d3e93a258d6070dcdc58871fdfabccabfabb90c44fe0586", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rese-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/reset-solutions", "canonical": "https://thisglp.com/reviews/reset-solutions", "title": "Reset Solutions reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A program fee and a separate medication bill, with an in-person start near The Woodlands.", "hash": "7395df3e215e17fe67f87f782721bef5bf632898adef38b5d921a29762d40484", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/reset-solutions.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/restorlife-med", "canonical": "https://thisglp.com/reviews/restorlife-med", "title": "RestorLife Med reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The figures are high and they include a quarterly blood test, which almost nothing else here does.", "hash": "f78ca12862137d2cfdfed292168d925beb1acfd83f09c07fd2d9aaaad129e1d9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/restorlife-med.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/revel-health", "canonical": "https://thisglp.com/reviews/revel-health", "title": "Revel Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The tablet undercuts the injection on both molecules, which is the reverse of the usual order.", "hash": "35d6cfbf094f993532639f2de00d80176ee78629dbea803d0f2297486048b799", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/revel-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/revel-rx", "canonical": "https://thisglp.com/reviews/revel-rx", "title": "Revel RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two of the lowest flat figures published, with consultation and overnight cold shipping inside them.", "hash": "d0f2339358e492dcfdbb3d1b28ef5e6ee1b75987cca898579a875f64dd8d86f5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/revel-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/revive-longevity", "canonical": "https://thisglp.com/reviews/revive-longevity", "title": "Revive Longevity reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Revive offers a tirzepatide program and separate wellness membership tiers. The named product is billed every four weeks, not every calendar month.", "hash": "8886fba4cff6cb8e18d309ed49105589a2ea707c9b465fcfc57e7be1dce1c6ec", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/revive-longevity.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/revive-meds", "canonical": "https://thisglp.com/reviews/revive-meds", "title": "Revive Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "No subscription and no membership fee, and no price a reader can see before handing over an email.", "hash": "5bf6c8e72c7612b46ede01da8cec04739a4d80dbab67e7f3da08249ee131b3b2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/revive-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rewinding-rx", "canonical": "https://thisglp.com/reviews/rewinding-rx", "title": "Rewinding RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A fixed figure at any dose, four strengths listed, and no membership.", "hash": "ffc2de37aade47be427b619a40bcd1fc800bc95ad566797e3d5b32bf8b41d48a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rewinding-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rex-md", "canonical": "https://thisglp.com/reviews/rex-md", "title": "Rex MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The tablet is an approved brand product with a published figure. The injection is too, and its price belongs to someone else.", "hash": "c963f9189c2c69bf669120cd0e9060740b001adcab56e2a1bfba1665b05f9908", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rex-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rila", "canonical": "https://thisglp.com/reviews/rila", "title": "Rila reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Rila names its medical group and pharmacy partners and describes check-ins during the first month.", "hash": "20f96be48b9fdb0c9dd6c5923578ee435e87c6f21fd0854b93563afbe824a639", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rila.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/risen-labs", "canonical": "https://thisglp.com/reviews/risen-labs", "title": "Risen Labs reviews (2026): regional GLP-1 care | This GLP", "description": "Risen Labs requires a live video evaluation for compounded semaglutide or tirzepatide and identifies Olympia Pharmacy. The service is limited to New York and Colorado patients.", "hash": "3e9c2c6b3156532f32717d8e71fba6440ec3ae7f6e9c5239a1afe2a67cf335d5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/risen-labs.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rivas-medical", "canonical": "https://thisglp.com/reviews/rivas-medical", "title": "Rivas Medical Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The clinic gives the injection on site every seven days, and a telehealth program prices the same drugs by the month.", "hash": "497f74e853747b507f6b622652686e25c173533f232900113229e103bfa0dac1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rivas-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rivo-health", "canonical": "https://thisglp.com/reviews/rivo-health", "title": "Rivo Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four flat figures, all of them attributed to a seasonal sale that was still running out of season.", "hash": "1fef496360bca99f04c6c1f5c8bb77e1627f027df4832b4543260186476ce0b4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rivo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rixa-health", "canonical": "https://thisglp.com/reviews/rixa-health", "title": "Rixa Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The price rises at each dose level, and the ladder is published in full.", "hash": "f0313007310e596b8dced682b195b22cb2e1c151ba79c389a2750745513a2a88", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rixa-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ro", "canonical": "https://thisglp.com/reviews/ro", "title": "Ro reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Brand GLP-1s only, with the membership billed as a second monthly charge.", "hash": "43373f0639b395d7431733f086f1afd9983e5ea5f799cc1106015053c94d80f1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ro.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/robinhood-telehealth", "canonical": "https://thisglp.com/reviews/robinhood-telehealth", "title": "Robinhood Telehealth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The program describes physician review and structured check-ins. Its dosing concentrations and cancellation language need careful reading.", "hash": "6818cc4b80bb1da2140dd720e0c582430dbea8e987f836ddcf93ddd2ddc99baf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/robinhood-telehealth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/roboclinic", "canonical": "https://thisglp.com/reviews/roboclinic", "title": "Roboclinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "All three headline figures require a year committed, and buying by the month costs a hundred dollars more.", "hash": "98eb966b97e58d55d6f3b0a0275d816aa6b52c1009c6184cfd7f22fcf9188236", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/roboclinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/roen-rx", "canonical": "https://thisglp.com/reviews/roen-rx", "title": "Roen Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Insurance coordination for brand drugs, and a compounded bundle for everyone else.", "hash": "c258a3a51a923d8b178c92212283af6e7801f389d21c09bd7d82705f49e7cfd2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/roen-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/royal-medical-center", "canonical": "https://thisglp.com/reviews/royal-medical-center", "title": "Royal Medical Center reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Royal Medical Center describes a compounded GLP-1 weight-loss program with laboratory assessment, individualized dosing and follow-up. Confirm the precise medication and pharmacy.", "hash": "5eb62b82fda69892a8b36d8e1e390fee6ad8b3ad08dbf3af9181c75326840072", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/royal-medical-center.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rx-bella", "canonical": "https://thisglp.com/reviews/rx-bella", "title": "RX Bella reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One monthly price per drug, sold from a storefront that shares its software with seven other brands.", "hash": "3682b3a8dce38dcc3a8cff89c62d328557c89e66346e15e7826239164a84df5a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rx-bella.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rx-com", "canonical": "https://thisglp.com/reviews/rx-com", "title": "Rx.com reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The figure set in the largest type is a six-month plan charged once.", "hash": "8fb7115fd1ca7e9f5cca34dbdd452c03b2919cd2c172e189dff9de40a6046ef0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rx-com.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rxion-health", "canonical": "https://thisglp.com/reviews/rxion-health", "title": "RxION Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The headline rate is the six-month rung, and the monthly plan asks for no term.", "hash": "43048b3ec6c4906250111c13709df26ab24029e9707898274525b97e010ab7cc", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rxion-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rxpepsdirect", "canonical": "https://thisglp.com/reviews/rxpepsdirect", "title": "RxPepsDirect reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The vial price is the smaller half of what an order costs, because a visit fee lands on every one.", "hash": "047eaf9163d7636e6817e1656bf2ee1d1e31a5658bafa6680fb8f4cf82bc70e0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rxpepsdirect.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rxpros", "canonical": "https://thisglp.com/reviews/rxpros", "title": "RxPros reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One advertised figure needs a year paid ahead, and the other is a first-month discount.", "hash": "332f101e5ce3f5c702609b169f9f262fbec43dc690d8cec4f12dcef273404577", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rxpros.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rxsaludable", "canonical": "https://thisglp.com/reviews/rxsaludable", "title": "RxSaludable reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Spanish and English telehealth brand whose semaglutide refill rate sits in its FAQ, not on its price cards.", "hash": "a53cf536e7aeb3c83c59487545492909219715d3a8e80f97a34537243797b77b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rxsaludable.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rxspan-md", "canonical": "https://thisglp.com/reviews/rxspan-md", "title": "RxSpan MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The catalog leads with the standing rate, not the discounted one.", "hash": "acafb6c5a5802820721d283050cb394aa3816870bd97d4d8e8f2a6064851a416", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rxspan-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/rylo-health", "canonical": "https://thisglp.com/reviews/rylo-health", "title": "Rylo Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The no-contract rate holds at every dose, and the filling pharmacy is named.", "hash": "7d1130021fa355c3d71de44426773ee03016ba43e9765ea4bec0e00490bdc602", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/rylo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ryze-rx", "canonical": "https://thisglp.com/reviews/ryze-rx", "title": "Ryze Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide is sold vial by vial, and the price climbs with the strength the prescriber writes.", "hash": "f0708158a8b17883dbbe0fdf2b2202e75bee6565188e7efc16b79e00d86424f7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ryze-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/science-and-co", "canonical": "https://thisglp.com/reviews/science-and-co", "title": "Science & Co reviews (2026): plans and ongoing care | This GLP", "description": "Science & Co describes ongoing provider contact and dose adjustments, but its current headline prices require a twelve-month plan.", "hash": "bf4c8cfc31b7b6d794eacd3799e2d4af87b45ce0df9c347d1ac21ae4b7d6402f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/science-and-co.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/semaglutide-online", "canonical": "https://thisglp.com/reviews/semaglutide-online", "title": "Semaglutide Online reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four billing rungs sit in one table, and the headline figure belongs to the five-month commitment.", "hash": "138514a76616dc5ace2c78016c41b908df09445088a7ce2a32af0b67613cc9e3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/semaglutide-online.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sesame-care", "canonical": "https://thisglp.com/reviews/sesame-care", "title": "Sesame Care reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised introductory rate covers two months at the two lowest doses, and it is still displayed past the end date its own terms give.", "hash": "9357483d7b4c7b98dc898562c949644ce6cd48b73ec50e8118bdf9b06e7ebf57", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/sesame-care.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sexymd", "canonical": "https://thisglp.com/reviews/sexymd", "title": "SexyMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The no-commitment plan ships four weeks at a time, which is thirteen fills a year.", "hash": "d487ef890ff9b337362dae7820e7581637eea083915848bfba5c0c907376f7b0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/sexymd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/shapein-rx", "canonical": "https://thisglp.com/reviews/shapein-rx", "title": "ShapeIn Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide is priced in two dose bands, and the product page adds an appointment fee and a shipping charge.", "hash": "558c53e98513803fbe705f5ba0e9bf6dbf670dcfbfba4a4c3b00fd2296316800", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/shapein-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/shapely", "canonical": "https://thisglp.com/reviews/shapely", "title": "Shapely reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The membership and the medication are two separate charges, and the site says so.", "hash": "7266a477c47bf62e23a2c5ac1c36c9b55884b11bb97ee19c9b256cd341277a22", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/shapely.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/shedrx", "canonical": "https://thisglp.com/reviews/shedrx", "title": "ShedRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The same page quotes the medication at $149 and at $349-499, and the membership at $99 and at $125, without ever reconciling either pair.", "hash": "6ccc4b4462c2e3490808ef3d46ece17ce5bd43621564176758ec71f6b29709de", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/shedrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/signos", "canonical": "https://thisglp.com/reviews/signos", "title": "Signos reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A compounded GLP-1 comes bundled with a glucose sensor, sold only on three- or six-month terms.", "hash": "375c323e9785f99ea71c681e1e5e28166ea32f69de97c868d46112a033a4ccf3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/signos.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/silhouette-md", "canonical": "https://thisglp.com/reviews/silhouette-md", "title": "Silhouette MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both injections are advertised as a lowest tier. Both tablets cost substantially more and carry no such qualifier.", "hash": "24398718a0cd70e2aa1f50a0d85354021b4800e27174b0fdf352d54dee4b6e7b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/silhouette-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sipra", "canonical": "https://thisglp.com/reviews/sipra", "title": "Sipra reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Sipra publishes the ingredients and formats in its compounded weight-loss range and describes ongoing side-effect support.", "hash": "5bcefc178576f90b9e3b100d7a079eddf7129d34fc03f37bc1350d9ddb8d617b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/sipra.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/skinnyrx", "canonical": "https://thisglp.com/reviews/skinnyrx", "title": "SkinnyRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The semaglutide injection publishes an opening month and no standing rate anywhere, while tirzepatide publishes a standing rate after its first month.", "hash": "026bd0df13c8d8173de5dcadeba0d3b86089ffdb3f6f842bcdc261bc0ad0643f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/skinnyrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/skyrx", "canonical": "https://thisglp.com/reviews/skyrx", "title": "SkyRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The asterisk on $199 resolves at the foot of the page, among the citations.", "hash": "3248fbe72e30fd953fbbf91d349690674baaadf4cdfc60350fea64ccaf4d22f6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/skyrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/snagrx", "canonical": "https://thisglp.com/reviews/snagrx", "title": "SnagRx reviews (2026): GLP-1 sellers by price | This GLP", "description": "Four billing cycles are published on each molecule, and the gap between the shortest and the longest is only thirty dollars a month.", "hash": "73ca0a72d7f4474542304143c1c3750c8861f5cea3ee802e5b900c87de99ac27", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/snagrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/society-of-you", "canonical": "https://thisglp.com/reviews/society-of-you", "title": "Society of You reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both injection cards lead with a first-month figure, and the standing rate is shown only after contact details are entered.", "hash": "0dd0017e1a8293a9d1666295b03d798461d0e8d7bc0ff0a31f99ff104fdf3eb6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/society-of-you.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/somi-health", "canonical": "https://thisglp.com/reviews/somi-health", "title": "Somi Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The seller states the flat-dose claim in its own capital letters, and prices its tablet at more than double the shot.", "hash": "20dc84e68318ba36fa73fcc8ccbd862dc186643c3adfaf39d0272ad338835007", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/somi-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/somira-health", "canonical": "https://thisglp.com/reviews/somira-health", "title": "Somira Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The price is stated as locked while the dose rises, on both plan lengths.", "hash": "9d49cd67c544902d6ae98063784071f786bc9f62f7240a3e409135d6adf31f31", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/somira-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sommar-club", "canonical": "https://thisglp.com/reviews/sommar-club", "title": "Sommar Club reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Sommar markets online compounded care for women. Confirm the clinical follow-up and dispensing pharmacy for the chosen program.", "hash": "b877d52c14bea1da1c575ac33f35bbf880fe932dc1537ed216313e0e4c309fd1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/sommar-club.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/southern-vitality-weight-loss", "canonical": "https://thisglp.com/reviews/southern-vitality-weight-loss", "title": "Southern Vitality and Weight Loss reviews (2026): GLP-1 telehealth sellers", "description": "Every plan is a one-time package, and none of them renews on its own.", "hash": "7098a8773374f64b7a89c51af67ba9dcfaa8b31a8c93c178b4e371f2be0c6765", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/southern-vitality-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sprout-health", "canonical": "https://thisglp.com/reviews/sprout-health", "title": "Sprout Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly plan bills every four weeks and the six-month plan bills by the calendar, which are different years.", "hash": "34c23be386c2018aa59df0d7a21c173337f010cf69b847add559d75845bd1399", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/sprout-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/spry", "canonical": "https://thisglp.com/reviews/spry", "title": "Spry reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two GLP-1 rates on the front page, billed on a four-week cycle the cards never mention.", "hash": "87ae98b61f9cadc607f5f6b08ed230a7ba7521f4b56683fe1d5fcb5fccf861cd", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/spry.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/stackmd", "canonical": "https://thisglp.com/reviews/stackmd", "title": "StackMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Five priced rungs on one molecule and six on the other, printed where a reader can find them before starting.", "hash": "26628963fb9e181aa7384f7cb66e8dffc54362ce252e9fcca312aa8a250c4a83", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/stackmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/stavemd", "canonical": "https://thisglp.com/reviews/stavemd", "title": "StaveMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "StaveMD advertises flat-dose treatment and a refund if no prescription is issued. Its introductory period and ongoing plan should be read separately.", "hash": "af8d98f5606ea0d4b375229ccf47a7ba205bd20ffc3da64314465d996ef8bcea", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/stavemd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/steady-state-health", "canonical": "https://thisglp.com/reviews/steady-state-health", "title": "Steady State Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Steady State Health places GLP-1 treatment within Josie Cowburn’s women’s health practice in Oregon and Washington. Medication is billed separately from membership.", "hash": "e9bf0d43f5204b4edca3c741569816b6e3308b4b6c94c8ed52171a3cdea965fe", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/steady-state-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/strut-health", "canonical": "https://thisglp.com/reviews/strut-health", "title": "Strut Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four advertised rates across two molecules, with an oral semaglutide at $99 a month.", "hash": "fd66f9c728f0f1de99524ab15b47c7836beb4dcbfd0c3d093cf3558cf823c1b1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/strut-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sumbare-wellness", "canonical": "https://thisglp.com/reviews/sumbare-wellness", "title": "Sumbare Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A single from-price covers two molecules and a microdose plan, so it describes none of them in particular.", "hash": "6ce5c986c21de08de5636a0b6c4b729ebdbcf6de63da48b90578a7c89244a26b", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/sumbare-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/sunlight", "canonical": "https://thisglp.com/reviews/sunlight", "title": "Sunlight reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A price-forever guarantee attached to a four-week fill rather than a calendar month.", "hash": "722e556a8ccecec11c5b4b76070c9455ef32f834c3ca47db5a8cd5289a064ca1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/sunlight.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/super-healthy-rx", "canonical": "https://thisglp.com/reviews/super-healthy-rx", "title": "Super Healthy Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Super Healthy Rx publishes compounded semaglutide and tirzepatide plans with physician review and ongoing support. The care relationship and subscription terms need equal attention.", "hash": "88d5b5cc213bf87dd5999543a0629b8b2120e5342c49b9873f4c287927006b0c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/super-healthy-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/superior-remedies", "canonical": "https://thisglp.com/reviews/superior-remedies", "title": "Superior Remedies reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The only number on screen names neither a drug nor a term, and the figures in the page data belong to a shared template.", "hash": "25525c25e0b4181d08991fa9581d43b263a9922debcee5ebd50b09acd52c0f8a", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/superior-remedies.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/superpower-health", "canonical": "https://thisglp.com/reviews/superpower-health", "title": "Superpower reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Semaglutide is sold only to members of a lab-testing service, and the membership fee is printed two different ways.", "hash": "c7921bf3b4ec9256be27145bdb03a6eb28ead4bc1711373f72b11d1fb7c4caf8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/superpower-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/surpassmd", "canonical": "https://thisglp.com/reviews/surpassmd", "title": "SurpassMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The figure depends on eligibility, medication, dose and provider approval, all stated.", "hash": "0f07e4e9cfd9871cb2afb2e2eeaa6ad56d05d77be0147ff8fb098a1a9a5cc588", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/surpassmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/synergenx", "canonical": "https://thisglp.com/reviews/synergenx", "title": "SynergenX Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A hormone clinic chain that sells compounded semaglutide online, with each visit priced apart from the medication.", "hash": "018926a44c76c05c74cdd5d4261ae0f95f8a0c0a5dab3a4fb96e3bf819bef228", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/synergenx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/synergy-rx", "canonical": "https://thisglp.com/reviews/synergy-rx", "title": "Synergy Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both molecules are priced in both forms, which most sellers in this category do not do.", "hash": "957c869242ee9dc076a737a0ea38b38194b0384e33606967f7d12258fc043b5c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/synergy-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/t2d", "canonical": "https://thisglp.com/reviews/t2d", "title": "T2D.com reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One price includes the prescriber; a second, lower one is for buyers who already have a prescription.", "hash": "13d6799b8f36a46a31568e98aeb6bfacc43d911a4ba6205a1262462f4c3547e5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/t2d.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tablet-health", "canonical": "https://thisglp.com/reviews/tablet-health", "title": "Tablet Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tablet Health lists oral and injected GLP-1 products. Its oral tirzepatide offering should not be mistaken for an FDA-approved version of an injectable brand.", "hash": "0091bf82f31cd2014e597986d707a46de9bb3df2fdf22f2422b34e0131a77c7f", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/tablet-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/td-teledoc", "canonical": "https://thisglp.com/reviews/td-teledoc", "title": "TD Tele-Doc Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Richmond weight-loss practice that runs its GLP-1 prescribing through insurance and weekly video visits rather than a cash price list.", "hash": "93d9fc4529b949eb8c0110fab3755b2588e96c5317226abb981394282e3a2667", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/td-teledoc.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/teladoc-health", "canonical": "https://thisglp.com/reviews/teladoc-health", "title": "Teladoc Health reviews (2026): virtual weight-management care | This GLP", "description": "Teladoc Health combines weight-management support with GLP-1 assessment where the member’s program includes prescribing. Coverage and care eligibility must be checked first.", "hash": "e3e677c9a98e91ccd01474c1a1f6e3dc002ba3b88589d25455fb3706474ed331", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/teladoc-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telecarespot", "canonical": "https://thisglp.com/reviews/telecarespot", "title": "TeleCareSpot reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A separate consult fee applies and is credited toward the package if the patient is approved.", "hash": "4a37120726b4bbbafca1310fce1a6e3f0bc4ad6fff1026a19288e84c67c6bf64", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/telecarespot.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/teleclinic", "canonical": "https://thisglp.com/reviews/teleclinic", "title": "TeleClinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each molecule starts on a discounted first quarter billed quarterly, and the standard monthly rate is stated beside it.", "hash": "2998b42f8480125d4f77aa43308067e5acb7edde36369873c55dd07ba83d2432", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/teleclinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/teledocs360", "canonical": "https://thisglp.com/reviews/teledocs360", "title": "TeleDocs360 reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "TeleDocs360 describes the evaluation and follow-up pathway, with a higher tirzepatide price at the top two doses.", "hash": "9f40db631920a73a5f790cb46c8e274470ff4d2f00b3cbe57286d7752919af14", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/teledocs360.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telehealth-med", "canonical": "https://thisglp.com/reviews/telehealth-med", "title": "TeleHealth Med reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A compounded GLP-1 storefront that promises one price for every dose and shows no figure before checkout.", "hash": "85462eba5f6c2b8989110ba190c04fe520bd5fb0d99211c8bcdbcb40039aa784", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/telehealth-med.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telehealth-weight-solutions", "canonical": "https://thisglp.com/reviews/telehealth-weight-solutions", "title": "TeleHealth Weight Solutions reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The opening charge buys about ten weeks, and refills afterwards depend on vial size.", "hash": "58073ed51aae6c82221c16f17f7292a59223ee552d26f4cdf1e89e0397348233", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/telehealth-weight-solutions.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/teleios-health", "canonical": "https://thisglp.com/reviews/teleios-health", "title": "Teleios Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Teleios Health advertises continuing support, but its exact monitoring schedule and narrow refund window need attention before treatment starts.", "hash": "6a920c32919997274111e96686b62fcf92ef12ef43424c5cf733cda189729175", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/teleios-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telepeptide", "canonical": "https://thisglp.com/reviews/telepeptide", "title": "TelePeptide reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every line publishes a month-to-month figure and three commitment rates, each stated as covering the evaluation, the prescription, the medication and the shipping — and no figure anywhere states a dose.", "hash": "7d79d4f1d184851f7bf751a5a3e8375d484cd6a90339781bd7fa0bd5a276ceb2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/telepeptide.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/teleslim-clinic", "canonical": "https://thisglp.com/reviews/teleslim-clinic", "title": "TeleSlim Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Chicago obesity-medicine practice that sells a monthly doctor subscription and sends the prescription to whichever pharmacy the patient chooses.", "hash": "2f24f29f9ad2c12e387569e1e5e2e094aceecc66b7c11cfe7d7269254e64137f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/teleslim-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telewellnessmd", "canonical": "https://thisglp.com/reviews/telewellnessmd", "title": "TeleWellnessMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "TeleWellnessMD offers a GLP-1 assessment and a location-dependent formulary. Its terms allow patients to request an outside pharmacy before completing an order.", "hash": "27d22860d9272bd415205dadf22fa0a1af9b7807e4aa336afe3ee203f1d2129f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/telewellnessmd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telezen-md", "canonical": "https://thisglp.com/reviews/telezen-md", "title": "TeleZen MD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A four-rung plan ladder on both molecules, with the month-to-month rate printed at the bottom of each card.", "hash": "fa242dad837b84cb2311049e447dfe144fb88c39092dd205484a5455bc532bf8", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/telezen-md.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tellherdoc", "canonical": "https://thisglp.com/reviews/tellherdoc", "title": "Tell Her Doc reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four physicians listed by NPI and four pharmacies by phone, beside one starting figure whose billing period is never given.", "hash": "3c6d099d3bb1ce609b6dc9e0c41ae873658a9b6eda33baab9a5955ec75ba88b4", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tellherdoc.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/telos-rx", "canonical": "https://thisglp.com/reviews/telos-rx", "title": "Telos Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised figures belong to the longest plan, and no monthly rate is published for either molecule.", "hash": "b7541673b5dc0c579b71dd5753155b4a93360fc17baa0b953b1b5491a9fbbbb0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/telos-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/the-aesthetic-concierge", "canonical": "https://thisglp.com/reviews/the-aesthetic-concierge", "title": "The Aesthetic Concierge reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A physician-led practice that bills semaglutide in five-week cycles, after a kick-off appointment that carries its own price.", "hash": "8cd927dd2d6eef45d9eb3db9827b413295f1341befff3f20b4c51b6dc0b1c227", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/the-aesthetic-concierge.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/the-calibrate-clinic", "canonical": "https://thisglp.com/reviews/the-calibrate-clinic", "title": "Oxford's Medical Weight Loss (The Calibrate Clinic) reviews (2026) | This GLP", "description": "A Lafayette practice that quotes a new-patient first month, then bills a flat rate that it says covers every dose.", "hash": "a7220e60146dd6250bcd4de4b21c338582fa83fd140111fbd4d7e401a5490c9c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/the-calibrate-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/the-edit", "canonical": "https://thisglp.com/reviews/the-edit", "title": "The Edit reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The first month is priced below the standing rate for a limited time, and only once.", "hash": "e8042d388287ca938f1375b55298f4ffefcac7f1735a373c7e57567475149649", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/the-edit.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/the-protocole", "canonical": "https://thisglp.com/reviews/the-protocole", "title": "The Protocole reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The Protocole lists compounded semaglutide and tirzepatide as four-week supplies, with a consultation credited toward an order if treatment proceeds.", "hash": "507d21b3df8a0d9c8eadcf9e15e190fc07616c94ab563f5aeff7b72162426baa", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/the-protocole.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/the-virtual-np", "canonical": "https://thisglp.com/reviews/the-virtual-np", "title": "The Virtual NP reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A nurse practitioner's telehealth practice that charges for the visit and bills brand-name medication separately.", "hash": "b6de3cedaa7ea3bdd866466df9c7add76bb23d14e7894740f996f3791281b772", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/the-virtual-np.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tidemedix", "canonical": "https://thisglp.com/reviews/tidemedix", "title": "TideMedix reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "TideMedix offers online GLP-1 assessment with semaglutide and tirzepatide pathways. Clinical approval, the actual formulation and ongoing costs must be confirmed after the opening offer.", "hash": "09db9e2f2b6b34e3a29c12c5ad027a30e196cafab4051aaf14c92d1af2ca7250", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tidemedix.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tmates", "canonical": "https://thisglp.com/reviews/tmates", "title": "TMates reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The format does not change the price, and every rung of the term ladder is published with its total.", "hash": "ff2ca55e89073815f4ecde6ab2134930914bf2d5e4b7ae3765c6fff5de443233", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tmates.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tom-weight-loss", "canonical": "https://thisglp.com/reviews/tom-weight-loss", "title": "TOM Weight Loss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A one-physician obesity medicine practice in Texas and Utah, with medication inside the monthly price.", "hash": "683a46d0855b8ccbc58e0811c787a515be770c61be05b5ac54fc12d373d9a95f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tom-weight-loss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tomorrow", "canonical": "https://thisglp.com/reviews/tomorrow", "title": "Tomorrow reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tomorrow names its compounded preparations and separates monthly from quarterly semaglutide purchases. Its order-cancellation terms deserve equal attention.", "hash": "0c3e8b7a636cf0c058ff070f6ce7522fb80e3fab7bd84e30fadbc9c028da40ff", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tomorrow.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tonik-wellness", "canonical": "https://thisglp.com/reviews/tonik-wellness", "title": "Tonik Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A hormone and longevity clinic that prices both molecules on three terms, with a month-to-month card beside the yearly one it advertises.", "hash": "cd3401ffd0b0cdffa06c155c7aff0a45d8ba890c181ab879c604b61541f57fdd", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tonik-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/totalrx", "canonical": "https://thisglp.com/reviews/totalrx", "title": "TotalRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "TotalRx describes a medication-inclusive program with independent prescribing networks and ongoing support.", "hash": "596d14ed1c7ec845b50adc15878336db3b7da3eb5a744ba917dccb51b17f34a3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/totalrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/totara-health", "canonical": "https://thisglp.com/reviews/totara-health", "title": "Totara Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Oral and injectable programs sit inside a broader telehealth marketplace. The intake format depends on the patient’s state.", "hash": "1e299bc453536c4f1fd4091362af72a9ce4194f27f0130bd0a5281a5bb71a0af", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/totara-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trally-meds", "canonical": "https://thisglp.com/reviews/trally-meds", "title": "Trally Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Trally describes clinical approval before the first charge and check-ins before later treatment orders. The public price and dose cards need careful confirmation for the actual prescription.", "hash": "775b10bb5aefa67ad50b0f37fbf1a46204d2bfc7e21ba8841ebbe85188164499", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trally-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/transcarent", "canonical": "https://thisglp.com/reviews/transcarent", "title": "Transcarent reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Transcarent provides weight-management support through employer and benefit arrangements. GLP-1 medication management depends on both clinical suitability and the coverage selected for the program.", "hash": "c096e3c2daacc5e8827a9e300c42a8ff80c06f4cff2a0c4eaa1e9122e1bc093c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/transcarent.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/transparent-meds", "canonical": "https://thisglp.com/reviews/transparent-meds", "title": "Transparent Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two GLP-1 lines priced beside four peptide programs, each card carrying its own pair of figures.", "hash": "52e1fb5198b06e4dab4b8b2d9b8801672bdfafeda81075f74f8e339cdf2244a7", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/transparent-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trava-health", "canonical": "https://thisglp.com/reviews/trava-health", "title": "Trava Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each product page prints a monthly price for every dose on the ladder, so the cost of titration is visible before intake.", "hash": "7592033f2226fe8aff81a494c45cf1d94d6b7e75aaca7f9ca172a3630eaeb714", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trava-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trellis-vitality", "canonical": "https://thisglp.com/reviews/trellis-vitality", "title": "Trellis Vitality reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A three-term price table at one price per dose, with the pharmacy and the medical group both named.", "hash": "768b43587ccd64999cfdd8340f07f79d30c4bb607d2ccc1d0db9442b2d1c5e6d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trellis-vitality.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trillium-meds", "canonical": "https://thisglp.com/reviews/trillium-meds", "title": "Trillium Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A pharmacy picker with its own table of plan totals under every pharmacy it lists.", "hash": "6dd277d1a431c4751eb7e45b45a5201c7324cd3366c939ab0f6c72595ca30d56", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trillium-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trimi-health", "canonical": "https://thisglp.com/reviews/trimi-health", "title": "Trimi Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both monthly figures here are an annual plan divided by twelve, charged in a single payment at the start.", "hash": "14bbb3f75457f1bde80449c8bb84153ab9a08e236caa79b00a98df0288a324e5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trimi-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trimrx", "canonical": "https://thisglp.com/reviews/trimrx", "title": "TrimRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The compounded tiles name a mechanism rather than a drug, the bundle prices have gone behind a quiz, and the first-month discount lands on the same figure as the standing rate.", "hash": "8e2b6f3feee140a1d0554742c95766617deb2ddfdb4d8a015d19a4100a692450", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trimrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trinity-meds", "canonical": "https://thisglp.com/reviews/trinity-meds", "title": "Trinity Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A flat monthly rate at every dose, printed beside a countdown and a promise of pricing for life.", "hash": "992900365516a8f6cee3b6aceb485dec07b28fa504fbee596e4cea78f9165a0c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trinity-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trt-kingdom", "canonical": "https://thisglp.com/reviews/trt-kingdom", "title": "TRT Kingdom reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "TRT Kingdom offers lab-informed weight-management care alongside hormone services. Its compounded GLP-1 categories need a named prescription and clear continuing-care terms.", "hash": "41ab0f1a3b6363572b2aabe4c47331fcf39fcf4f00f5e9a2c43c97e0fd574d15", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trt-kingdom.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trt-nation", "canonical": "https://thisglp.com/reviews/trt-nation", "title": "TRT Nation reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One tirzepatide rate, fixed at every dose, sold in three-month blocks.", "hash": "cf8ff3dbf07496451d4fa62c3fc04f1662e9d5158b2106d23a40fa291b940a8a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trt-nation.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tru2u", "canonical": "https://thisglp.com/reviews/tru2u", "title": "Tru2u reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Flat pricing across four lines, plus a combined product that pairs both molecules for $275.", "hash": "770974608a4f70e901a29a85f0f9b610b1f19a2dbddbe23af125ddd6e3b0b51d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tru2u.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trueme", "canonical": "https://thisglp.com/reviews/trueme", "title": "TrueMe reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The product page says no intake form is required before payment.", "hash": "1fde358fcdc60679551ec48a5335e40f5e07ef194ae0737e33f630c4b218bfb3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trueme.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/try-ageless", "canonical": "https://thisglp.com/reviews/try-ageless", "title": "Try Ageless reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The same product carries one price in the shop and a different one in the plan funnel, and which is cheaper depends on the line.", "hash": "b511ab59db5a1395816c06f62b461983df9cc96fc5c5ea04de81e3a95a2ac3d5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/try-ageless.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/trym-health", "canonical": "https://thisglp.com/reviews/trym-health", "title": "TRYM Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The menu leads to a daily rate, and the daily rate belongs to a twelve-month plan.", "hash": "afc5f282816167eec0e248fc5fc64e3b4d23a1f0fd80b8f44438439d228f2c54", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/trym-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tryozi", "canonical": "https://thisglp.com/reviews/tryozi", "title": "Tryozi reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The opening figure is the first four weeks, at half the standing rate.", "hash": "25f9b6730c9a35a43ccbc492665c19ce0f47b42cbc4ceff30f3ec04c620e7682", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tryozi.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tummala-health", "canonical": "https://thisglp.com/reviews/tummala-health", "title": "Tummala Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tummala offers compounded semaglutide with nutrition guidance and support. The treating practice and monitoring schedule need confirming.", "hash": "5223b47838cbe3995e4ce021c9c43d0f1234106e3b1315112289f6d530ba7449", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tummala-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tuyo-health", "canonical": "https://thisglp.com/reviews/tuyo-health", "title": "Tuyo Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two columns, compounded against brand-name, with the membership fee attached to only one of them.", "hash": "208eb34359f2b6c0d7345c9ef28aa9cb2a38c0e739a5c41048cdac321b7cb04d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tuyo-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/tyde-wellness", "canonical": "https://thisglp.com/reviews/tyde-wellness", "title": "Tyde Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A women's weight-loss program that names every compounding pharmacy it uses and prices each molecule with a single floor across two strengths.", "hash": "6f0a769dac2d58ffbcd75c91211fd4b4ee7d73a792c25f806f4ce44994171ee0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/tyde-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ur-meds", "canonical": "https://thisglp.com/reviews/ur-meds", "title": "UR Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A single starting figure for GLP-1 care, labeled limited-time, with no drug, dose or end date attached to it.", "hash": "e6ddd238778364521cbce92e52ebae28b589b31ea202a28f29eee26eb0c9488f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/ur-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/valhalla-vitality", "canonical": "https://thisglp.com/reviews/valhalla-vitality", "title": "Valhalla Vitality reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A broad telehealth catalog that shows its GLP-1 prices only to account holders, after sign-up.", "hash": "0d9384c918e84fb5ae155b6dff97643457eec9b42e0774aa986307b32b41e7c0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/valhalla-vitality.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vaylen", "canonical": "https://thisglp.com/reviews/vaylen", "title": "Vaylen reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every figure on the page is a twelve-month program paid upfront.", "hash": "72f543f89b521bdc9b8fd3c7b9265b4c22ba5ffbbdbfeac509d53d85f72e3e00", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vaylen.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vea-health", "canonical": "https://thisglp.com/reviews/vea-health", "title": "Vea Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Vea lists standard and microdose GLP-1 options alongside an iPhone app. Its own terms make the independent clinical practice responsible for prescribing decisions.", "hash": "0924214929c211099f2f1a4fada2a179b65b8de913fa8a295c1a932f183024d3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vea-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vela-rx", "canonical": "https://thisglp.com/reviews/vela-rx", "title": "Vela Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Vela offers compounded injections and provider messaging. Its product FAQ and terms disagree about cancellation notice.", "hash": "f200bc170bcbfbfa23b5809bdf5bc45ef44cb4906c47d39febbbe5343706bea0", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vela-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/velvet-rx", "canonical": "https://thisglp.com/reviews/velvet-rx", "title": "Velvet Rx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three GLP-1 cards priced for the first four weeks, with no renewal rate printed beside any of them.", "hash": "3beb2f6f6acb1b2cd9ca74ceda4ac3beb656623b6aca58721b317bd308f315bd", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/velvet-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/verge", "canonical": "https://thisglp.com/reviews/verge", "title": "Verge reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Verge names Telegra MD as its clinical group. Pharmacy transmission creates an important deadline for changing a prescription.", "hash": "b37eb18c898517dd36e94817fa86cb75deb0c9b21315f3c74b77283d90133bf2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/verge.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vevarx", "canonical": "https://thisglp.com/reviews/vevarx", "title": "VevaRX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The cards and the paragraph beneath them quote different numbers.", "hash": "3b011ebc7f2e365c1ef30ca9a0d7ffb05eae9d4f11558d9bb0407c08b5d7bdb6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vevarx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vida-health", "canonical": "https://thisglp.com/reviews/vida-health", "title": "Vida Health reviews (2026): virtual metabolic care | This GLP", "description": "Vida Health combines clinical assessment, dietitian care and behavioral support. GLP-1 prescribing depends on the available program, benefits and individual medical assessment.", "hash": "f9960c36809737e3083809601a9b2bbd5ced69e9f63a81271cb851204f789810", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vida-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vigormeds", "canonical": "https://thisglp.com/reviews/vigormeds", "title": "VigorMeds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Taking it under the tongue costs less here than taking it by injection.", "hash": "dbdbe7b26d2cec208f86438f75caaa1961338471a68d2ed028cf5d06a0cbf4c1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vigormeds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/virgo-meds", "canonical": "https://thisglp.com/reviews/virgo-meds", "title": "Virgo-Meds reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Virgo names OpenLoop and describes four-week check-ins while the dose is being established.", "hash": "fae007a51a02f167b32d05f5f0b3807d63828b8a802b5a12eca6af2132ce89c9", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/virgo-meds.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/virta-health", "canonical": "https://thisglp.com/reviews/virta-health", "title": "Virta Health reviews (2026): metabolic care programs | This GLP", "description": "Virta Health offers nutrition-centered metabolic care with GLP-1 prescribing in selected programs. Its medication and deprescribing pathways depend on the individual care plan.", "hash": "905a09e2bbcc9d3659a3ffc0cadd1545901571eb73987c07984289dc3fa5df4b", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/virta-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/virtualcare2go", "canonical": "https://thisglp.com/reviews/virtualcare2go", "title": "VirtualCare2Go reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One card covers three different molecules and tells you outright that which one arrives depends on what is in stock — a disclosure almost nobody else in this market volunteers.", "hash": "b3948561718faa495b500601d47891d9d21bd2cb927ad5a97920935ab18afd61", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/virtualcare2go.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vita-bella", "canonical": "https://thisglp.com/reviews/vita-bella", "title": "Vita Bella reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The hero figure carries an asterisk, and the asterisk names two charges beside it.", "hash": "41ee9ac6e072f4b366a463c9e192361cda88093828fb25cfa90a1e90edd8b0b1", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vita-bella.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vitafusions-iv", "canonical": "https://thisglp.com/reviews/vitafusions-iv", "title": "VitaFusions IV reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A Dallas IV practice selling two injectables across Texas, one price per drug at any dose.", "hash": "87786df45bf93ff693dda0b078398fd282cf64705fb02343a8cd794ecfbdd3d2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vitafusions-iv.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vitakey", "canonical": "https://thisglp.com/reviews/vitakey", "title": "Vitakey reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Vitakey promises continuity with the same provider. Verify the responsible practice, prescription and follow-up arrangements.", "hash": "2d2767c78d46934bec0712f911ef6911de8875600bf7eb5bb7e9d97d98e30ee3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vitakey.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vital-edge", "canonical": "https://thisglp.com/reviews/vital-edge", "title": "Vital Edge reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The daily capsule costs $151 less a month than the weekly injection.", "hash": "b5de2da26229da560ef3cfb1296c767dc8d4d4252e6fba0614cec3f4bc8d0f13", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vital-edge.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vital-step", "canonical": "https://thisglp.com/reviews/vital-step", "title": "Vital Step reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Vital Step identifies Dr. TelX as a clinical group and offers oral and injectable compounded treatment.", "hash": "dc9a2e82ae946b0e15ff3fc1894e2ba6ffbcba02395b20b0b6f63032b0bdc445", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vital-step.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vitalex-health", "canonical": "https://thisglp.com/reviews/vitalex-health", "title": "Vitalex Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One starting figure covers both molecules, and the site says the plan price is confirmed after provider review.", "hash": "374944d1a6973c6573146a77d8d457defe049de538107b4c05f0ad4a43c8f94a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vitalex-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vitara-rx", "canonical": "https://thisglp.com/reviews/vitara-rx", "title": "Vitara RX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Three figures for one semaglutide program on one site, and nothing that says which of them a buyer will be charged.", "hash": "73644fb9c1c73bd13feac478906407d7caf3770a40ebe9aad754769c7e08e208", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vitara-rx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vitastir", "canonical": "https://thisglp.com/reviews/vitastir", "title": "VitaStir reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The lowest listing covers one week, and the ladder above it climbs to nearly four hundred dollars.", "hash": "48134d6b754086e729d00c17cd502395f3c1aed15a81493c5968a22cf5c91d99", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vitastir.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vivanta-care", "canonical": "https://thisglp.com/reviews/vivanta-care", "title": "Vivanta Care reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Vivanta identifies a consultation step and a pharmacy partner. The public GLP-1 category leaves the actual treatment to be confirmed.", "hash": "b5f326579ce76af12b8883aee49552eb44f4b37e0dcf8bcaa7293b651422af58", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vivanta-care.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/viviomd", "canonical": "https://thisglp.com/reviews/viviomd", "title": "VivioMD reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "VivioMD names its pharmacy partners and offers care-team messaging. Its clinical follow-up schedule is less specific than the promise of access.", "hash": "b37fbc6618d0331601f5988aa1741cbb8582d3b13b0cd49fd9a647a91edd3a90", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/viviomd.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/voxy", "canonical": "https://thisglp.com/reviews/voxy", "title": "Voxy reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The figure in the headline belongs to the twelve-month plan, and every other rung is published beside it.", "hash": "bf44e29a83339195bf0e5d8917f3b93e57bc0780281ee040997d50570c66cf26", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/voxy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vyora-wellness", "canonical": "https://thisglp.com/reviews/vyora-wellness", "title": "Vyora Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two monthly figures, one per molecule, and a written promise that neither moves with the dose.", "hash": "141ce9c8dabf035e23f8c0a2ddc3686910dcfd3b9e4e4857ac3b726ae30873b3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vyora-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vyrarx", "canonical": "https://thisglp.com/reviews/vyrarx", "title": "VyrarX reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both figures are entry-tier, and maintenance-dose pricing is not disclosed.", "hash": "95bff3dd59aec49e21b8f7f08d3833244a28f5ff10847cb303cf0084b42b01eb", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vyrarx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/vytora-health", "canonical": "https://thisglp.com/reviews/vytora-health", "title": "Vytora Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A monthly price that stays put as the dose climbs, with prescribing handled by a named Florida medical group.", "hash": "0688e7836b03ac1f95f200ec5e2f61ae4d3785a1c8587d82dd3182bb39cf1858", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/vytora-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/walgreens-weight-management", "canonical": "https://thisglp.com/reviews/walgreens-weight-management", "title": "Walgreens Weight Management reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The pharmacy states each fill is a 28-day supply, which is thirteen fills a year rather than twelve.", "hash": "2cdb43ef603257098dcaac6a94dad31c3390081069d9ad6934fce63faac1756e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/walgreens-weight-management.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/weight-watchers", "canonical": "https://thisglp.com/reviews/weight-watchers", "title": "WeightWatchers Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every self-pay figure is footnoted to a separate membership the buyer cannot decline and whose price is given as a span rather than a number.", "hash": "4a8bdad270cecdb8b85adf2dd93d7818939b38bf5fbd3c7d6e8cc63fd32741be", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/weight-watchers.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/weightcare", "canonical": "https://thisglp.com/reviews/weightcare", "title": "WeightCare reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The monthly plan carries no commitment, and the longer tirzepatide terms cap the dose they cover.", "hash": "91d4f13d56a7060e602885b60b39889f84c7d88270af5bc68398b1dbea75728f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/weightcare.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/weightlessrx", "canonical": "https://thisglp.com/reviews/weightlessrx", "title": "WeightlessRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Every plan is a three-month supply, and the card is charged only after a clinician approves.", "hash": "3aa2915fe271d2270da5a726fdff6486e9ea0f25f2ae6059fea9bcb8efc5968e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/weightlessrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/weightrx", "canonical": "https://thisglp.com/reviews/weightrx", "title": "WeightRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Tirzepatide costs $83 and semaglutide costs $250, which reverses the usual order.", "hash": "2e1d61a9c1346a145324c19cfa3a5b068715bd4a2b1015dca0ac06c609af3689", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/weightrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/welling-health", "canonical": "https://thisglp.com/reviews/welling-health", "title": "Welling Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The medication carries no markup, and the margin is charged as a separate track.", "hash": "d2aecf7bed307dcc598f88f3eba5f47f60e683d08d9a2bfae09b1f00acd1ba6a", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/welling-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/wellmedr", "canonical": "https://thisglp.com/reviews/wellmedr", "title": "welludr. reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The wellmedr.com site now presents itself as welludr. Its weight-care offering includes compounded semaglutide and tirzepatide, with important differences between membership and medication-plan cancellation.", "hash": "ec3bba1477212e2fa10fb7753317451ce91658f86f7c86eac842c5a100520764", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/wellmedr.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/wellorithm", "canonical": "https://thisglp.com/reviews/wellorithm", "title": "Wellorithm reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The landing page and the checkout catalog publish different figures, and the bundle price is a first cycle only.", "hash": "0f9fe19abbbf27aa438e7713ebf373011928108d570468af32c3cf267eb15025", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/wellorithm.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/wellspring-longevity-clinic", "canonical": "https://thisglp.com/reviews/wellspring-longevity-clinic", "title": "Wellspring Longevity Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both lines are described as personalized and both figures say starts at.", "hash": "09eb95058d76cffda8f1315022a4dc59b15da81aa3c6124275f0611803d05aba", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/wellspring-longevity-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/wepeptiderx", "canonical": "https://thisglp.com/reviews/wepeptiderx", "title": "WePeptideRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The starting price is the first dose tier, and the monthly figure climbs with each step up the ladder.", "hash": "870d42bdb52b4239d66891a28a03091b1527946d1b64c3c59c097b9a256ad97d", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/wepeptiderx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/wholesome-clinic", "canonical": "https://thisglp.com/reviews/wholesome-clinic", "title": "Wholesome Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four products, each with its dose ladder printed rather than a single opening figure.", "hash": "359645630ee69deae8ecb9ee1df34742ab7a3d88836d31b12371ada3551d41b5", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/wholesome-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/whoosh-wellness", "canonical": "https://thisglp.com/reviews/whoosh-wellness", "title": "Whoosh Wellness reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Nothing is billed unless a prescription is approved, and the prepay tabs print totals where monthly rates appear.", "hash": "d3417c432c38ffee42ac50ff95cee48c1bfbc92d0c8d08f2415943ea9c46f817", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/whoosh-wellness.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/willow", "canonical": "https://thisglp.com/reviews/willow", "title": "Willow reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four compounded GLP-1 products at two monthly prices, with a dozen named physicians and a program aimed at women.", "hash": "7acb0d7abe5365763a1c864151ad81a14145d82ea805c593ab09b1cf12f6a89f", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/willow.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/wisp", "canonical": "https://thisglp.com/reviews/wisp", "title": "Wisp reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A daily sublingual drop at $225 a month, which the seller says has not yet been tested in the human body.", "hash": "98cd0d44e0934718943dce8bbe3cfdf9086deb213aaea1e90518a3de858e09c3", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/wisp.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/woodwork", "canonical": "https://thisglp.com/reviews/woodwork", "title": "Woodwork reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The advertised figure carries an asterisk, and the asterisk says forty-eight weeks.", "hash": "ffc812386e9e10497b51ac86a79702bb78966266e44c25be21b251c4e02170b6", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/woodwork.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/yes-clinic", "canonical": "https://thisglp.com/reviews/yes-clinic", "title": "Yes Clinic reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Yes Clinic makes the product and price structure relatively easy to identify. Clinical follow-up still deserves a direct conversation.", "hash": "e86b9adcc0cdc6ba0154aedfd694508dec0859de109241cf52e961a1a20b271b", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/yes-clinic.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/yourera", "canonical": "https://thisglp.com/reviews/yourera", "title": "YourEra reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Both advertised figures need six months, and no month-to-month rate is published for either.", "hash": "b0cc302545bf92f005023af72d9fe32f7803795b1a80067f5015de2a9ee67e7f", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/yourera.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/yourhealthrx", "canonical": "https://thisglp.com/reviews/yourhealthrx", "title": "YourHealthRx reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "One flat price regardless of dose, an oral option, and coverage in every jurisdiction.", "hash": "52fe46b7e795ced4591513614bd8f88122615601a6d31ba7975be4292fcc2420", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/yourhealthrx.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/yourx-health", "canonical": "https://thisglp.com/reviews/yourx-health", "title": "YOURx Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "YOURx offers physician-directed semaglutide within a wider longevity service. Its public pages describe different consultation formats, a detail worth resolving before enrollment.", "hash": "a080e17a06e1f16a01a6a4ffcfac64cc99bd807be61a5bdb3786314a42303176", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/yourx-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/youth-and-soul", "canonical": "https://thisglp.com/reviews/youth-and-soul", "title": "Youth & Soul reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Youth & Soul brings injections, lozenges and a spray into one menu. They are not interchangeable versions of a single medicine.", "hash": "41036c5bf89d5b17b7c9b8f902f9773b5d03eb9105a975b16eb6fb5174a45d5c", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/youth-and-soul.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/yucca-health", "canonical": "https://thisglp.com/reviews/yucca-health", "title": "Yucca Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A banner promises a rate for life, and the asterisk names the plan it belongs to.", "hash": "822838e8da02efdfb32d8c74f56ecb00b019f62b23571581249c7a0a48006d13", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/yucca-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/zappy-health", "canonical": "https://thisglp.com/reviews/zappy-health", "title": "Zappy Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Its lowest-priced plan holds the starting dose for three months.", "hash": "5300c71bee4dd29c2dd396494b2e689942e7b1762e39cf9abafdba7ecae175ed", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/zappy-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/zealthy", "canonical": "https://thisglp.com/reviews/zealthy", "title": "Zealthy reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "The ranked figure adds a recurring membership to a medication rate bought three months at a time.", "hash": "6f549a82bde071fd7b0ab28e219827ccff4555c60769eb60cdec6d7809223b24", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/zealthy.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/zenbody", "canonical": "https://thisglp.com/reviews/zenbody", "title": "Zenbody reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Zenbody identifies different pharmacies for its injections and tablets and describes continuing clinical contact. Route and monitoring deserve as much attention as the first-month discount.", "hash": "d5410b7f55350b4b92b63909b9e21ea9fd07ebcd329386416299134b91c630e0", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/zenbody.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/zera-health", "canonical": "https://thisglp.com/reviews/zera-health", "title": "Zera Health reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Each product page leads with a first-month figure and prints the monthly rate that follows it.", "hash": "6012cf9ae7e7a26631e27fded498f45b9e407048a1f07811cdc2b2c4442bdcad", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/zera-health.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/zeuss", "canonical": "https://thisglp.com/reviews/zeuss", "title": "Zeuss reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Two compounded injections sold as single 60-day purchases, with nothing renewed unless the buyer orders again.", "hash": "18687e67a6db0cb0f6736d01a9bfc8caf1439e2a02237c016e004d4e4f4e1f5e", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/zeuss.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/ziphealth", "canonical": "https://thisglp.com/reviews/ziphealth", "title": "ZipHealth reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "Four brand-name GLP-1 medicines with starting estimates, a separate clinical fee and final pricing from the pharmacy.", "hash": "60131a033b7185b086fd58106404dc6fb813c6bc3ac0aad23f1a7665e95f29b9", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/reviews/ziphealth.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "CreativeWork", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/reviews/zyp-medical", "canonical": "https://thisglp.com/reviews/zyp-medical", "title": "ZYP Medical reviews (2026): GLP-1 telehealth sellers | This GLP", "description": "A one-provider clinic near Omaha that prices each order by how long the vial will last, and prints the arithmetic.", "hash": "610e7b709fe4034d2f5a456893b235b5bc07ca360e545e8d5e24331991fabad2", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/reviews/zyp-medical.md", "schemaTypes": [ "Answer", "Article", "BreadcrumbList", "FAQPage", "ImageObject", "ListItem", "Organization", "Question", "WebPage", "WebSite" ] }, { "path": "/terms", "canonical": "https://thisglp.com/terms", "title": "Terms of Use | This GLP", "description": "The terms for using This GLP — what the site is, what it isn't, and the ground rules for reading and linking to it.", "hash": "5c983af6d69865167149a7048fa10e51135189e2c5ccb88a1c529db43e9c42d3", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/terms.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/tools", "canonical": "https://thisglp.com/tools", "title": "Tools | This GLP", "description": "Ten GLP-1 tools: a true monthly cost from any headline, the approved dose ladder, the five marks every seller is scored on, which of them publish a full dose ladder, and how many reach your state.", "hash": "ddcbb4de6d572d8d724d6f8a177428245c22d04260a3f3982f7591a0c537f6a0", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/tools.md", "schemaTypes": [ "ItemList", "ListItem", "Organization", "WebPage", "WebSite" ] }, { "path": "/tools/billing-cadence-check", "canonical": "https://thisglp.com/tools/billing-cadence-check", "title": "When a GLP-1 'month' is not a month | This GLP", "description": "A seller billing every four weeks charges thirteen times a year, not twelve. Every seller whose own pricing note names an interval other than a calendar month, with how many charges a year that implies.", "hash": "3b2a8899a20f60f4495c1df0cf2776baf12311bed6b49e9c7a3fc5c290777bcd", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/tools/billing-cadence-check.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/tools/coverage-by-state", "canonical": "https://thisglp.com/tools/coverage-by-state", "title": "GLP-1 coverage by state: providers and reviews | This GLP", "description": "Find GLP-1 providers with recorded coverage in your state. Filter by medication, read reviews and check source disclosures before enrolling.", "hash": "d4276e3fa3a3713ecef0e95c3529cddbeb750085e9a9ab87d2ec383f1760ca08", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/tools/coverage-by-state.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/tools/glp1-cost-calculator", "canonical": "https://thisglp.com/tools/glp1-cost-calculator", "title": "GLP-1 Cost Calculator: True Monthly Price | This GLP", "description": "See what a 'starting at' headline hides. Enter a monthly price, plan term and any up-front fee to get the true cost per month and total for the term — checked against real published GLP-1 prices.", "hash": "378cd1632cae821db853d0e2824777b8a4b6ecccb84d96b27a14c50ce29a41bf", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/tools/glp1-cost-calculator.md", "schemaTypes": [ "Organization", "WebApplication", "WebPage", "WebSite" ] }, { "path": "/tools/glp1-expected-weight-loss", "canonical": "https://thisglp.com/tools/glp1-expected-weight-loss", "title": "Expected Weight Loss on a GLP-1: the Spread, Not the Average | This GLP", "description": "Enter a starting weight and see the published distribution from STEP 1 and SURMOUNT-1 applied to it — how many participants reached each threshold, and how many did not.", "hash": "119cb0d8308c7e52adbe2b993ba7ce7c84f0c81c1654afce292dcb05ab04b829", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/tools/glp1-expected-weight-loss.md", "schemaTypes": [ "Organization", "WebApplication", "WebPage", "WebSite" ] }, { "path": "/tools/glp1-price-check", "canonical": "https://thisglp.com/tools/glp1-price-check", "title": "GLP-1 Price Check: Is What You Were Quoted Normal? | This GLP", "description": "Enter the monthly price a seller quoted you and see where it sits against every published GLP-1 price we hold — corrected for fees and terms, with the median and the range.", "hash": "d727c06e2c704977c620fcb4b767dda6957e43dd993578b96379d56c6888a050", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/tools/glp1-price-check.md", "schemaTypes": [ "Organization", "WebApplication", "WebPage", "WebSite" ] }, { "path": "/tools/glp1-titration-planner", "canonical": "https://thisglp.com/tools/glp1-titration-planner", "title": "GLP-1 Titration Planner: the Ladder, and What It Costs | This GLP", "description": "The approved week-by-week dose schedules for semaglutide and tirzepatide, read off the current labels — with the cost of climbing them at a flat seller against a dose-indexed one.", "hash": "27d64c476195672e22aa0551f9c102ff64b2d78ce02c047436fc06b77117a116", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/tools/glp1-titration-planner.md", "schemaTypes": [ "Organization", "WebApplication", "WebPage", "WebSite" ] }, { "path": "/tools/molecule-and-format-finder", "canonical": "https://thisglp.com/tools/molecule-and-format-finder", "title": "Which GLP-1 sellers offer a tablet, and which only inject | This GLP", "description": "Not every seller carries both molecules, and most carry one format. What each ranked seller lists by molecule and by form, so a reader wanting a tablet or wanting tirzepatide can stop reading the ones that cannot supply it.", "hash": "762d671fdb4fd731aebef64ec7db3470e432351fc081d48f659a1ac4abe43885", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/tools/molecule-and-format-finder.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/tools/published-dose-ladders", "canonical": "https://thisglp.com/tools/published-dose-ladders", "title": "Which GLP-1 sellers publish the whole dose ladder | This GLP", "description": "Saying a price rises with the dose is one disclosure; publishing what it rises to is another. Every seller whose own pricing note prints three or more rungs, so a buyer can price month six before enrolling.", "hash": "5f22b362a946a23acef9f381836f923fb8afce7433799de3d5467459e2d3a98c", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/tools/published-dose-ladders.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/tools/questions-they-leave-open", "canonical": "https://thisglp.com/tools/questions-they-leave-open", "title": "The questions GLP-1 sellers leave you to ask | This GLP", "description": "Counted across every seller ranked on this site: how many publish nothing about what the price does at a higher dose, nothing about where they ship, nothing about a second format — and the question to put to each one before ordering.", "hash": "77b7a51dd510170dc4400602482131a52bc5097fccba7b5ca6d8b682e2356444", "modified": "2026-10-28", "markdown": "https://thisglp.com/ai/tools/questions-they-leave-open.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/tools/what-sellers-publish", "canonical": "https://thisglp.com/tools/what-sellers-publish", "title": "What each GLP-1 seller actually publishes | This GLP", "description": "The five things this site scores every seller on — whether a price exists before you make an account, whether the headline is the billed figure, whether it holds across the dose ladder, where it ships and what it sells — as a single scorecard.", "hash": "be4a27815b1f772a8105295aa56cf9b43027b1cd5e3753eddfdff6d8b643ab47", "modified": "2026-10-26", "markdown": "https://thisglp.com/ai/tools/what-sellers-publish.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] }, { "path": "/trademarks", "canonical": "https://thisglp.com/trademarks", "title": "Trademarks | This GLP", "description": "Third-party product and company names on This GLP belong to their respective owners. Our use is nominative, for identification and comparison.", "hash": "9b7d344c777d253ed6cce098709c9f840acf6823e356dd4438fa18ca08e8adae", "modified": "2026-09-16", "markdown": "https://thisglp.com/ai/trademarks.md", "schemaTypes": [ "Organization", "WebPage", "WebSite" ] } ], "retired": [ { "path": "/research/a-cohort-that-checked-itself-twice", "canonical": "https://thisglp.com/research/a-cohort-that-checked-itself-twice", "hash": "af5715f575999005533e1767cc53e0621850c16bc91d80b2c37e71945b28c72f", "modified": "2026-10-21" }, { "path": "/research/a-fourth-drug-tested-in-one-country", "canonical": "https://thisglp.com/research/a-fourth-drug-tested-in-one-country", "hash": "9fa746ccc07f58850d5cecc797ccd1b61f5e14a88bbcd3430ea5a2a084ca27f9", "modified": "2026-10-21" }, { "path": "/research/a-heart-pump-and-a-result-without-numbers", "canonical": "https://thisglp.com/research/a-heart-pump-and-a-result-without-numbers", "hash": "8b4c5c259b080505f407c5d722868463f3e949bd7baf3a26172b28ecdeaf0893", "modified": "2026-10-21" }, { "path": "/research/a-mortality-number-that-cannot-be-right", "canonical": "https://thisglp.com/research/a-mortality-number-that-cannot-be-right", "hash": "565a8631f63789e77b365d02170e705652b7133067597ce8d4be0954cd8bb7ea", "modified": "2026-10-21" }, { "path": "/research/a-second-drug-to-hold-the-muscle", "canonical": "https://thisglp.com/research/a-second-drug-to-hold-the-muscle", "hash": "22f083ff4cb0e7ec3c3e5088509f01158603563bd1f99e9a759b3fce6db12d5c", "modified": "2026-10-21" }, { "path": "/research/a-study-that-checked-its-own-work", "canonical": "https://thisglp.com/research/a-study-that-checked-its-own-work", "hash": "7a606bb6d8dc74030b692f49b94c0bc4799db8828a5b92b1f3718b6518b60d80", "modified": "2026-10-21" }, { "path": "/research/a-tablet-to-hold-what-an-injection-took", "canonical": "https://thisglp.com/research/a-tablet-to-hold-what-an-injection-took", "hash": "928a19cf31b50a2969a0ba62438914fa89cb8e1e6d0ea7bf3300a04d7a16f4ec", "modified": "2026-10-21" }, { "path": "/research/a-trial-designed-to-tie-that-won", "canonical": "https://thisglp.com/research/a-trial-designed-to-tie-that-won", "hash": "071bff8678327d1c402ae35894120f4f71d2c65ebc0e3ba90bd0a842aaa5dc7e", "modified": "2026-10-21" }, { "path": "/research/a-trial-result-extrapolated-to-everyone", "canonical": "https://thisglp.com/research/a-trial-result-extrapolated-to-everyone", "hash": "980c55c37fda07179aa4faa0b1a3c32e7ab62b9081395a7d1fc0e832e2ea28b6", "modified": "2026-10-21" }, { "path": "/research/aspiration-after-a-stroke-procedure", "canonical": "https://thisglp.com/research/aspiration-after-a-stroke-procedure", "hash": "8c799093c248f1277daf531731980bccc1aa7d27d25727649542d3e8db77452b", "modified": "2026-10-21" }, { "path": "/research/bipolar-one-drug-not-the-class", "canonical": "https://thisglp.com/research/bipolar-one-drug-not-the-class", "hash": "732bc9e9a78fed921c1412c36d945db669c2d0c816c0ab4a2878629269159a63", "modified": "2026-10-21" }, { "path": "/research/clozapine-weight-and-what-came-back", "canonical": "https://thisglp.com/research/clozapine-weight-and-what-came-back", "hash": "70cc518224c9a6489f5c6691aa90c44380e4fc5f733ae3f2ee64eeb4d4e1a7e3", "modified": "2026-10-21" }, { "path": "/research/compounded-glp1-invisible-in-the-record", "canonical": "https://thisglp.com/research/compounded-glp1-invisible-in-the-record", "hash": "683b1d7b69231ee0ea2b25bbcabb5babd3edc02b75c22b0c0f5d87a25dae461c", "modified": "2026-10-21" }, { "path": "/research/compounded-semaglutide-starting-dose", "canonical": "https://thisglp.com/research/compounded-semaglutide-starting-dose", "hash": "d8de4fd15013d46adac61704bb921595ec6d482312f2c6a7b5e0d6a075cc71b7", "modified": "2026-10-21" }, { "path": "/research/crohns-and-the-outcome-that-bills", "canonical": "https://thisglp.com/research/crohns-and-the-outcome-that-bills", "hash": "63681e2eef5986026193abf316adf6c93033cae52915f5019318de0237317338", "modified": "2026-10-21" }, { "path": "/research/forty-thousand-pregnancies-and-one-unadjusted-signal", "canonical": "https://thisglp.com/research/forty-thousand-pregnancies-and-one-unadjusted-signal", "hash": "c12da4cb8b33864c93011ba6b55395cc04b36741d06c14de6584422ad761806a", "modified": "2026-10-21" }, { "path": "/research/glaucoma-a-comparison-with-no-baseline", "canonical": "https://thisglp.com/research/glaucoma-a-comparison-with-no-baseline", "hash": "bd5ae7f31cf0e50f2e3d4449faa5ea0e5287e4ecbb430f26efe27d6aa2384b53", "modified": "2026-10-21" }, { "path": "/research/glp1-af-ablation-two-cohorts", "canonical": "https://thisglp.com/research/glp1-af-ablation-two-cohorts", "hash": "a9efd5a8984644787a0090c6a31da1eaec50ba6be165096acc8362d149bf05da", "modified": "2026-10-21" }, { "path": "/research/glp1-and-cancer-risk", "canonical": "https://thisglp.com/research/glp1-and-cancer-risk", "hash": "1885f32a33177e52fbc94041d654f3645058d43c3181a6cb7310a4d926d17bd0", "modified": "2026-10-21" }, { "path": "/research/glp1-and-gastroparesis", "canonical": "https://thisglp.com/research/glp1-and-gastroparesis", "hash": "6ce1e70581599bccc494beb552478b47028fc50350f84618cefb104f724e40ac", "modified": "2026-10-21" }, { "path": "/research/glp1-and-hair-loss", "canonical": "https://thisglp.com/research/glp1-and-hair-loss", "hash": "f3b067d1f8acb87ec0239ecdffc57d6cfbc27d4f4abaf3e06699a2ba2001031a", "modified": "2026-10-21" }, { "path": "/research/glp1-and-knee-osteoarthritis", "canonical": "https://thisglp.com/research/glp1-and-knee-osteoarthritis", "hash": "fc2b15e45c382abadbc6e9029b3e69b58e7be454f5c050eb5e27530b33829a2f", "modified": "2026-10-21" }, { "path": "/research/glp1-and-pancreatitis", "canonical": "https://thisglp.com/research/glp1-and-pancreatitis", "hash": "04ba4f9214e6fc01e13615fd9325f060644a38b88d2b6e29628cbc5f551bd43b", "modified": "2026-10-21" }, { "path": "/research/glp1-and-sexual-function", "canonical": "https://thisglp.com/research/glp1-and-sexual-function", "hash": "3be9e4529709cdf6fb6df2fd793f474083a8c192cc7841ef9fe7709e67f4ae2d", "modified": "2026-10-21" }, { "path": "/research/glp1-and-taste", "canonical": "https://thisglp.com/research/glp1-and-taste", "hash": "234d38ce73c35bedef6790d62b5c93cdf45b67013ecfc18696fdbfc7678889c7", "modified": "2026-10-21" }, { "path": "/research/glp1-and-thyroid-cancer", "canonical": "https://thisglp.com/research/glp1-and-thyroid-cancer", "hash": "18afa9cac02e9117b3b5c2f85bf4f6f8fa77eabc91e522d710f0eb526423f00f", "modified": "2026-10-21" }, { "path": "/research/glp1-and-ulcerative-colitis", "canonical": "https://thisglp.com/research/glp1-and-ulcerative-colitis", "hash": "e77cb3b5535a89bf27ebd1b1f997ef6d8d6286ecda4cc645301ccbee1fff83cf", "modified": "2026-10-21" }, { "path": "/research/glp1-before-knee-replacement", "canonical": "https://thisglp.com/research/glp1-before-knee-replacement", "hash": "7fba6fbad673180bba2e28fc6cdbe96e96c9a32b0947dfc5a8133d67d3d860f9", "modified": "2026-10-21" }, { "path": "/research/glp1-bmi-threshold-china-taiwan", "canonical": "https://thisglp.com/research/glp1-bmi-threshold-china-taiwan", "hash": "97437c4838e694496dea272cd72f07b345e76ee96aa03184e1f378bb2d0825d6", "modified": "2026-10-21" }, { "path": "/research/glp1-breast-surgery-underpowered-null", "canonical": "https://thisglp.com/research/glp1-breast-surgery-underpowered-null", "hash": "10502edbff0e70a199f4677785c3df237c85afd12a09ea96dc7708a0cea6ce46", "modified": "2026-10-21" }, { "path": "/research/glp1-care-standards-vs-online-sellers", "canonical": "https://thisglp.com/research/glp1-care-standards-vs-online-sellers", "hash": "3a81bcdbe1e7733a2ff4357f5a206a042a3457f6c2ec8af3e2870fcf2a157ced", "modified": "2026-10-21" }, { "path": "/research/glp1-contrast-induced-kidney-injury", "canonical": "https://thisglp.com/research/glp1-contrast-induced-kidney-injury", "hash": "2cdfb0e8602834e1f8777a964a08eedf03759cbee50bc8fd7ce520d5bb98e391", "modified": "2026-10-21" }, { "path": "/research/glp1-copd-exacerbations-three-trials", "canonical": "https://thisglp.com/research/glp1-copd-exacerbations-three-trials", "hash": "92132314264f2e334a7d352bca4d3eb94141a5d9124ab84a2fed23ed08a4668e", "modified": "2026-10-21" }, { "path": "/research/glp1-diabetic-foot-reporting-ratio", "canonical": "https://thisglp.com/research/glp1-diabetic-foot-reporting-ratio", "hash": "336ef14ae52eddd966a553bf403969ecfc32369fc846d3bf274cd99112d97901", "modified": "2026-10-21" }, { "path": "/research/glp1-endothelial-function-two-answers", "canonical": "https://thisglp.com/research/glp1-endothelial-function-two-answers", "hash": "25973cfe796e670474e1afede3eadafeb6a50209d73eb0ce1871d7108370cf2a", "modified": "2026-10-21" }, { "path": "/research/glp1-hypertensive-pregnancy-disorders", "canonical": "https://thisglp.com/research/glp1-hypertensive-pregnancy-disorders", "hash": "ab1ec2950c55f76cce86289a7b3c085cc9b6c5d8615a9a9543230190e54ad9be", "modified": "2026-10-21" }, { "path": "/research/glp1-in-adolescents", "canonical": "https://thisglp.com/research/glp1-in-adolescents", "hash": "71b50ad78872d114960cfbbc44109dc35401bb5e6a50bb1f82f61d6f8f476f8f", "modified": "2026-10-21" }, { "path": "/research/glp1-in-menopause", "canonical": "https://thisglp.com/research/glp1-in-menopause", "hash": "2145df94f71ff5d1e7ea605c31bde0fcd706517ccfec84f1edaf444414068d96", "modified": "2026-10-21" }, { "path": "/research/glp1-liver-enzymes-review", "canonical": "https://thisglp.com/research/glp1-liver-enzymes-review", "hash": "c67945e6ebccb1f4d492d6c1e52fcb3a9fdcadc9cf435e18c99a9e128acffdd6", "modified": "2026-10-21" }, { "path": "/research/glp1-lose-lean-regain-fat", "canonical": "https://thisglp.com/research/glp1-lose-lean-regain-fat", "hash": "0d4cda6c1500f46e131aed16b9c79ce65f21478d2ab09eb6401d5c6d8bdf77f6", "modified": "2026-10-21" }, { "path": "/research/glp1-nausea-and-appetite-one-circuit", "canonical": "https://thisglp.com/research/glp1-nausea-and-appetite-one-circuit", "hash": "d3f56e6e05fb1c0003bec4f5fffd960a4b382490a3923921eebf3d6787f7ad1e", "modified": "2026-10-21" }, { "path": "/research/glp1-on-dialysis-evidence-base", "canonical": "https://thisglp.com/research/glp1-on-dialysis-evidence-base", "hash": "e23e8f355e5eb1a284a66c3f175bc0e7b3df2632521dcf4537051295c3c2e664", "modified": "2026-10-21" }, { "path": "/research/glp1-pancreatic-cancer-six-comparators", "canonical": "https://thisglp.com/research/glp1-pancreatic-cancer-six-comparators", "hash": "1dc2e42a3a965ab2a89e3dfb9edfe202fff9abbcb8c21d79c367cb1059d73ccf", "modified": "2026-10-21" }, { "path": "/research/glp1-parkinsons-risk-conclusion", "canonical": "https://thisglp.com/research/glp1-parkinsons-risk-conclusion", "hash": "7fe21bcc13205e421a9d05ad50f75dc30f28b4cf3175d8dbd0ad4e3a0f65bce5", "modified": "2026-10-21" }, { "path": "/research/glp1-serious-adverse-events-pooled", "canonical": "https://thisglp.com/research/glp1-serious-adverse-events-pooled", "hash": "9c3e3114b1e861c67a40fe72baed4d017d251e68e11cfe9614f15121ff687f9f", "modified": "2026-10-21" }, { "path": "/research/glp1-spinal-fusion-databases", "canonical": "https://thisglp.com/research/glp1-spinal-fusion-databases", "hash": "19ccd7d6dfb987e46a329a421947b8dc89d9271f556cc9172efbfe0263bd2f2c", "modified": "2026-10-21" }, { "path": "/research/glp1-vitamin-and-mineral-intake", "canonical": "https://thisglp.com/research/glp1-vitamin-and-mineral-intake", "hash": "ce6a1a15922b13b85f389a4ef62e6f5ab7c4031e9c1159cc4ec4a5582ddad63a", "modified": "2026-10-21" }, { "path": "/research/glp1-vs-sglt2-gout", "canonical": "https://thisglp.com/research/glp1-vs-sglt2-gout", "hash": "479bcb03cb39dd5cab9edb0adcdda3c933d8c847db4c0a6d97dc8f67c3cc01de", "modified": "2026-10-21" }, { "path": "/research/glp1-vs-sglt2-kidney-stones", "canonical": "https://thisglp.com/research/glp1-vs-sglt2-kidney-stones", "hash": "a3802ce87f2a025e17feba4519d37e417ee5c6b002fac100e5512ed7d4cf92c8", "modified": "2026-10-21" }, { "path": "/research/how-much-you-regain-decides-how-much-comes-back", "canonical": "https://thisglp.com/research/how-much-you-regain-decides-how-much-comes-back", "hash": "958c333a526dd569a24489ec71e8fb02f0b390aeb7eb68f868e260c34512ecd7", "modified": "2026-10-21" }, { "path": "/research/inflammation-fell-before-the-weight", "canonical": "https://thisglp.com/research/inflammation-fell-before-the-weight", "hash": "ffbc982bbcdb604cc3b35d98e50ce773b949c80d02c91b5a499dff5644a580bd", "modified": "2026-10-21" }, { "path": "/research/ketoacidosis-without-diabetes", "canonical": "https://thisglp.com/research/ketoacidosis-without-diabetes", "hash": "31ca647cb06390f77950f221cd9940afb8db9495e2112c1dc50343cc70ae8e78", "modified": "2026-10-21" }, { "path": "/research/metformin-cardiovascular-ranking", "canonical": "https://thisglp.com/research/metformin-cardiovascular-ranking", "hash": "d22bd9724583e73b80b75d4bc1514798833f3cedd2a6999ec75ce4a500a84450", "modified": "2026-10-21" }, { "path": "/research/obesity-documented-vs-measured", "canonical": "https://thisglp.com/research/obesity-documented-vs-measured", "hash": "4e12babdac23bf9de4b87dfb7c9fc6e20c047a70019f764c646cbbc5b8310a10", "modified": "2026-10-21" }, { "path": "/research/obesity-drugs-storefronts-do-not-sell", "canonical": "https://thisglp.com/research/obesity-drugs-storefronts-do-not-sell", "hash": "1e8833b28ce40baaa93c883686194b0a6c1a27139ca7c0cbaf985d6680ce20e9", "modified": "2026-10-21" }, { "path": "/research/obesity-low-testosterone-treatments", "canonical": "https://thisglp.com/research/obesity-low-testosterone-treatments", "hash": "580621eee8b4d52f44cbd8ae43da4e32650cb6f914e821457c3c57470d987e1e", "modified": "2026-10-21" }, { "path": "/research/older-adults-who-got-into-trials", "canonical": "https://thisglp.com/research/older-adults-who-got-into-trials", "hash": "62282cca818bb3bb1581b1d55530d9b7350636c87fcc2d5e478ce811c83c330d", "modified": "2026-10-21" }, { "path": "/research/one-lunch-measured-properly", "canonical": "https://thisglp.com/research/one-lunch-measured-properly", "hash": "d59a58973c2deb972cc085df1b391930ac074695dea880f2032b0f1be53232a3", "modified": "2026-10-21" }, { "path": "/research/oral-semaglutide-bioavailability", "canonical": "https://thisglp.com/research/oral-semaglutide-bioavailability", "hash": "a6ae812dcee374af8a3e3ff56deb2b29ff83adb8c993656a8d1347bfcf95b057", "modified": "2026-10-21" }, { "path": "/research/orforglipron-a-pill-without-a-needle", "canonical": "https://thisglp.com/research/orforglipron-a-pill-without-a-needle", "hash": "0c2781653edff7eb1cecc7ce5c12d0f673729c7c21a6f37540a551e506827641", "modified": "2026-10-21" }, { "path": "/research/psoriasis-a-composite-with-a-free-half", "canonical": "https://thisglp.com/research/psoriasis-a-composite-with-a-free-half", "hash": "fcf07d51d0a6d7e1daf0c9bd2ab7936bde7522b1d68d09daeab0ff774814c7b8", "modified": "2026-10-21" }, { "path": "/research/randomized-after-the-surgery-underdelivered", "canonical": "https://thisglp.com/research/randomized-after-the-surgery-underdelivered", "hash": "e6c19f36be18a74cc028278ab8fb0cf39b06b8bd46c6b42acb87867e1b2a2d13", "modified": "2026-10-21" }, { "path": "/research/reflux-one-drug-ran-the-other-way", "canonical": "https://thisglp.com/research/reflux-one-drug-ran-the-other-way", "hash": "b446883ea181f633012a95c2cf52fdb2a8b2c268157b1ef955f1e36e164deaf1", "modified": "2026-10-21" }, { "path": "/research/resistant-hypertension-same-pressure", "canonical": "https://thisglp.com/research/resistant-hypertension-same-pressure", "hash": "7b7623a64d8af73c582802e1ae5e2e0df862aced4f1d7830c448d263ed405e6e", "modified": "2026-10-21" }, { "path": "/research/retatrutide-cagrisema-not-for-sale", "canonical": "https://thisglp.com/research/retatrutide-cagrisema-not-for-sale", "hash": "a676f3b1e144d838b428ee09795f3af437f2b640f4030c562808715a8afdd435", "modified": "2026-10-21" }, { "path": "/research/rheumatoid-arthritis-one-component-moved", "canonical": "https://thisglp.com/research/rheumatoid-arthritis-one-component-moved", "hash": "a5d31bb254436604feb00aafcba67ea74af97fff6db4a6a348c287d6c2134036", "modified": "2026-10-21" }, { "path": "/research/same-percentage-different-kilograms", "canonical": "https://thisglp.com/research/same-percentage-different-kilograms", "hash": "6f0503d294df7d0d03d25dab10681952f640a3be6d4d85febb613167255072ec", "modified": "2026-10-21" }, { "path": "/research/scores-moved-toward-the-middle", "canonical": "https://thisglp.com/research/scores-moved-toward-the-middle", "hash": "ea099ca696bd158c88dca1d744f80c4925ff481058607cb670067ebfc110af38", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-a-dementia-risk-score", "canonical": "https://thisglp.com/research/semaglutide-and-a-dementia-risk-score", "hash": "168523a44e420f492ebfa20a64e54b1342d15e39b291beab5dcdc6014de31040", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-aging-clocks", "canonical": "https://thisglp.com/research/semaglutide-and-aging-clocks", "hash": "4b1b4ec700dbb1021babe9991288a35ec8f5662e7b309aed0bcba44adbf4b8f7", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-alcohol-use", "canonical": "https://thisglp.com/research/semaglutide-and-alcohol-use", "hash": "a5606792ee83f802a22b39be6448a4dcd50b4652bfdfd5c538e8ce2261e61ae7", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-diabetic-retinopathy", "canonical": "https://thisglp.com/research/semaglutide-and-diabetic-retinopathy", "hash": "ac8f3e2002556fe0fe293fc37eae47803d54dcc36c142921337e15eb7d482a0b", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-heart-failure", "canonical": "https://thisglp.com/research/semaglutide-and-heart-failure", "hash": "48e074e8d53d69daa5e55e811b6f8db9a1ed043b4c2996b49f3c3c368f02eca1", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-migraine", "canonical": "https://thisglp.com/research/semaglutide-and-migraine", "hash": "373dc8042225c4d017163b7e65a26ab0cfe994b9216043bb3a4918ef0503335e", "modified": "2026-10-21" }, { "path": "/research/semaglutide-and-sudden-vision-loss", "canonical": "https://thisglp.com/research/semaglutide-and-sudden-vision-loss", "hash": "20081033f0e5c1edcec1f24e1945d9fac0a50154003f02659f07e6b45c65e078", "modified": "2026-10-21" }, { "path": "/research/semaglutide-appetite-at-fourteen-months", "canonical": "https://thisglp.com/research/semaglutide-appetite-at-fourteen-months", "hash": "6e4b231c57ac0ea9280bdff2d3abad0df89782f85a662327bda6eed173bb4220", "modified": "2026-10-21" }, { "path": "/research/semaglutide-dry-mouth-and-teeth", "canonical": "https://thisglp.com/research/semaglutide-dry-mouth-and-teeth", "hash": "2682524ab7251d55ca1856be74854c50ef5a1e79dd23c103ad0c042dc6add1d5", "modified": "2026-10-21" }, { "path": "/research/semaglutide-hidradenitis-small-study", "canonical": "https://thisglp.com/research/semaglutide-hidradenitis-small-study", "hash": "9a9e90d511754f0e927d44505a10abb6d80359d2febc692e94d932d3b18a2c0b", "modified": "2026-10-21" }, { "path": "/research/semaglutide-kidney-egfr-and-muscle", "canonical": "https://thisglp.com/research/semaglutide-kidney-egfr-and-muscle", "hash": "863df9765bbbea4783ae0f836e3f68fd9a4769f75bdd0ed147203be8c991ac7e", "modified": "2026-10-21" }, { "path": "/research/semaglutide-liver-approval-fibrosis-stage", "canonical": "https://thisglp.com/research/semaglutide-liver-approval-fibrosis-stage", "hash": "61c7c9c9483a47957a2553646de654279ea3ec7ae917ea2cef368e9ed2f83642", "modified": "2026-10-21" }, { "path": "/research/semaglutide-seven-point-two-milligrams", "canonical": "https://thisglp.com/research/semaglutide-seven-point-two-milligrams", "hash": "8636a12306305c2032dc37d1099d96f0714861f9c296e86dc8fbe062b7605c05", "modified": "2026-10-21" }, { "path": "/research/semaglutide-videos-popularity-quality", "canonical": "https://thisglp.com/research/semaglutide-videos-popularity-quality", "hash": "bdf4e636712cdac57dd7862193526d1f656e01552c3cc8c0d4bab751e327f199", "modified": "2026-10-21" }, { "path": "/research/semaglutide-vs-testosterone-fertility", "canonical": "https://thisglp.com/research/semaglutide-vs-testosterone-fertility", "hash": "ab550d2ba04c1cf66ba03439c926d1200155ce2a8fa3e7d973e67b6d6aa1bb59", "modified": "2026-10-21" }, { "path": "/research/sickle-cell-a-population-rarely-studied", "canonical": "https://thisglp.com/research/sickle-cell-a-population-rarely-studied", "hash": "ebabbb31415a8c5b8e455803a5f8502983fdc4828dab55315075720201e5a5ea", "modified": "2026-10-21" }, { "path": "/research/six-cases-of-thiamine-deficiency", "canonical": "https://thisglp.com/research/six-cases-of-thiamine-deficiency", "hash": "84a294b44241f38be80c90a2c9a6989f7b20f2d15d04d3f5e7a5ba6c92fbbdb4", "modified": "2026-10-21" }, { "path": "/research/sixteen-percent-lower-six-hundredths-of-a-point", "canonical": "https://thisglp.com/research/sixteen-percent-lower-six-hundredths-of-a-point", "hash": "aaf656a1b840845ba5c5de94b6a71bea494cf48c703185484b34dbab7526a650", "modified": "2026-10-21" }, { "path": "/research/stopping-glp1-what-else-reverses", "canonical": "https://thisglp.com/research/stopping-glp1-what-else-reverses", "hash": "e7105051f12dcd006e9e35c6f0bd7e1814ef6809c5333a29d9dd28b615733996", "modified": "2026-10-21" }, { "path": "/research/the-authors-called-their-own-trial-underpowered", "canonical": "https://thisglp.com/research/the-authors-called-their-own-trial-underpowered", "hash": "b801111193ee1144ac2b45e6789eb8da52b411371ce0dd466eabfc558e84d016", "modified": "2026-10-21" }, { "path": "/research/the-combination-lost-to-its-own-ingredient", "canonical": "https://thisglp.com/research/the-combination-lost-to-its-own-ingredient", "hash": "ad0a1294090c02c8d50ef8eb49dc83a294cee3d3d4f74e3a7303969d9f4d38a0", "modified": "2026-10-21" }, { "path": "/research/the-comparator-was-what-doctors-actually-do", "canonical": "https://thisglp.com/research/the-comparator-was-what-doctors-actually-do", "hash": "3f7b363dc475ae0edc26cc22beda29ac9b46ee1ffd407af8cf5d5dbf32ff00d1", "modified": "2026-10-21" }, { "path": "/research/the-comparison-group-was-people-not-taking-it", "canonical": "https://thisglp.com/research/the-comparison-group-was-people-not-taking-it", "hash": "8db344a303360456689e975205f13a007f3cc6ad61c0da00598651dc2560cffb", "modified": "2026-10-21" }, { "path": "/research/the-drug-that-causes-this-made-it-better", "canonical": "https://thisglp.com/research/the-drug-that-causes-this-made-it-better", "hash": "5e79a0754540afc7621a6e7981951b248a6e1cdfd8b14ccd4b9735786bf55f2c", "modified": "2026-10-21" }, { "path": "/research/the-drug-that-lost-more-was-the-easier-one", "canonical": "https://thisglp.com/research/the-drug-that-lost-more-was-the-easier-one", "hash": "2b7d488ed48a6afe4683f5a75f23c86c1fc31cf572d68768965686cfedcfeba4", "modified": "2026-10-21" }, { "path": "/research/the-higher-dose-bought-eight-tenths-of-a-point", "canonical": "https://thisglp.com/research/the-higher-dose-bought-eight-tenths-of-a-point", "hash": "f5a257070d093e4bfc4f4ac85ca3f7e6229fa0e6cab715be4a5fb7079557f5e8", "modified": "2026-10-21" }, { "path": "/research/the-insulin-came-off-before-the-weight-did", "canonical": "https://thisglp.com/research/the-insulin-came-off-before-the-weight-did", "hash": "3d94ee423c58251998430cf93ba1d39c8e264b9612e7271386824ed17a4ca5bb", "modified": "2026-10-21" }, { "path": "/research/the-missing-comparison-finally-run", "canonical": "https://thisglp.com/research/the-missing-comparison-finally-run", "hash": "87ac40ac8a6b6e702b3f38e82edfa64a94e5c25a56e5c572637740475283d696", "modified": "2026-10-21" }, { "path": "/research/the-oral-one-is-approved-now", "canonical": "https://thisglp.com/research/the-oral-one-is-approved-now", "hash": "56a472d8c28bd40bd16347ee453977d4e371a4d87068c47f11603c14e71f4eb2", "modified": "2026-10-21" }, { "path": "/research/the-primary-outcome-said-no", "canonical": "https://thisglp.com/research/the-primary-outcome-said-no", "hash": "9e514eb556d40e97025c7202f089b2c8c42d87f51ac58ebe6199e9f7bb20e316", "modified": "2026-10-21" }, { "path": "/research/three-hormones-and-a-placebo-that-worked", "canonical": "https://thisglp.com/research/three-hormones-and-a-placebo-that-worked", "hash": "2f3087f568742673fe7a6261b1da6048b6917f1d1fa04dbbed5f311e37a98750", "modified": "2026-10-21" }, { "path": "/research/three-hundredths-of-a-quality-adjusted-life", "canonical": "https://thisglp.com/research/three-hundredths-of-a-quality-adjusted-life", "hash": "67060138e44b24473df905e1a988a316272ec6b14b6582a2209e7a9570f9be16", "modified": "2026-10-21" }, { "path": "/research/tirzepatide-against-semaglutide", "canonical": "https://thisglp.com/research/tirzepatide-against-semaglutide", "hash": "2f149c82d28a1a9781a250cd8e30324f55ac20465145d193243d6b39c05a20cb", "modified": "2026-10-21" }, { "path": "/research/tirzepatide-and-carpal-tunnel", "canonical": "https://thisglp.com/research/tirzepatide-and-carpal-tunnel", "hash": "6e8758038f0932a85f06354e959e64baa1486420a379208ca1d0b1d468de108f", "modified": "2026-10-21" }, { "path": "/research/tirzepatide-arrhythmia-intervals", "canonical": "https://thisglp.com/research/tirzepatide-arrhythmia-intervals", "hash": "7ae4bbf9086585d07b4075ea57e2986edb205f9ca922bec41bdd1f83481a3bc1", "modified": "2026-10-21" }, { "path": "/research/tirzepatide-sleepiness-score", "canonical": "https://thisglp.com/research/tirzepatide-sleepiness-score", "hash": "180f8428c0add8cf1d6940c95f986fcbd56a06ff8b5cb4e29d23553bad1300f5", "modified": "2026-10-21" }, { "path": "/research/tirzepatide-vs-dulaglutide-network", "canonical": "https://thisglp.com/research/tirzepatide-vs-dulaglutide-network", "hash": "2e4af16e2b9c91c46247b3e97f26949d5d9578c303a3e857760c6d9d636fc487", "modified": "2026-10-21" }, { "path": "/research/titration-and-nausea", "canonical": "https://thisglp.com/research/titration-and-nausea", "hash": "08eb7c51b0c0216df5254b57cf303ce32f05f9ad271131cd8e799e49f95c9511", "modified": "2026-10-21" }, { "path": "/research/what-sellers-will-not-tell-you", "canonical": "https://thisglp.com/research/what-sellers-will-not-tell-you", "hash": "ebb05b485c5156fbff5f545856e9620ff3da7511cffb10ea0ee2a89805d2d787", "modified": "2026-10-21" }, { "path": "/reviews/amp-health", "canonical": "https://thisglp.com/reviews/amp-health", "hash": "1fc33f37a7bee1f118d8f7855dbf7c6709c12a4065016c2bc941a13ab6cd8a66", "modified": "2026-10-21" }, { "path": "/reviews/bioglow-health", "canonical": "https://thisglp.com/reviews/bioglow-health", "hash": "22258beb4e0c65f5ebb77cc45bcfc92b0d21ced7cf9eb2746925812c2fbb8660", "modified": "2026-10-21" }, { "path": "/reviews/curve", "canonical": "https://thisglp.com/reviews/curve", "hash": "412fefbd8c2d976e2f4a4ed98f4d63e2707a9291c212cbad589d265ff02a1ecc", "modified": "2026-10-21" }, { "path": "/reviews/levity", "canonical": "https://thisglp.com/reviews/levity", "hash": "1e88edc414bae1dff758cc879a5067c06902ce48cf09e667988cd1b96255fdb0", "modified": "2026-10-21" }, { "path": "/reviews/magnolia-regenerative-medicine", "canonical": "https://thisglp.com/reviews/magnolia-regenerative-medicine", "hash": "97b3dd8ed3501d36e0b1fb993e7a1f72c872e822f839661ff543ce1aa18d02d1", "modified": "2026-10-21" }, { "path": "/reviews/nuvahealth", "canonical": "https://thisglp.com/reviews/nuvahealth", "hash": "d4bc8b48e537bf889f1161ea3b2b36f29e2a5299d58953a4a5561deb66d3f502", "modified": "2026-10-21" }, { "path": "/reviews/redboxrx", "canonical": "https://thisglp.com/reviews/redboxrx", "hash": "41d7672d086d4c7a0cfff01ed0bc528cbeff6b5c72f502f664221ab5a9ee28fe", "modified": "2026-10-21" } ] }